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Abstract 
 
The syntheses of natural products based on biogenetic hypotheses have the potential 
not only for giving access to short, elegant and efficient synthetic routes, but also to 
shine light on how nature constructs these breathtaking structures. This work, divided 
in three experimentally interconnected chapters, will highlight the importance of this 
approach with the syntheses of taiwaniaquinoid and icetexane natural products. 
 A protecting-group-free route to (−)-taiwaniaquinone F based on a 
Wolff-rearrangement ring contraction and subsequent aromatic oxidation of a sugiol 
derivative was deviced following a proposed biogenetic pathway. In addition, the first 
synthesis of (+)-taiwaniaquinol A is reported via short time exposure of 
(−)-taiwaniaquinone F to sunlight triggering a remote C−H functionalization. The 
hypothesis that the biogenesis of several methylenedioxy bridged natural products 
could proceed via similar nonenzymatic mechanisms is presented. 
 
 
 
 A divergent synthesis of thirteen members of icetexane natural products based 
on a proposed biogenetic cationic ring expansion of a reduced carnosic acid derivative 
is described. Among these members, (+)-salvicanol, (−)-cyclocoulterone, 
(−)-coulterone, (−)-obtusinone D, (−)-obtusinone E, and (−)-euolutchuol E are 
synthesized for the first time. Following this approach, an additional support to our 
methylenedioxy biogenetic hypothesis is reported via the photolysis of 
(+)-komaroviquinone to (−)-cyclocoulterone and (+)-komarovispirone. 
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 Preliminary results towards the mechanistic elucidation of the discovered 
remote C−H activation are outlined. Photolysis of a model substrate shows the 
formation of the methylenedioxy moiety for the first time on a non-natural quinone. 
Preliminary evidence that account for the formation of biradical species are given. 
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1.!Introduction 
1.1.!Natural products 
 
 “... everything that living things do can be understood in terms of the jiggling 
and wiggling of atoms”. 1  This statement of Feynman in 1963, shortly after the 
discovery of the double-helical structure of DNA, emphasizes how life can be 
described in terms of the structure and the reactivity of the natural products 
constituting the living organisms. 
 Metabolites are small organic compounds that derive from the metabolism, the 
chemical reactions taking place in living organisms. These organisms need to 
transform organic compounds from the environment in crucial molecules necessary 
for their survival, to grow, to develop normally and for reproducing.2 These reactions 
are performed by a regulated set of enzymes, which provide the organism with 
various metabolites (e.g. sugars, fatty acids, amino acids, and nucleic acids). Energy 
precursors of adenosine triphosphate (ATP) and building blocks for the construction 
of tissues are provided for this purpose. Not all organisms have the same ability to 
transform and synthesize primary metabolites equally. For instance, plants are very 
efficient in synthetizing primary metabolites from inorganic nutrients (soil) via 
photosynthesis.3 Animals rely on food degradation pathways to supply their organism 
with primary metabolites, whereas the rest is synthesized. However, most of these 
processes are common for the majority of organisms. 
 In contrast to these life-essential metabolites, another class, which is not 
required for the organism survival, is called secondary metabolites. However, these 
compounds are very important for the prosperity of the organism in its ecological 
context. The advantage of the produced secondary metabolites is not always known, 
                                               
1 Feynman, R. P.; Leighton, R. B.; Sands, M. The Feynman Lectures on Physics 
Addison Wesley, Reading, 1963. 
2  Dewick, P. M. "Secondary Metabolism: The Building Blocks and Construction 
Mechanism." Medicinal Natural Products a Biosynthetic Approach. 2nd ed. 
Chichester, West Sussex, England: Wiley, 2002. 7-8. Print. 
3  Smith, A. “Metabolism.” Plant Biology, Garland Science: 2009. 167-299. Free 
download from http://www.garlandscience.com/res/pdf/9780815340256_ch04.pdf 
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but it can be assumed that their synthesis confers benefit to the producers. Indeed, 
these metabolites can endorse various roles, such as repellant, attractant, defense 
chemical, and pigment, rendering the organism more competitive for the natural 
selection. Interacting with all types of biological targets, such as proteins, nucleotides 
and membranes of multiple organisms, the immense variety of these organic 
compounds is consequently a major source of pharmacologically active ingredients. 
Significantly less distributed in nature than their primary congeners, secondary 
metabolites are usually referred to as natural products (despite the fact that primary 
metabolites are natural product as well). As a matter of fact, natural products are only 
found in specific organisms or family of organisms and are even individually 
regulated depending on the environmental circumstances. For instance, carnosic acid 
was found in the leaves of Rosemarinus officinalis in highly variable amounts 
depending on the leave maturation, the season, and the growing origins (wild or 
cultivated).4 
 Terpenoids belong to one of the largest family of natural products. A linear 
presursor of terpenoids is geranyl pyrophosphate (GPP, 1.1, Scheme 1.1), 
biosynthetically obtained by a transferase mediated condensation of the activated 
monomers isopentenyl pyrophosphate (IPP, 1.2) and its isomer dimethylallyl 
pyrophosphate (DMAPP, 1.3). These building blocks originate from the primary 
metabolite acetyl-coenzyme A (AcSCoA, 1.4).5 Cyclization of GPP (1.1), mediated 
by a cyclase, leads to limonene (1.5), a precursor of monoterpenoids (C10). Two 
successive condensations of IPP (1.1) lead to the synthesis of farnesyl pyrophosphate 
(FPP, 1.6) and geranylgeranyl pyrophosphate (GGPP, 1.7). Cyclization of 1.6 and 1.7 
results in sesquiterpenoids (C15) such as germacrene A (1.8) and diterpenoids (C20) 
like abietadiene (1.9). Furthermore, coupling of two FPP (1.6) and two GGPP (1.7) 
provides the linear squalene (1.10) and lycopene (1.11), respectively, which, after 
cyclization, afford trideterpenoids (C30) such as hopene (1.12) and tetraterpenoids 
(C40) such as β−carotene. Additional condensation reactions allow the formation of 
polymers such as latex. 
 
                                               
4 Hidalgo, P. J.; Ubera, J. L.; Tena, M. L.; Valcárcel, M. J. Agric. Food Chem. 1998, 
46, 2624−2627. 
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Scheme 1.1: Biosynthetic overview of terpenoids5 
1.2.!Syntheses based on biogenetic hypotheses 
 
 In admiration of the grandeur of the biosynthesis of various natural products, 
chemists became interested in mimicking these routes to access the synthesis of 
several natural products belonging to the same family with elegance and efficiency.6 
In 1917, Robinson invented the concept of biomimetic synthesis with the synthesis of 
                                               
5  Review : Ajikumar, P. K.; Tyo, K.; Carlsen, S.; Mucha, O.; Phon, T. H.; 
Stephanopoulos, G. Mol. Pharmaceutics 2008, 5, 167−190. 
6 Skyler, D.; Heathcock, C. H. Org. Lett. 2001, 3, 4323−4324. 
Terpene
class
C10 
Mono-
terpenoids
C15 
Sesqui-
terpenoids
C20
Di-
terpenoids
C30
Tri-
terpenoids
C40
 Tetra-
terpenoids
Cn 
Poly-
terpenoids
OPP
DMAPP (1.3)
OPP
IPP (1.2)
IPP
- PPi
SCoA
O
OPP
GPP (1.1)
IPP
- PPi
OPP
FPP (1.6)
transferase
"Mg2+"
germacrene A (1.8)
IPP
- PPi
GGPP (1.7)
OPP
H
H
abietiadiene (1.9)
squalene (1.10)
H H
H
H
hopene (1.12)
latex
β-carotenelycopene (1.11)
limonene (1.5)
1.4
n
!Chapter 1 4 
tropinone (1.13) via a one-pot double Mannich reaction of succinaldehyde (1.14), 
methylamine (1.15) and calcium acetonedicarboxylate (1.16).7 
 
 
Scheme 1.2: Robinson’s synthesis of tropinone (1.13).7 
 The interest in this topic has dramatically increased in the scientific 
community over the last 15 years. This trend can be illustrated by the rising number 
of publications containing the concept “biomimetic synthesis” (Figure 1.1).8 
 
 
Figure 1.1: Analysis reference search by Research Topic on SciFinder® (19/05/15) using the entry: “biomimetic 
synthesis”.  
 A reaction or a sequence of reactions is qualified as biomimetic when it 
mimics a proposed biosynthetic pathway. 9  This definition, which is still used 
nowadays, can be problematic if the corresponding biomimetic reaction is based on a 
hypothetical biogenetic route. For example, if two successful biomimetic syntheses of 
                                               
7 R. Robinson, J. Chem. Soc. 1917, 111, 762−768. 
8 "Biomimetic Organic Synthesis: An Introduction." Biomimetic Organic Synthesis 
Ed. Erwan Poupon and Bastien Nay. Vol. 1. Weinheim: Wiley-VCH, 2011. XXIII-
XXIV. Print. 
9 Van Tamelen, E. E. Fortchr. Chem. Org. Naturst. 1961, 19, 242−290. 
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a natural product from the same organism are based on two distinct biosynthetic 
hypotheses, at least one of them does not mimic what nature actually does. Both 
metabolic pathways are indeed possible for the same natural product, however, not in 
the same organism. For instance, the biosynthesis of IPP (1.2) from AcSCoA (1.4) 
can be achieved via the so-called mevalonic acid pathway (e.g. in animals) and the 
non-mevalonic acid pathway (e.g. in green algea).10 This problematic was exemplified 
by a cause célèbre in this field: the biosynthesis of the polyether monensin 
(1.17, Scheme 1.4).10, 11  Initially, Westley and co-workers suggested that a multi-
epoxidation of polyalkene 1.18 would generate the tris-epoxide 1.19, which upon 
acidic conditions would furnish 1.17 via a polyepoxide opening cascade (Scheme 
1.3, A). 12  Alternatively, Basak and Towne proposed ten years later that a syn-
oxidative polycyclization of acetal 1.20 mediated by a cytochrome P450 would 
furnish monensin (1.17, Scheme 1.3, B).13 Formation of the hemiacetal-bound oxo 
metallate 1.21 followed by a [2+2] cycloaddition with the next double bond would 
generate the metallaoxetane 1.22. Final reductive elimination along with ring closure 
would give the tetrahydrofuran 1.23. Reoxydation of the metal center would 
regenerate an active metaloxo necessary for the next cyclizations. 
 
                                               
10  Review: De la Torre, M. C.; Sierra, M. A. Angew. Chem. Int. Ed. 2004, 43, 
160−181. 
11Koert, U. Angew. Chem. Int. Ed. 1995, 34, 298−300 
12  Cane, D. A.; Celmer, W. D.; Westley, J. W. J. Am. Chem. Soc.1983, 105, 
3594−3600. 
13 a) Townsend, C. A.; Basak, A. Tetrahedron 1991, 47, 2591−2602; b) McDonald, 
F. E.; Towne, T. B. J. Am. Chem. Soc. 1994, 116, 7921−7922. 
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Scheme 1.3: Biosynthetic hypotheses of monensin (1.17) by A) Westley12 and B) Basak-Towne.13 
  Neither of these hypotheses has been directly supported experimentally by the 
transformation of 1.18 or 1.20 to monensin (1.17). However, model substrate 1.24 and 
1.25 were successfully converted to the polyether product 1.26 (Scheme 1.4, A)14 and 
1.27 (Scheme 1.4, B)15, using in the first case m-CPBA followed by an basic/acid 
treatment of polyepoxy 1.28, and in the second case Re2O7 via a one pot tandem 
oxidative cyclization. Therefore, these “biomimetic” syntheses endorse two distinct 
biosynthetic hypotheses. 
                                               
14 Still, W. C.; Romero, A. G. J. Am. Chem. Soc. 1986, 108, 2105−2106. 
15 Sinha, S. C.; Sinha, A.; Sinha, S. C.; Keinan, E. J. Am. Chem. Soc. 1997, 119, 
12014−12015. 
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Scheme 1.4: Synthetic routes based on the A) Westley14 and B) Basak hypotheses.15 1) m-CPBA, NaHCO3; 
2) i. NaOH; ii. AcOH; 3) Re2O7, TFAA. 
 A more suitable description of a synthesis, which aims to support a 
biosynthetic hypothesis, should be consequently: a synthesis based on a biogenetic 
hypothesis. If such a synthesis is successfully carried out, only the corresponding 
hypothesis is supported, as other alternative pathways can also be endorsed 
experimentally. 
  The terminology biomimetic should be employed for a synthesis based on an 
accepted biosynthetic pathway. Indeed, establishment of biogenetic pathways are for 
example achieved by first identifying the gene cluster responsible for the synthesis of 
the natural product by gene knockout experiments and/or homology comparison.16 
Identification of the role of each gene followed by their expression constitutes the 
next steps. Incubations of the natural product precursors with each isolated enzyme 
would determine their role if the desired transformations were successfully carried 
out, thus validating the hypothesis. 
 The impressive structural diversity of natural products can partly be explained 
by the intrinsic reactivity of natural product precursors that will undergo 
self-assembling to create complex structures with a minimal (or non-) enzymatic 
participation.10 In fact, if each biosynthetic step towards a natural product would 
require an enzyme (without taking to account unspecific enzymes), the amount of 
genes encoding for them would be colossal. 17  Mimicking biosynthetic pathways, 
relying on the formation of such reactive precursors, would be easier than a fully 
enzymatic process. It is difficult to compete with the efficiency and selectivity of 
                                               
16 Li, H.; Zhang, Q.; Li, S.; Zhu, Y.; Zhang, G.; Zhang, H.; Tian, X.; Zhang, S.; Ju, J.; 
Zhang, C. J. Am. Chem. Soc. 2012, 134, 8996−9005. 
17 Review: Gravel, E.; Poupon, E. Eur. J. Org. Chem. 2008, 27−42. 
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enzymatic reactions, but it should not be concluded that such reactions can not be 
mimicked. 18  It could be envisaged that sunlight promoted photochemical and 
multi-component reactions, as well as inter- or intramolecular cycloadditions, are 
responsible for the synthesis of complex natural products in nature without or with 
minimal enzyme participation. The photosynthesis of vitamin D in the skin of animals 
is probably the best example of a sunlight-mediated biosynthesis that does not require 
any enzyme.19 Grandione (1.17) is an example of a dimeric natural product that was 
proposed to be biosynthetically produced via a Diels-Alder cycloaddition of the 
orthoquinone 1.18, which was obtained by oxidation of demethylsalvicanol (1.19).20 
This biogenetic hypothesis was supported synthetically by heating 1.18 to furnish 
grandione (1.17). A important example of a multi-component reaction, where such 
reactive intermediates are produced is the previously described Robinson synthesis.7 
 
 
Scheme 1.5: Biosynthetic hypothesis and the corresponding synthesis of grandione (1.17).20 The red arrows 
represents the proposed biosynthetic steps, the blue ones represents the synthetic ones. 
 The advantage of syntheses forming reactive intermediates is the ability to 
identify which step within a biosynthetic pathway is non-enzymatic. Indeed, these 
steps should be easily mimicked synthetically. In contrary, the steps, which required 
the use of specific reagent such as chiral Lewis acid (e.g. amino acids), could 
highlight an enzymatic route. Moreover, syntheses based on biogenetic hypothesis 
have proven to be very efficient in terms of preventing the use of protecting-groups.21 
                                               
18 Review: Baunach, M.; Franke, J.; Hertwerck, C. Angew. Chem. Int. Ed. 2015, 54, 
2604−2626. 
19 Holick, M. F. Am. J. Clin. Nutr. 2004, 80, 1678−1688. 
20  Aoyagi, Y.; Takahashi, Y.; Satake, Y.; Fukaya, H.; Takeya, K.; Aiyama, R.; 
Matsuzaki, T.; Hashimoto, S.; Shiina, T.; Kurihara, T. Tetrahedron Lett. 2005, 46, 
7885−7887. 
21 Jana, C. K.; Scopelliti, R.; Gademann, K. Chem. Eur. J. 2010, 16, 7692−7695. 
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2.! Total synthesis of taiwaniaquinone F and 
taiwaniaquinol A via an unusual remote C−H 
activation 
2.1.!Introduction 
2.1.1.! Taiwaniaquinoids 
 
Taiwaniaquinoids are natural products with a rearranged diterpenoid structure 
and were isolated first in 1995 by Cheng and co-workers 22  from Taiwania 
cryptomerioides, an evergreen tree occuring in Taiwan (Figure 2.1). 
 
 
Figure 2.1: Picture of Taiwania cryptomerioides by Prof. Dr. Karl Gademann (Brissago Islands, Switzerland). 
 Some members of this family were isolated later on from abietane-rich plants 
such as Salvia dichroantha23 and Thuja standishii.24 Although the biological activity 
of taiwaniaquinoids was not studied in detail, some of these compounds possess 
interesting biological properties. Standishinal (2.1, Figure 2.2), an aromatase inhibitor 
(enzymes involved in the synthesis of hormones) acts against breast cancer, as the 
                                               
22 Lin, W. H.; Fang, J. M.; Cheng, Y. S. Phytochemistry 1995, 40, 871−873. 
23 Kawazoe, K.; Yamamoto, M.; Takaishi, Y.; Honda, G.; Fujita, T.; Sesik, E.; and 
Yesilada, E. Phytochemistry 1999, 50, 493−497. 
24 Ohtsu, H.; Iwamoto, M.; Ohishi, H.; Matsunaga, S.; Tanaka, R. Tetrahedron Lett. 
1999, 40, 6419−6422. 
!Chapter 2 10 
growth of these cancerous cells is hormone dependent.25 Taiwaniaquinone D (2.2) and 
F (2.3) showed potent cytotoxicity against epidermoid carcinoma (KB) cancer cell 
lines. Their unsual 6-5-6 tricyclic core structure in combination with the aldehyde 
group is believed to be responsible for this activity.26 As common structural feature, 
they all possess a 6-5-6 carbon skeleton bearing a highly oxidized C ring. They are 
divided into two subclasses namely the C19 (e.g. taiwaniaquinol E (2.4) and 
dichroanone (2.5) isolated by Chang26 and Kawazoe,23 respectively) and C20 (e.g. 
taiwaniaquinone F (2.3) and taiwaniaquinone E (2.6) isolated by Kuo and co-
workers27  and by Lin et al.,28 respectively) taiwaniaquinoids, describing the numbers 
of C atoms in their carbon skeleton. Taiwaniaquinones display a quinone C ring in 
contrast to taiwaniaquinols, which have a phenolic C ring. Moreover, some members 
of this family are bearing a cis fused A/B ring like taiwaniaquinol B (2.7)22 while the 
majority displays a trans fused A/B ring such as taiwaniaquinone G (2.8).26 
Interestingly, taiwaniaquinol A (2.9) is so far the only taiwaniaquinoid bearing a 
methylenedioxy bridge22. Furthermore, more complex structures, such as 
taiwaniadduct C (2.10), a Diels-Alder cycloaddition adduct of taiwaniaquinone A 
(2.11) and transozic acid (2.12), were isolated from T. cryptomerioides.28  
 
                                               
25 Katoh, T.; Akagi, T.; Noguchi, C.; Kajimoto, T.; Node, M.; Tanaka, R.; Nishizawa, 
M.; Ohtsu, H.; Suzuki, N.; Saito, K. Bioorg. Med. Chem. 2007, 15, 2736−2748. 
26 Chang, C. I.; Chang, J. Y.; Kuo, C. C.; Pan, W. Y.; Kuo, Y. H. Planta Med. 2005, 
71, 72−76. 
27 Chang, C. I.; Chien, S. C.; Lee, S. M.; Kuo, Y. H. Chem. Pharm. Bull. 2003, 51, 
1420−1422. 
28 Lin, W. H.; Fang, J. M.; Cheng, Y. S. Phytochemistry 1996, 42, 1657−1663. 
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Figure 2.2: Structure of some representative taiwaniaquinoids (2.1 to 2.11) and trans-ozic acid (2.12). 
2.1.2.! Biogenetic hypotheses of taiwaniaquinoids 
 
 As the biogenesis of taiwaniaquinoids has not yet been investigated in detail, 
general hypotheses for the biosynthetic origin of the unusual 6−5−6 ring system have 
been proposed by our group29 and others,22,24,30 based on the structural features of 
isolated C20 diterpenoids (Scheme 2.1). The first three hypotheses postulate a 
dehydroabietane derivative (2.13) as the biosynthetic precursor. Cheng and co-
workers proposed, a Pinacol rearrangement of the diol 2.14 to access the ring-
contracted aldehyde 2.15 via the formation of the benzylic carbocation 2.16.22 
However, Alvarez-Manzenada and co-workers30 recently assessed this hypothesis by 
treating a diol like 2.14 with different acids. Unfortunately, they only isolated a 
                                               
29 (a) Jana, C. K.; Scopelliti, R.; Gademann, K. Synthesis 2010, 2223−2232; (b) Jana, 
C. K.; Scopelliti, R.; Gademann, K. Chem. Eur. J. 2010, 16, 7692−7695. 
30  Tapia, R.; Guardia, J. J.; Alvarez, E.; Haidöur, A.; Ramos, J. M.; Alvarez-
Manzaneda, R.; Chahboun, R.; Alvarez-Manzaneda, E. J. Org. Chem. 2012, 77, 
573−584. 
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dehydrated product. In 1999, Tanaka and co-workers reported the co-isolation of 
dialdehyde 2.17 and standishinal (2.1). They proposed that 2.17, derived from a 
C6-C7 oxidative cleavage of 2.13 is biosynthetically converted to standishinal 
(2.1) by a Prins-type reaction.24 This hypothesis was experimentally supported by 
converting 2.17 to 2.1, using BF3!OEt2 in CH2Cl2.24 The Gademann group recently 
proposed that C19 taiwaniquinoids could be biosynthetically accessed via a benzylic 
acid rearrangement of a suitably oxidized ferruginol or abietane C20 substrate.29 This 
hypothesis is the only one that could explain the formation of such nor-diterpenoids. 
Proposed was that the key step of this reaction is an external base facilitated 
intramolecular benzilic acid rearrangement of hydroxydiketone 2.18, followed by a 
decarboxylation to furnish C19 taiwaniaquinoids. 
 
 
Scheme 2.1: Biosynthetic hypotheses for taiwaniaquinoids. 
 To validate this hypothesis, hydroxydiketone 2.18, obtained by an 
over-oxidation of 2.13 using Sharpless dihydroxylation conditions, was treated with 
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benzilic acid rearrangement. Decarboxylation of the lactone intermediate gave 
hexahydrofluorenone 2.19, which was then utilized for the total synthesis of 
taiwaniaquinone H and dichroanone (2.5). Moreover, access to cis fused A/B ring 
taiwaniaquinoids, such as 2.7, could be envisaged. Finally, based on the abietanes 
isolation work of Zhang and co-workers31, Alvarez-Manzenada et al. suggested that 
an oxidation of ferruginol via a hydride transfer to NAD+ (2.19) produces the reactive 
para-quinone methide 2.20. Oxidative cleavage of the C7-C8 bond in the presence of 
singlet oxygen (1O2), furnished the new seco-dipernoid 2.21. An intramolecular 
1,4-addition of the enol aldehyde of 2.21 to the quinone moiety would afford the 
C6-C11 bond of the newly formed C20 taiwaniaquinoid 2.22.30 
 The last hypothesis by Alvarez-Manzaneda30 relies on an intramolecular 
1,4-addition, which, according to the Baldwin’s rules for ring closure, would be a 
disfavored 5-endo-trig ring closure.32 Even though, a disfavored ring closure could 
still proceed, yet is unlikely, a favored ring closure reaction is possible. Indeed, the 
same enolate 2.23 can react in an intramolecular 1,2-addition with the quinone moiety 
via a favored 5-exo-trig to furnish the C6−C8 tertiary alcohol 2.24. Dehydration of 
2.24 would give the para-quinone methide 2.25, which upon tautomerization, would 
furnish the aromatic alkene 2.26. Such an advanced intermediate could be used for the 
synthesis of the related natural product 2.2. Moreover, the synthesis of the 6-5-6 ring 
system by Alvarez-Manzenada (section 2.1.3.2) contains a 5-exo-trig ring closure 
instead of a 5-endo-trig process. This finding supports the exo-pathway rather than the 
endo one. 
 
Scheme 2.2: Hypothetical biosynthetic step towards 2.2 and 2.22 utilizing a 5-exo-trig ring closure and a 5-endo-
trig,30 respectively. 
                                               
31 Chen, X.; Ding, J.; Ye, Y.-M.; Zhang, J.-S. J. Nat. Prod. 2002, 65, 1016−1020. 
32 Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734−736. 
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2.1.3.! Previous syntheses of taiwaniaquinoids 
2.1.3.1.! Main Strategies 
 
 The rare 6-5-6 ring skeleton of taiwaniaquinoids, coupled with their wide-
ranging stereochemical and functional group variety, in combination with promising 
biological activities and intriguing biogenetic origins, make these compounds 
challenging targets. Indeed, these compounds attracted considerable interest from 
both isolation and synthetic chemists alike, and several syntheses of members of this 
family have been reported.25,29a,29b,33 
 Five mains strategies were used to build the challenging 6-5-6 tricyclic core, 
whereas the AC−ABC approach was the most extensively studied one. 
a)! The AC-ABC approach 
 
 This predominant strategy for the synthesis of taiwaniaquinoids was 
accomplished through the coupling of the A ring with the C ring, followed by the 
construction of the B ring. Trauner and co-workers33g, which named these compounds 
“taiwaniaquinoids” for the first time, connected the C ring (2.27) with β-cyclocitral 
(2.28) via a Li/Br exchange followed by an addition to the aldehyde. The resulting 
                                               
33 (a) Banerjee, M.; Mukhopadhyay, R.; Achari, B.; Banerjee, A. K. Org. Lett. 2003, 
5, 3931−3933; (b) Fillon, E.; Fishlock, D. J. Am. Chem. Soc. 2005, 127, 
13144−13145; (c) Planas, L.; Mogi, M.; Takita, H.; Kajimoto, T.; Node, M. J. Org. 
Chem. 2006, 71, 2896−2898; (d) Banerjee, M.; Mukhopadhyay, R.; Achari, B.; 
Banerjee, A. J. Org. Chem. 2006, 71, 2787−2796; (e) McFadden, R. M.; Stoltz, B. 
M. J. Am. Chem. Soc. 2006, 128, 7738−7739; (f) Bhar, S. S.; Ramana, M. M. V. 
Tetrahedron Lett. 2006, 47, 7805−7807; (g) Liang, G.; Xu, Y.; Seiple, I. B.; 
Trauner, D. J. Am. Chem. Soc. 2006, 128, 11022−11023; (h) Li, S.; Chiu, P.; 
Tetrahedron Lett. 2008, 49, 1741−1744; (i) Tang, S.; Xu, Y.; He, J.; He, Y.; Zheng, 
J.; Pan, X.; She, X. Org. Lett. 2008, 10, 1855−1858; (j) Alvarez-Manzaneda, E.; 
Chahboun, R.; Cabrera, E.; Alvarez, E.; Haidöur, A.; Ramos, J. M.; Alvarez-
Manzaneda, R.; Charrah, Y.; Es-Samti, H. Org. Biomol. Chem. 2009, 7, 5146−5155; 
(k) Alvarez-Manzaneda, E.; Chahboun, R.; Cabrera, E.; Alvarez, E.; Haidöur, A.; 
Ramos, J. M.; Alvarez-Manzaneda, R.; Hmamouchi, M.; Es-Samti, H. Chem. 
Commun. 2009, 592−594; (l) Alvarez-Manzaneda, E.; Chahboun, R.; Cabrera, E.; 
Alvarez, E.; Haidöur, A.; Alvarez-Manzaneda, R.; Meneses, R.; Es-Samti, H.; 
Fernàndez, A. J. Org. Chem. 2009, 74, 3384−3388; (m) Majetich, G.; Shimkus, J. 
M. Tetrahedron Lett. 2009, 50, 3311−3113; (n) Alvarez-Manzaneda, E.; Chahboun, 
R.; Alvarez, E.; Tapia, R.; Alvarez-Manzaneda, R. Chem. Commun. 2010, 
9244−9246; (o) Liao, X; Stanley, L. M.; Hartwig, J. F. J. Am. Chem. Soc. 2011, 133, 
2088−2091; (p) Yan, X.; Hu, X. J. Org. Chem. 2014, 79, 5282−5286. 
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allylic alcohol was oxidized by DMP to enone 2.29 (Scheme 2.3). A Nazarov 
cyclization of 2.29 to 2.30, bearing the desired 6-5-6 skeleton, was achieved using 
TMSOTf. Completion of the synthesis of taiwaniaquinol B (2.7) was achieved 
through a selective C14 demethylation using BCl3 followed by CAN oxidation to give 
a 2-methoxy-1,4-quinone. Reduction of the later one through a Na2S2O4 aqueous 
work-up yielded the natural product. 
 
 
Scheme 2.3: Trauner’s synthesis of taiwaniaquinol B: 33g 1) n-BuLi, then 2.28; 2) DMP; 3)TMSOTf; 4) BCl3; 
5) i. CAN, ii. Na2S2O4. 
b)! The A+C-ABC approach 
 
 This strategy is related to the first one as the A and C ring are coupled in the 
view of forming the B ring. The difference in the synthesis is the single step 
construction of the taiwaniaquinoid skeleton. The She approach33i of the formal 
synthesis of the same natural product 2.7 includes a domino Friedel-Crafts 
acylation/alkylation reaction to give the same intermediate 2.30 (Scheme 2.4). This 
domino reaction was initiated by treating 2.31 and 2.32 with Eaton’s reagent 
(CH3SO3H/P2O5). 
 
 
Scheme 2.4: Formal synthesis of taiwaniaquinol B by She.33i 
c)! The C-ABC approach 
 
 This approach exploited by Fillon and co-workers for the synthesis of 2.7 
features the construction of the 6-5-6 cyclic skeleton 2.30 in one step, starting with 
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the C ring 2.33 via a domino Friedel-Crafts acylation/alkylation protocol (Scheme 
2.5) similar to the previously discussed strategy (see Scheme 2.4). Formation of the 
ketene 2.34 from Meldrum’s acid type 2.33 is believed to be a key intermediate for 
the acylation/alkylation domino reaction, which upon acidic work-up, affords the 
decarboxylated product 2.30. 
 
 
Scheme 2.5: Fillon’s synthesis of taiwaniaquinol B.33b 
d)! The A-AB-ABC approach 
 
 Alvarez-Manzaneda’s approach33k for the synthesis of taiwaniaquinone G (2.8, 
Scheme 2.6), involves the stepwise synthesis of the B and C ring from the A ring. The 
synthesis started from the commercially available (+)-sclareolide (2.35). The A ring 
2.36 was obtained from inexpensive 2.35 through the following steps: (1) reduction of 
the lactone moiety to a diol; (2) treatment of this diol using Appel conditions 
simultaneously converting the primary alcohol moiety to a primary alkyl iodide and 
the tertiary alcohol moiety to the quaternary double bond by dehydration; 
(3) ozonolysis of the double bond provided the desired substituted A ring 2.36, ready 
for cyclization (Scheme 2.6). Indeed, a DBU catalyzed 5-exo-trig aldol reaction 
followed by a HI elimination lead to tertiary alcohol 2.37. A difficult dehydration 
under harsh acidic conditions followed by the TMSOTf treatment of the acetyl moiety 
gaving triene 2.38. A 6π-electrocyclization of this triene allowed the formation of the 
6-5-6 tricyclic core (2.39). An methyl ester was then introduced at C13 by using 
NCCO2Me and LDA. The C ring was aromatized using DDQ. Final alkylation of the 
ester moiety with MeMgBr was followed by a reduction of the resulting benzylic 
alcohol furnishing the desired taiwanaiquinoid skeleton phenol 2.40, which was 
further transformed to taiwaniaquinone G. This synthesis represents one of the few 
approaches to access taiwaniaquinoids containing such trans fused A/B ring systems. 
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Scheme 2.6: Alvarez-Manzaneda’s synthesis of taiwaniaquinone G:33k 1) KBH4; 2) I2, PPh3; 3) O3; 4) DBU; 
5) H2SO4; 6) TMSOTf; 7) 80 °C; 8) LDA, then NCCO2Me; 9) DDQ; 10) MeMgBr; 11) Et3SiH, TFA. 
e)! The A-ABC approach 
 
 Finally, the last synthetic strategy employed by Hu and co-workers resemble 
to the Fillon’s C−ABC approach in the sense that two new rings are formed 
simultaneously from an already established one (Scheme 2.7). The synthesis of 
taiwaniaquinone H (2.41) started with β-cyclocitral (2.28), which was treated with 
ethynylmagnesium bromide, followed by t-BuLi. The resulting alkyne lithium reacted 
with 2.42 to give the diol 2.43 in a one pot reaction. A thermal electrocyclic ring 
opening/ring-closure cascade of 2.43 was then performed giving the C ring 2.44 
probably via ketene 2.45. The mechanism is suggested to proceed through a biradical 
species.34 Under thermal conditions only, the formation of the B ring of 2.41 was not 
observed. However, with addition of TiCl4 to the reaction mixture after the thermal 
treatment, resulted in the formation of taiwaniaquinone H (2.41).33p 
 
Scheme 2.7: Hu’s synthesis of taiwaniaquinone H: 33p 1) i. HC2MgBr, ii. t-BuLi, iii. 2.42; 2) 80 °C, then TiCl4. 
                                               
34 Foland, L. D.; Karlsson, J. O.; Perri, S. T.; Schwabe, R.; Xu, S. L.; Patil, S.; Moore, 
H. W. J. Am. Chem. Soc. 1989, 111, 975−989. 
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2.1.3.2.! Syntheses based on biogenetic hypothesis 
a)! Biomimetic total synthesis of (−)-taiwaniaquinone H 
 
 In 2010, the total synthesis of taiwaniaquinone H was reported based on the 
biogenetic hypothesis connecting C20 diterpenoids to C19 nor-diterpenoids (see 
Scheme 2.1).29 The synthesis started from dehydroabietane (2.46), which was 
obtained from abietic acid via known procedures (Scheme 2.8). Treatment of the 
alkene under standard Sharpless dihydroxylation conditions (AD-mix(β)) furnished 
the over-oxidized precursor 2.47, suitable for the subsequent ring contraction 
(Scheme 2.1). Basic treatment of 2.47 gave the ring-contracted ketone 2.48. NaBH4 
reduction of the ketone 2.48 gave the benzylic alcohol 2.49, which was used as a 
directing group to achieve an ortho-lithiation of the aromatic ring. The resulting 
phenyl lithium was reacted with B(OMe)3 followed by H2O2 to deliver the phenol 
2.50. This advanced intermediate was further functionalized to give 
(−)-taiwaniaquinone H (2.40). 
 
 
Scheme 2.8: Gademann’s total synthesis of (−)-taiwaniaquinone H:29 1) AD-mix(β); 2) LHMDS; 3) NaBH4; 
4) i. n-BuLi, ii. B(OMe)3, iii. H2O2; 5) HCl; 6) Frémy’s salt; 7)Br2; 8) NaOMe. 
b)! Biomimetic, divergent total syntheses of taiwaniaquinoids 
 
 As already described in section 2.1.2, Alvarez-Manzaneda and co-workers 
achieved the total synthesis of several members of this natural product class based on 
a biogenetic hypothesis.30 The synthesis started with the abietane 2.51, which was 
synthesized from carnosic acid (2.52). Ozonolysis of the C7−C8 double bond 
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furnished the ketoaldehyde 2.53, which underwent a 5-exo-trig ring closure under 
basic conditions (DBU) and therewith afforded the taiwaniaquinoids skeleton (2.54). 
Compound 2.54 was used as common intermediate to synthesize natural products 2.5, 
2.7, 2.8, 2.40, 2.55 and taiwaniaquinone F (2.3), which will be of specific interest in 
the next sections. 
 
Scheme 2.9: Alvarez-Manzaneda's biomimietic synthesis of the taiwaniaquinoid skeleton 2.54 and application to 
the divergent synthesis of several members (2.3, 2.5, 2.7, 2.8, 2.41, and 2.55):30 1) O3, then Me2S; 2) DBU. 
2.1.4.! Target motivations and synthetic strategies 
2.1.4.1.! Goal of the study 
 
 In continuation of the previous work for the investigation of the biogenesis of 
taiwaniaquinoids, we became interested to the possible biogenesis of C20 
taiwaniaquinoids bearing a formyl group at the C6 position. We proposed that the 
6-5-6 tricyclic skeleton of C20 taiwaniaquinoids could be achieved via the ring 
contraction of a benzylic cyclohexanone, such as sugiol methyl ether (2.56, Scheme 
2.10). This ring contraction was envisaged to be achieved by an oxidative 
rearrangement of enol 2.57 in MeOH mediated by a metal such as Tl(III) via 
intermediate 2.58. The resulting ring-contracted intermediate 2.59 could be used for 
the synthesis of a C20 taiwaniaquinoids via an aromatic oxidation. Due to its 
intriguing bioactivities and the few numbers of existing synthetic methods targeting 
the fused trans A/B ring system, taiwaniaquinone F (2.3) was chosen as the primary 
target for these synthetic studies. 
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Scheme 2.10: Hypothetical biosynthetic ring contractions of abietanes to taiwaniaquinoids. 
2.1.4.2.! Retrosynthetic analysis 
 
 As mentioned in section 2.1.2, the different biosynthetic hypotheses of C19 and 
C20 taiwaniaquinoids, whereby an abietane was suggested as the precursor. Indeed, 
the abietane origin of taiwaniaquinoids is well accepted in the scientific 
community.22,24,29,30 However, the formation of these rearranged abietane skeletons is 
still under debate, as the biogenesis of these fascinating natural products were not 
investigated in details. Recognizing the rearranged abietane core of taiwaniaquinoids, 
we decided to start our synthesis of taiwaniaquinone F (2.3, Scheme 2.11) with abietic 
acid (2.2), an inexpensive and abundant abietane acid, which is readily available. This 
acid is found in high content in the resin of many conifers, such as Abies grandis and 
Pinus contorta, and acts as a chemical weapon against insects and pathogens through 
secretion.35 Such resins are used for a variety of applications such as food additives 
and friction-increasing agents (used by musicians, rugby players).36 
 
                                               
35 Dewick, P. M. Nat. Prod. Rep. 1997, 14, 111−144. 
36  Fiebach, K.; Grimm, D. Ullmann's Encyclopedia of Industrial Chemistry 2000, 31, 
477−494. 
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Scheme 2.11: Retrosynthetic analysis of taiwaniaquinone F (2.3). 
 Functional group interconversion of taiwaniaquinone F (2.3) would give the 
primary alcohol 2.60 as a precursor. The quinone moiety formation of 2.60, described 
in Scheme 2.11, was envisaged to occur via two consecutive aromatic oxidations at 
the C ring. Oxidation of phenol 2.61, using, for instance, Fremy’s salt or Salcomine 
under aerobic conditions would provide taiwaniaquinone F (2.3). The C14 hydroxyl 
group in 2.61 could be obtained from 2.62, using the rather long but usually efficient 
three step protocol, consisting of a Friedel-Crafts acylation followed by a 
Bayer-Villiger oxidation and transesterification. Alternatively, a more direct approach 
would be the directed one pot ortholithiation/boronation/oxidation procedure, 
developed by Seebach and co-workers,37 which has been successfully applied in our 
group for the total synthesis of (−)-taiwaniaquinone H.29b The precursor of 2.62 could 
be the methyl ester derivative 2.63, which could be obtained via a metal mediated 
oxidative ring contraction38 of (+)-sugiol methyl ether (2.56). This known natural 
product could be synthesized from the inexpensive and commercially available (−)-
abietic acid (2.59). 
                                               
37 Meyer, N.; Seebach, D. Angew. Chem. 1978, 90, 553−554. 
38  (a) Singh, O. V.; Muthukrishnan, M. Synthetic Communications 2006, 36, 
943−950; (b) Silva, L. F. Synlett 2014, 25, 466−476. 
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2.2.!Results and Discussion 
2.2.1.! Synthesis of (+)-sugiol methyl ether  
 
 Sugiol methyl ether (2.56) was synthesized from abietic acid (2.59), following 
known synthetic steps (Scheme 2.12) with experimental modifications. 39 
Aromatization of abietic acid (2.59) with palladium on charcoal afforded aromatic 
dehydroabietic acid (2.60) in excellent yield (95%). Reduction of the ester group to a 
methyl group was achieved in three consecutive steps: 1) LAH reduction of the 
carboxylic acid yielded dehydroabietinol (2.61, 84%); 2) tosylation using p-TsCl with 
pyridine furnished 2.62 in excellent yield (98%); 3) abietane (2.63) was obtained 
through a reductive removal of the tosyloxy group using NaI and Zn powder in DMF 
followed by an aqueous HCl workup. This reduction was proceeded in high yield 
(80%), although a SN2 reaction at a neopentylic position is known to be difficult. 
Having abietane (2.63) in hands, oxidation of its aromatic C ring was performed in 
three consecutive steps consisting of: 1) Friedel-Craft acylation of 2.63 yielded the 
12-acetyldehydroabietane (2.64) in very high yield (90%) using aluminium chloride 
and acetyl chloride; 2) Bayer-Villiger oxidation of 2.64 with m-CPBA affording 
acetate 2.65 in excellent yield (93%); (3) transesterification with sodium methoxide in 
MeOH providing the natural phenol ferruginol (2.66) in quantitative yield. Finally, 
methylation of phenol 2.66 using K2CO3 and Me2SO4 (94%), followed by benzilic 
oxidation of the resulting ferruginol methyl ether (2.67) with CrO3 in AcOH/Ac2O 
(79%), provided our natural precursor sugiol methyl ether (2.56) in nine linear steps 
with very good overall yield (36%) and interconnecting eight natural products. 
 
                                               
39  (a) Portmann, C.; Prestinari, C.; Myers, T.; Scharte, J.; Gademann, K. 
ChemBioChem 2009, 10, 889−895; (b) González, M. A.; Pérez-Guaita, D.; Correa-
Royero, J.; Zapata, B.; Agudelo, L.; Mesa-Arango, A.; Betancur-Galvis, L. Eur. J. 
Med. Chem. 2010, 45, 811−816; (c) Fujimoto, Y.; Tatsuno, T. Tetrahedron Lett. 
1976, 17, 3325−3326; (d) Akita, H.; Oishi, T. Chem. Pharm. Bull. 1981, 29, 
1567−1579; (e) Brandt, C. W.; Neubaeur, L. G. J. Chem. Soc. 1939, 1031−1037; 
(f) Gan, Y.; Li, A.; Pan, X.; Chan, A. S. C.; Yang, T.-K. Tetrahedron: Asymmetry 
2000, 11, 781−787. 
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Scheme 2.12: Synthesis of (+)-sugiol methyl ether (2.7) from (−)-abietic acid (2.1): 1) Pd/C, p-xylene, 148 °C, 48 
h, 95%; 2) LAH, THF, 0 °C-rt, 2.25 h, 84%; 3) p-TsCl, pyridine, 0 °C-rt, overnight, 98% 4) NaI, Zn, DMF, 
100 °C, 3 days, then 1M HCl, 80%; 5) AcCl, AlCl3, CH2Cl2, 0 °C-rt, 2 h, 90%; 6) peracetic acid, CH2Cl2, rt, 72 h, 
93%; 7) NaOMe, MeOH, rt, 1 h, 99%; 8) K2CO3, Me2SO4, acetone, 60 °C, overnight, 94%; 9) CrO3, AcOH/Ac2O, 
50 °C, 2 h, 79%. 
2.2.2.! Ring contraction of sugiol methyl ether 
 
 Having our synthetic sugiol methyl ether (2.56) in hand, the ring contraction 
of the B ring to obtain the 6-5-6 ring system was addressed next. The ring contraction 
of such cyclohexanone rings is usually performed by an oxidative 
thallium (III) mediated oxidative rearrangement in trimethyl orthoformate under 
acidic conditions. 40  A general, plausible mechanism for this ring contraction is 
depicted in Scheme 2.13. Trimethyl orthoformate can generate the oxonium species 
2.68 under acidic conditions, which might react as a methylating agent with the 
ketone 2.69 to form the enol ether 2.70. Coordination of the Tl(III) species, usually 
Tl(NO3)3, to the double bond, followed by a nucleophilic attack affords the 
C-thallated intermediate 2.71. A successive migration of the electron rich C−Ar bond 
to the electron poor C−Tl(III) carbon generates the ring contracted ester 2.72 upon 
hydrolysis. 
 
                                               
40 Singh, O. V.; Muthukrishnan, M. Synthetic Communications 2006, 36, 943−950. 
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Scheme 2.13: Thallium (III) mediated oxidative ring contraction.40 
 Therefore, the B ring contraction of 2.56, using Tl(NO3)3 in trimethyl 
orthoformate with a catalytic amount of perchloric acid was studied. Unfortunately, 
no ring-contracted product could be detected; instead the formation of the known 
natural product 5,6-dehydrosugiol methyl ether (2.73) was obtained in high yield 
(65%).41 This could occur through a β-hydride elimination of the thallated substrate 
2.74. (Scheme 2.14). 
 
 
Scheme 2.14: Failed ring contraction tentative of sugiol methyl ether. 
 As the thallium oxidative ring contraction failed to deliver the desired ring-
contracted product, an alternative approach was explored. All carbons of 2.56 must be 
part of the ring-contracted product in order to access C20 taiwaniaquinoids. Such a 
ring contraction was successfully applied by Mander and co-workers for the total 
synthesis of gibberellin GA73 (2.75) via a Wolff rearrangement protocol (hν, 
MeOH) of the diazo-ketone 2.76. 42  Rearrangement of the resulting carbene 2.77 
would form the ketene 2.78, which would subsequently be attacked by an MeOH to 
give the ring contracted ester product 2.79, a precursor of gibberellin GA73 (2.75, 
Scheme 2.15). 
 
                                               
41 Huo, Y-H. ; Yu, M. T. Phytochemistry 1996, 42, 779−781. 
42 King, G. R.; Mander, L. N.; Monck, N. J. T.; Morris, J. C.; Zhang, H. J. Am. Chem. 
Soc. 1997, 119, 3828−3829. 
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Scheme 2.15: Synthesis of gibberillin G73 (2.75) by Mander.42 
 Recognizing the analogous 6-6-6 ring system, we decided to investigate the 
feasibility of such a Wolff rearrangement on our substrate. Therefore, the synthesis of 
the α-diazoketone 2.80 was addressed next (Scheme 2.16).  
 
 
Scheme 2.16: Ring contraction of sugiol methyl ether diazo derivative (2.80) to ester 2.28 and C6-epimerization 
of 2.80 to 2.63. AH: Brønsted acid species. 
 We were pleased to observe a clean conversion of sugiol methyl ether using 
standard diazo-transfer reaction conditions (p-ABSA, DBU), affording the diazo 
derivative 2.80 in high yield (65%) together with a smaller amount of recovered 
starting material (30%). The structure of 2.80 was confirmed by X-ray 
crystallographic analysis (Figure 2.3, A). 
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Figure 2.3: X-ray crystallographic analysis of A) 2.27, B) 2.28 and C) 2.30. Blue = nitrogen, red = oxygen, 
grey = carbon, white = hydrogen. 
 With the α-diazoketone 2.80 in hand, different transition metals, such as Rh 
and Cu, were investigated to generate stabilized carbenes, which could undergo the 
desired Wolff rearrangement. However, treating 2.80 with Rh2(OAc)4 or CuI in the 
presence of MeOH did not lead to conversion or formation of enone 2.73, 
respectively. Furthermore, a ring-contracted product could not be detected. In the case 
of the Rh catalyst, unproductive coordination of the terminal nitrogen or the oxygen 
of the keto group of 2.80 to the Rh center could cause catalyst deactivation.43 In the 
case of the Cu catalyst, we suppose that a fast 1,2-C−H migration takes place instead 
of the desired 1,2-C−aryl bond migration. Nevertheless, we were delighted to observe 
a clean and relatively efficient Wolff rearrangement yielding the ring-contracted ester 
2.81, when a dilute solution of the diazoketone 2.80 was irradiated in MeOH using a 
                                               
43 (a) Tishinov, K. Phd Thesis: “New catalytic strategies for DNA and RNA alkylation 
using rhodium(II) and copper(I) carbenes − a versatile tool for applications in 
chemical biology“ 2015, Chapter 1, 21−22; (b) Nowland, D. T.; Gregg, T. M.; 
Davies, H. M, L.; Singleton, D. A. J. Am. Chem. Soc. 2003, 125, 15902−15911 
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medium pressure Hg lamp. Remarkably, the reaction was also effective by exposing 
the dilute solution to direct sunlight (Figure 2.4) giving the same yield (54%) and the 
same diastereoselectivity (6R:6S, 1:20, determined by 1H-NMR analysis). However, 
the stereoselectivity obtained was opposite to the one required for the configuration of 
the natural product. We postulate that the desired (6R)-2.63 is the thermodynamic 
more stable product due to the angular C20 methyl group, forcing the bulky ester 
group into the equatorial position. Therefore, the major product (6S)-2.81 obtained 
would be the kinetic product. This kinetic selectivity is predicted by the 
stereoselectivity of ketonization of enols and enolates, developed by Zimmerman in 
1955.44 The protonation of the enolate 2.82 occurs from the less hindered face of the 
double bond, in this case from the α-face of 2.82 due to the open trajectory for the 
protonating species (AH approach vs AH approach in 2.82), therefore yielding the 
thermodynamically less stable product 2.81. However, under thermal and acidic or 
basic conditions, the thermodynamic equilibrium can be reached. Thus, the kinetic 
product 2.81 was treated with KOH in ethylene glycol under thermal conditions 
(145 °C) and the (6S)-carboxylic acid 2.83 was successfully obtained in good yield 
(88%) and diastereoselectivity (6R:6S, 8.3:1, determined by 1H-NMR analysis). The 
(6R)-ester 2.63, required for the next steps, was quantitatively obtained by 
methylation of (6R)-2.83 using TMSCHN2. Alternatively, 2.63 was quantitatively 
obtained in excellent diastereoselectivity (6R:6S, 33:1, determined by 1H-NMR 
analysis) by the epimerization of 2.81 using NaOMe in MeOH under microwave 
irradiation (100 °C, 12 h). The absolute configuration of 2.81 and 2.83 was 
determined by 1H-NMR analysis and confirmed by X-ray crystallographic analysis 
(Figure 2.3, B and C respectively). Therefore, these isomerization reactions 
confirmed 2.63 to be the thermodynamic product and 2.81 as the kinetic one. 
 
                                               
44 (a) Zimmerman, H. E. J. Org. Chem. 1955, 20, 549−557; (b) Zimmerman, H. E.; 
Linder, L. W. J. Org. Chem. 1985, 50, 1637−1646 
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Figure 2.4: Sunlight experimental set-up of the Wolff rearrangement. 
 It is noteworthy to mention that a few weeks after our publication, 45  a 
divergent synthesis of taiwaniaquinoids including taiwaniaquinone F (2.3) was 
reported by Li and co-workers.46 In this report, a similar Wolff rearrangement was 
used for the ring contraction of a diazoketone abietane substrate. This emphasizes the 
generality of this concept for the synthesis of such natural products. 
 
2.2.3.! First and second aromatic oxidation and synthesis of 
taiwaniaquinone F 
 
 With the ring-contracted ester in hand, the aromatic oxidation to access phenol 
2.61, was investigated next. Following the Seebach methodology for the aromatic 
hydroxylation of benzylic alcohols,37 the reduction of ester 2.63, was achieved using 
LAH in THF, yielding the desired alcohol 2.62 in quantitative yield. Although the 
Seebach strategy relies on the formation of ortho-lithiated benzylic alcohol 
derivatives, the ortho-lithiation of the homobenzylic 2.62 alcohol was nevertheless 
performed using n-BuLi, TMEDA, followed by B(OMe)3 and H2O2 in hexane at 
75 °C. NMR data analysis of the product, obtained in 55% yield, showed the presence 
of phenol 2.84, the C11 regio isomer of the desired 2.61 (Scheme 2.17). These results 
emphasize the importance of the benzylic nature of the alcohol to achieve a directed 
                                               
45 Thommen, C.; Jana, C. K.; Neuburger, M.; Gademann, K. Org. Lett. 2013, 15, 
1390−1393. 
46 Deng, J.; Li, R.; Luo, Y.; Li, J.; Zhou, S.; Li, Y.; Hu, J.; Li, A. Org. Lett. 2013, 15, 
2022−2025. 
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ortho-lithiation. Therefore, the obtained selectivity can be explained by an ortho-
lithiation assisted by the C12 methoxy subtituent and not by the homobenzylic 
alcohol. As the obtained isomer was also synthetically useful, we decided to continue 
our synthesis with 2.84. However, the harsh conditions employed (n-BuLi, 75 °C), 
necessary to achieve conversion, did not allow us to reproduce these results in 
synthetically useful amounts. Alternatively, the synthesis of bromo compound 2.85 
was carried out in high yield (82%). Subsequently, a one pot lithiation-boronation-
oxidation reaction using n-BuLi, TMEDA, B(OMe)3 and H2O2 was attempted to 
convert 2.85 to phenol 2.84. Interestingly, traces of product could already be detected 
by TLC after the lithiation step, which led us to the assumption that O2 (dissolved in 
the solvent) could act as the oxidant in this reaction. To our great satisfaction, a 
simplified, reproducible and scalable procedure, using a one pot 
lithiation/oxygenation protocol with n-BuLi, TMEDA and oxygen at low temperature 
(−10 °C), afforded the phenol 2.84 in 58% yield together with a smaller amount of 
recovered starting material (2.85, 30%). This methodology was described for the first 
time by Parker and co-workers in 1986,47 and has received only little attention from 
the scientific community. Oxidation of phenol 2.84 to the corresponding p-quinone 
2.60 was accomplished in quantitative yield using Co(salen) with oxygen in CH3CN 
at rt.48 It is noteworthy that the reaction and the purification of the product were 
carried out under exclusion from light to avoid decomposition of this sensitive 
compound. Final oxidation of 2.3 was achieved by treatment with Dess−Martin 
periodinane (DMP) in CH2Cl2 in the dark, to furnish (−)-taiwaniaquinone F (2.1) in 
quantitative yield. All spectroscopic data of this synthetic compound were in 
agreement with those reported for the isolated natural product.6 
 
                                               
47 Parker, K. A.; Koziski, K. A. J. Org. Chem. 1987, 52, 674−676. 
48 Liu, W.; Liao, X.; Dong, W.; Yan, Z.; Wang, N.; Liu, Z. Tetrahedron 2012, 68, 
2759−2764.
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Scheme 2.17: Completion of the synthesis of taiwaniaquinone F (2.3). 
2.2.4.! Photolysis of taiwaniaquinone F and first synthesis of 
taiwaniaquinol A 
 
 To avoid decomposition of the natural product (−)-taiwaniaquinone F (2.3), it 
was essential to perform the work-up and purification under strict exclusion from 
light. To our great surprise, if such precautions were not taken, minor amounts of 
impurities corresponding to (+)-taiwaniaquinol A (2.9) were detected by 1H-NMR 
analysis (Figure 2.5). 
 
Figure 2.5: 1H-NMR spectrum of taiwaniaquinone F synthesized and purified in the ambient light (A) and in the 
dark (B). The arrows show the 1H-NMR peaks corresponding to taiwaniaquinol A (2.9). 
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 Consequently, a diluted solution of (−)-taiwaniaquinone F (2.3) in Et2O was 
exposed to direct sunlight to produce (+)-taiwaniaquinol A (2.9) in 30% yield 
(Scheme 2.18). All spectroscopic data of synthetic 2.9 were in agreement with the 
isolated natural product. 
 
 
Scheme 2.18: First synthesis of (−)-taiwaniaquinol A (2.9) via the photolysis of taiwaniaquinone F (2.3). 
 Mechanistic studies to investigate this transformation will be discussed in 
chapter 4, however, several possible hypotheses have been postulated for related 
quinone photolysis reactions (Scheme 2.19). 49  Photolysis involving a possible 
1,5-hydrogen abstraction reaction (1,5-HAT) of a similar quinone moiety was 
achieved in 1978 by Edwards et al., but has received only little attention afterwards.50 
Indeed, photolysis of royleanone methyl ether (2.86) produced the methylenedioxy 
2.87, however, in lower yield (16%). Moreover, irradiation in benzene lead to the 
Yang photocyclized product 2.88, most probably via a successive 1,5-HAT and 
radical recombination of the resulting 1,4-diradical. The first step (the γ-hydrogen 
abstraction) is therefore proposed to take place in the mechanism of the formation of 
2.87. Analogous to the Baldwin’s hypothesis for the formation of the methylenedioxy 
2.89 from quinone 2.90,32 Edwards and co-workers suggested that a dipolar ionic 
intermediate generated via a direct intramolecular electron transfer of a biradical 
species, was responsible for the methylenedioxy bond formation. The presence of this 
zwitterionic species was supported by the absence of methylenedioxy product when 
the photolysis was conducted in an apolar solvent such as benzene. Kozuka and co-
workers reported an impressive photolysis of the 2-alkylated-1,4-quinone 
                                               
49 (a) Review: Bach, T.; Hehn, J. P. Angew. Chem. Int. Ed. 2011, 50, 1000−1045. 
Selected examples: (b) Bruce, J. M. Q. Rev. Chem. Soc. 1967, 21, 405−428; 
(c) Bruce, J. M.; Creed, D.; (d) Dawes, K. J. Chem. Soc. C 1971, 2244−2252; 
(e) Kozuka, T. Bull. Chem. Soc. Jpn. 1982, 55, 2415−2423; (f) Farid, S. J. Chem. 
Soc. D 1971, 73−74; (g) Maruyama, K.; Kozuka, T. Chemistry Letters 1980, 
341−342. 
50 Edwards, O. E.; Ho, P.-T. Can. J. Chem. 1978, 56, 733−742. 
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2.91 bearing an ester group in the alkyl side chain. The obtained high yield of 2.92 
was rationalized by the conformation of the alkyl chain, where the γ-hydrogen 
pointing towards the C1 oxygen atom due to the dipole-dipole repulsion between the 
ester and the C1=O bond. In a similar manner, Baldwin suggested that the bulky Br 
group in 2.90 forces the methoxy substituent to point in the direction to the quinonoid 
carbonyl, therefore facilitating the 1,5-hydrogen transfer. Additionally to the steric 
argument, the dipole-dipole minimization could also be considered for substrate 2.86, 
2.90 and 2.3. Indeed, as depicted in Scheme 2.19, the dipole moment of the O−CH3 
bond minimizes the one of the C1=O bond.  
 
 
Scheme 2.19: A) Photolysis of royleanone methyl ether by Edwards;50 B) Synthesis of a methylenedioxy from a 
methoxy-group by Baldwin;32 C) Photocylization of quinone 2.39 by Kozuka.49e 
 The photolysis of 2.3 could generate an alkoxy radical (2.93) that would 
abstract a proton from the OMe group, which is sterically and electronically forced to 
occupy a favorable position for 1,5−HAT abstraction (Scheme 2.20) to give the 
methoxy radical 2.94.51 With the recent emergence of remote C−H functionalization 
methods for complex unprotected substrates,52 this interesting transformation might 
add novel aspects for strategic disconnections in natural product synthesis. Hydrogen 
atom transfer from the C14 hydroxyl to the C11 hydroxy radical would generate the 
1,5-biradical 2.95, which upon recombination, would afford taiwaniaquinol A (2.9). 
                                               
51 Baldwin, J. E.; Brown, J. E. J. Chem. Soc. D. 1969, 167−168. 
52 (a) Renata, H.; Zhou, Q.; Baran, P. S. Science 2013, 339, 59−63; Bigi, M. A.; Reed, 
S. A.; White, M. C. J. Am. Chem. Soc. 2012, 134, 9721−9726; (b) Jana, C. K.; 
Hoecker, J.; Woods, T. M.; Jessen, H. J.; Neuburger, M.; Gademann, K. Angew. 
Chem. Int. Ed. 2011, 50, 8407−8411. 
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The fact that the photolysis was achieved in a non-polar and aprotic solvent 
(Et2O) brings support to our fully radical mechanism as the formation of a 
zwitterionic species requires a polar and protic solvent. In such a case, a switch to 
ionic pathways appears difficult. However, further experimental studies need be 
performed to validate this hypothesis. 
 
 
Scheme 2.20: Mechanistic proposal for the formation of taiwaniaquinol A (2.9). 
2.2.5.! Biosynthetic proposal for the formation of 
taiwaniaquinol A 
 
 The ease of this remote C−H activation by simply exposing the quinone to 
sunlight leading to product conversion suggests that this transformation could be part 
of the biosynthetic pathway at Taiwania cryptomoides. Interestingly, taiwaniaquinone 
F (2.3) was isolated from the bark of T. cryptomerioides, whereas taiwaniaquinol A 
(2.9) was isolated from the leaves of the same tree,7 further supporting this 
biosynthetic hypothesis. It might be possible that the transformation observed in our 
synthetic studies also occurs in the leaves of T. cryptomerioides that are exposed to 
sunlight. 
 The previously proposed mechanisms for the biogenesis of methylenedioxy 
bridged natural products invoked the participation of cytochrome P450 enzymes in an 
oxidative cyclization of a 1,2-hydroxymethoxy-substituted aromatic ring as depicted 
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in Scheme 2.21. 53  It is suggested that the cytochrome P450 undergoes a 
monooxygenation of the methoxy group via the usual oxygenation sequence 
consisting of a C−H abstraction of the methoxy 2.96 followed by a rebound 
mechanism with the resulting reduced FeIII−OH catalyst and the methoxy-radical 2.97 
to produce the hemiacetal 2.98. Dehydration of 2.98 would produce the oxonium ion 
2.99, which upon nucleophilic attack of the ortho alcohol would furnish the 
methylenedioxy moiety 2.100. The absence of any enzymes in our synthetic route 
suggests that this non-enzymatic pathway could present a viable biogenetic option for 
other methylenedioxy bridged catechols, in particular the ones having an extra para-
hydroxylate carbon. Given the prevalence of these compounds in nature,54 we propose 
that other members of this class could be formed by a similar non-enzymatic 
mechanism. 
 
 
Scheme 2.21: Generaly accepted cyt. P450 mechanism for the biosynthesis of methylenedioxy natural products.54 
2.2.6.! Conclusion and outlook 
 
 In summary, a new protecting-group-free route to (−)-taiwaniaquinone F 
(2.3) and the first synthesis of (+)-taiwaniaquinol A (2.9) was developed starting from 
commercially available abietic acid. Salient features of this synthesis include: 
(1) a Wolff ring contraction of the diazo derivative of (+)-sugiol methyl ether 2.80; 
(2) an aromatic oxidations of the ring contracted product 2.81 by molecular oxygen; 
and (3) an unanticipated formation of a methylenecatechol moiety via the photolysis 
of (−)-taiwaniaquinone F (2.3) to (+)-taiwaniaquinol A (2.9) via a remote C−H 
                                               
53 (a) Bauer, W.; Zhenk, M. H. Phytochemistry 1991, 30, 2953−2961; (b) Ono, E.; 
Nakai, M.; Fukui, Y.; Tomomori, N.; Fukuchi-Mizutami, M.; Saito, M.; Satake, H.; 
Tanaka, T.; Katzuka, M.; Umezawa, T.; Tanaka, Y. PNAS 2006, 103, 10116−10121; 
Ikezawa, N.; Iwasa, K.; Sato, F. FEBS Journal 2007, 274, 1019−1035. 
54 Review: Kerr, R. G.; Miranda, N. F. J. Nat. Prod. 1995, 58, 1618−1621. 
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functionalization. A hypothesis for the biogenesis of the frequently encountered 
methylenedioxy motif in natural products was proposed, and bioactive compounds, 
such as ecteinascidin 743 (ET-743, 2.101) and cyclocoulterone (2.102),55 could be 
generated either synthetically or biosynthetically from a quinone precursor (2.103 and 
2.104 respectively) through a very similar mechanism. This hypothesis may provide 
further insight to the biogenesis of this interesting class of natural products. 
 
 
Scheme 2.22: Possible targets for the remote C−H functionalization. 
 Moreover, the potential of the “biomimetic” nature of our synthesis could be 
further investigated. Indeed, the known hydroxy-derivatives of sugiol methyl ether 
(2.56), 2.105 and 2.106,56  could, upon solvolysis, generate the carbocation 2.107 
(Scheme 2.23, A). This carbocation could be trapped intramolecularly by the electron 
rich aromatic ring to form the cyclopropanone intermediate 2.108, resembling an 
intermediate of a Favorskii reaction.57 Nucleophilic attack of methanol would open 
the cyclopropanone moiety of 2.108 to form the ring contracted ester 2.109. Such 
                                               
55 Uchiyama, N.; Kiuchi, F.; Ito, M.; Honda, G.; Takeda, Y.; Khodzhimatov, O. K.; 
Ashurmetov, O. A. J. Nat. Prod. 2003, 66, 128−131. 
56 Li, X.; She, X.; Zhang, J.; Wu, T.; Pan, X. Tetrahedron 2003, 59, 5737−5741. 
57 Kammath, V. B.; Šolomek, T.; Ngoy, B. P.; Heger, D.; Klán, P.; Rubina, M.; 
Givens, R. S. J. Org. Chem. 2013, 78, 1718−1729. 
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acidic Favorskii-type reactions have already been performed with α-bromo-
cycloalkyl-arylketone such as 2.110 using ZnCl258 or NiCl259 in methanol to yield the 
desired ring contracted methyl ester 2.111 (Scheme 2.23, B). The expected feasibility 
of this reaction could be experimentally assessed by treating the α-hydroxy-ketone 
2.105, its acetyl derivative 2.106 or a α-halo sugiol methyl ether derivative, with 
either a Brønsted or a Lewis acid in methanol (or other alcoholic or aqueous solvents). 
 
 
Scheme 2.23: A) Hypothetical Favorskii-type ring contraction of sugiol methyl ether derivative 2.105 or 2.106; 
B) Cationic Favorskii-type ring contraction by Chatterjee58 and Gautam.59 
 The synthesis of the ring contracted product 2.81, includes most probably the 
carbene intermediate 2.112, which formed the ketene 2.113 via an 1,2-aryl shift (red 
pathway, Scheme 2.24). However, it could be envisaged that such an electrodeficient 
carbene (2.112) could form the cyclopropyl enolate intermediate 2.114 through a 
nucleophilic attack of the electron rich aryl, which would furnish the same ring-
contracted ketene 2.113 (blue pathway, Scheme 2.24). Intermediate 2.114 would 
therefore resemble the hypothetical Favorskii-type cyclopropanone 2.108. 
 
                                               
58 Maiti, S. B.; Chaudhuri, S. R. R.; Chatterjee, A. Synthesis 1987, 806−809. 
59 Tandon, V. K.; Awasthi, A. K.; Singh, K. A.; Maurya, H. K.; Gautam, S. K. 
Heterocycles 2010, 80, 593−600. 
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Scheme 2.24: Wolff rearrangement of 2.80 via a hypothetical cyclopropyl enolate intermediate 2.114. 
 Unfortunately, neither this hypothesis, nor any of the previously described 
hypotheses accounted for the synthesis of C20 taiwaniaquinoids, having a formyl 
group at an unusual position such as dichroanal B (2.115). Therefore, other pathways 
must exist to generate such species. Indeed, orthoquinone aldehyde 2.116, which 
could be generated through the biogenetic hypothesis (Scheme 2.24, A) earlier 
described, would undergo a nucleophilic deformylation to yield the orthoquinone 
2.117. This process could be promoted by a cyt. P450 thereby generating a formyl 
radical and the reduced cyt.(+.)FeIII−OH (Scheme 2.25, A). 60  The addition of the 
formyl radical to 2.117 would generate the alkoxy radical 2.118, which, upon H atom 
transfer with cyt.(+.)FeIII−OH would yield dichroanal B (2.115) after tautomerization 
and the reoxidized cyt.(+.)FeIV=O. According to this mechanism, this process would be 
redox neutral. Alternatively, a nucleophilic amine could promote a deformylation of 
2.119 upon nucleophilic attack of aldehyde 2.116 (Scheme 2.25, B). The resulting 
orthoquinone methide 2.120 would provide the catechol 2.64 by tautomerization. 
Electrophilic acylation of 2.121 by the previously formed formamide could lead to 
dichroanal B (2.115). The second hypothesis could be straightforwardly be assessed 
in the laboratory. Treatment of 2.116 with NaN(Me)2 at high temperature would 
provide catechol 2.121  and DMF as by-product. A final Friedel-Crafts acylation 
                                               
60 Akhtar, M.; Corina, D.; Miller, S.; Shyadehi, A. Z.; Wright, J. N. Biochemistry 
1994, 33, 4410−4418. 
O
H CO2MeH
O
O
N2
H
O
O
H
O
•
O
MeOHhν
H
O
O
H
O
O
VS
2.1122.80 2.113 2.81
2.112 2.114
!Chapter 2 38 
using DMF and POCl3 would complete the synthesis of dichroanal B (2.115).61 Node 
and co-workers previously performed such a formylation of 2.121, using Rieche 
formylation conditions,62 therefore supporting this hypothesis. In Nature, formylations 
are performed by formyltransferase through a similar mechanism.63 
 
 
Scheme 2.25: Hypothetical nucleophilic deformylation biosynthesis of dichroanal B (2.115) via a A) radical or 
B) ionic mechanism. 
  
                                               
61 Ueki, R.; Yamaguchi, K.; Nonaka, H.; Sando, S. J. Am. Chem. Soc. 2012, 134, 
12398−12401. 
62 Node, M.; Ozeki, M.; Planas, L.; Nakano, M.; Takita, H.; Mori, D.; Tamatani, S.; 
Kajimoto, T. J. Org. Chem. 2010, 75, 190−196. 
63 (a) Dickerman H. W.; Steers E. Jr.; Redfield B. G.; Weissbach H. J. Biol. Chem. 
1967, 242, 1522−1525; (b) Qiao, Q. A.; Jin, Y.; Yang, C.; Zhang, Z.; Wang, M. 
Biophysical Chemistry 2005, 118, 78−83. 
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3.!Divergent Biomimetic Synthesis of 
Structurally Diverse Icetexane Members 
3.1.!Introduction 
3.1.1.! Plant extract as a source of bioactive compounds and their 
pharmacological and industrial use 
 
 The use of plants for medicinal, culinary or aromatic purposes is as old as 
human history. Indeed, archeological evidence showed that herbalism (the medicinal 
use of plants or their extracts) was already used by Neanderthals.64 Herbal medicine is 
still widely used due to its abundance, accessibility and low cost, especially in 
developing countries where modern medicine is not accessible to millions of people.65 
Nevertheless, a fast growing market of plant extracts is observed in industrialized 
countries, which contributes to the development of this traditional discipline. The 
commercially available extracts typically contain several active principles, which 
make them usually more effective than the standard mono-therapy in modern 
medicine thanks to possible synergic effect of the different active principles. 
However, the dosage of these plants (or their extract) has to carefully evaluated taking 
in account where and when the plant was harvested due to active principle variation. 
If not, over dosage can lead to severe side effects or even death. For instance, Datura 
stramonium, known as Jimeson weed, was used as very powerful treatment for 
asthma, however recreational misuse of this plant can lead to anticholinergic 
intoxication, which can be fatal. The toxicity is observed in slightly higher dosage 
than the medicinal usage.66 Moreover, due to resource limitations of certain plant 
species, especially the ones that can’t be easily cultivated, and the increasing demand 
for alternative medicine, the use of such medicine should only be seen as 
complementary medicine to avoid the diminution of natural resources. Apart from 
                                               
64 Solecki, R. C. Science 1975, 190, 880−881. 
65 WHO Traditional Medicine Strategy: 2014−2023; ISBN: 9789241506090, page 
15−19. 
66 Coremans, P.; Lambrecht, G.; Schepens, P.; Vanwelden, J.; Verhaegen, H. Clinical 
Toxicology 1994, 32, 589−592. 
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medicinal utilization of such extracts, industry widely uses natural products in a 
variety of applications ranging from fragrance to food supplements. Unfortunately, 
the preparation of such extracts is still done by some “specialists” using old methods 
that do not guarantee the integrity, the quality and the dosage of such preparations. 
These old technologies should therefore be replaced or improved by new or modified 
technologies of extraction, purification and formulations.67 For example the use of 
renewable and eco-friendly supercritical CO2 to replace petroleum based solvents or 
utilization of sonicators for extraction are important and effective alternatives. 
Furthermore, modern quality and quantity control measures ensure appropriate and 
high quality extracts for various consumer applications. The pharmacological industry 
utilizes such technologies to produce not only plant extracts in different galenical 
forms from natural sources, but also to isolate pure active compound for a direct use 
(fidaxomycin, quinine, carnosic acid, …) or intermediates for semi-synthesis of 
important biological principles (ET-743, Taxol, Vinorelbine, …).68 
3.1.2.! Icetexanes 
 
 Icetexanes69 are a variety of diterpenoids isolated from diverse plant sources 
especially from the Labiatae family. Icetexone was the first member to be isolated and 
characterized from Salvia ballotaeflora.70 These compounds exhibit a unique carbon 
skeleton consisting of a 6-7-6 tricyclic core structure (Figure 3.1) with the systematic 
name 9(10"20)-abeo-abietane. This systematic appellation refers to their 
hypothetical abietane biosynthetic origin (see details in section 3.1.3). As already seen 
in chapter 2, taiwaniaquinoids possess, compared to icetexanes, an 6(7"8)-abeo-
abietane or 5(6"7)-abeo-abietane skeleton depending on which biosynthetic 
hypothesis is postulated for these compounds.  
 
                                               
67 Bonati, A. J. Ethnopharmacol. 1980, 2, 167−171. 
68  De Silva, T. Industrial utilization of medicinal plants in developing countries 
Medicinal plants for conservation and health care, Food and Agricultural 
Organization of the United Nations 1995. 
69 Simmons, E. M.; Sarpong, R. Nat. Prod. Rep. 2009, 26, 1195−1217. 
70 Watson, W. H.; Taira, Z.; Dominguez, X. A.; Gonzales, H.; Guiterrez, M.; Aragon, 
R. Tetrahedron Lett. 1976, 17, 2501−2502. 
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Figure 3.1: Abietane and the rearranged taiwaniaquinoids and icetexane skeleton. 
 According to Sarpong’s classification of icetexanes69, abeo-abietanes can be 
differentiated depending on their oxygenation state at C3, C11, C14 and C19. Figure 
3.2 shows three subclasses of these natural products: (1) pisiferins, lacking of 
oxygenation at C3, C11, C14 and C19, obtained their name from the natural product 
pisiferin (3.1). It was first isolated from Chamaecyparis pisifera in 1980 and 
structurally misassigned71 before being reassigned four years later after re-isolation 
from the same plant 72 . Most of pisiferins were exclusively found in the 
Chamaecyparis genus. However, exceptions such as pisiferanol (3.2) and euolutchuol 
E (3.3) were isolated from Salvia lanigera and Euonymus lutchuensis, respectively. 
All other pisiferins shown in Figure 3.2 bearing a β-C10 oxygenation (3.2−3.4), in 
contrast to the parent compound pisiferin (3.1), will be discussed in more details in 
section 3.2.7. (2) The second class was named after barbatusol (3.5), bearing an 
additional oxygenation at C11 compared to pisiferins. It was isolated from Coleus 
barbatus and showed hypotensive activity in rats.73 Salvicanol (3.6), brussonol (3.7), 
przewalskin E (3.8) and other barbatusols bearing a β-C10 oxygenation, will be 
discussed in more details in section 3.2.6. (3) coulterones, which have an additional 
hydroxyl group at C14, are named after coulterone (3.9), which first isolated from 
Salvia coulteri in 199474 and eleven years later from Hyptis platanifolia.75 Congeners 
of coulterone (3.9), cyclocoulterone (3.10), komaroviquinone (3.11) and 
komarovispirone (3.12) were all isolated by Kiuchi and co-workers from 
Dracocephalum komarovi. Both 3.11 and 3.12 have shown trypanocidal activity 
                                               
71 Yatagai, M.; Takahashi, T. Phytochemistry 1980, 19, 1149−1151. 
72  Hasegawa, S.; Hirose, Y.; Yatagai, M.; Takahashi, T. Chem. Lett. 1984, 
1837−1838. 
73 Kelecom, A. Tetrahedron 1983, 39, 3603−3608. 
74 Frontana, B.; Cárdenas, J.; Rodríguez-Hahn, L. Phytochemistry 1994, 36, 739−741. 
75 Araujo, E. C. C.; Lima, M. A. S.; Nunes, E. P.; Silveira, E. R. J. Braz. Chem. Soc., 
2005, 16, 1336−1341. 
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against the parasite responsible for the Chagas disease, whereat komaroviquinone 
(3.11) showed the best results (LD50 = 0.4 µM).76 Although komarovispirone (3.12) 
bears a rearranged icetexane skeleton, 3.12 belongs to coulterone subclasses due to 
the proposed biosynthetic connection with 3.1176b,69. Nevertheless, 3.12 was assigned 
to another family name where it is the unique member: the komarovispiranes77. Two 
additional subclasses, the taxamarins and the icetexones carry oxygenations at C3 and 
C11, and at C11, C14 and C19 respectively. 
 
                                               
76 (a) Uchiyama, N.;  Kiuchi, F.;  Ito, M.;  Honda, G.;  Takeda, Y.; Khodzhimatov, O. 
K.; Ashurmetov, O. A. J. Nat. Prod. 2003, 66, 128−131; (b) Uchiyama, N.;  Ito, M.; 
Kiuchi, F.; Honda, G.; Takeda, Y.; Khodzhimatov, O. K.; Ashurmetov, O. A. 
Tetrahedron Lett. 2004, 45, 531−533. 
77 Srikrishna, A.; Beeraiah, B. Indian J. Chem. 2007, 46B, 1999−2003. 
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Figure 3.2: Examples of subclasses of icetexanes according to Sarpong.69 
 Other natural products were found to have an icetexane framework in their 
skeleton 78,79,80 (Figure 3.3). 
                                               
78 Bénéchie, M.; Khuong-Huu, F. Tetrahedron 1976, 32, 701−707. 
79 Parvez, A.; Choudhary, M. I.; Akhter, F.; Noorwala, M.; Mohammad, F. V.; Hasan, 
N. M.; Zamir, T.; Ahmad, V. U. J. Org. Chem. 1992, 57, 4339−4340. 
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Figure 3.3: Structures of natural products having a 6-7-6 membered ring system.78,79,80 
3.1.3.! Biogenetic hypothesis of icetexanes 
 
 As showed in section 3.1.2, the systematic name 9(10"20)-abeo-abietane 
given to icetexanes indicates that the abietane biosynthetic origin of icetexanes is well 
accepted throughout the scientific community. To the best of our knowledge, Watson 
and Dominguez70 were the first research group to propose such a connection between 
abietanes and icetexanes, but various other research labs81 have proposed a similar 
mechanism to associate abietanes to their rearranged congeners (see Scheme 3.1). 
 
 
Scheme 3.1: Hypothetical biogenetic abietane ring expansion to icetexanes.70,81 X = H or OH. 
                                                                                                                                      
80 (a) Ahmad, V. U.; Zahid, M.; Ali, M. S.; Ali, Z.; Jassbi, A. R.; Abbas, M.; Clardy, 
J.; Lobkovsky, E.; Tareen, R. B.; Iqbal, M. Z. J. Org. Chem. 1999, 64, 8465−8467; 
(b) Majetich, G.; Zou, G.; Shougang, H. Org. Lett. 2013, 15, 4924−4927. 
81  (a) Sánchez, C.; Cárdenas, J.; Rodríguez-Hahn, L.; Ramamoorthy, T. P. 
Phytochemistry 1989, 28, 1681−1684; (b) González, A. G.; Andrés, L. S.; Luis, J. 
G.; Brito, I.; Rodríguez, M. L. Phytochemistry 1991, 30, 4067−4070; (c) Fraga, B. 
M.; Díaz, C. E.; Guadaño, A.; González-Coloma, A. J. Agric. Food Chem. 2005, 53, 
5200−5206; (d) Simmons, E. M.; Yen, J. R.; Sarpong, R. Org. Lett. 2007, 9, 
2705−2707; (e) Ziang, Z.-Y.; Huang, C.-G.; Xiong, H.-B.; Tian, K.; Liu, W.-X.; Hu, 
Q.-F.; Wang, H.-B.; Yang, G.-Y.; Huang, X.-Z. Tetrahedron Lett. 2013, 54, 
3886−3888. 
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 Hydride abstraction from the angular methyl group (X = H) or solvolysis of 
the primary alcohol (X = OH) 3.13 generates a primary cation 3.14 that immediately 
rearranges to the more stable ring expanded tertiary carbocation 3.15, to form the 
icetexane core structure. Ring expansions which lead to alkenes 3.16 via a 
deprotonation of carbocation 3.15 were experimentally supported. Indeed, such 
rearrangement were performed by treating primary hydroxyl abietanes such as 3.13 
with either thionyl chloride in dry benzene or p-TsCl in dry pyridine to yield alkene 
icetexanes such as 3.16. 82  Although, the carbocation (3.15) trapping by a water 
molecule was frequently suggested to access icetexanes bearing a C10 hydroxyl group 
like 3.17, no experimental evidence of such a mechanism was given.  
 Before being reassigned,72 the structure of pisiferin (3.1) was initially 
described as shown in Scheme 3.2 (3.18).71 Indeed, three bonds are susceptible to take 
part in the formation of a more stable tertiary carbocation: (1) the C10-C9 bond 
migration (red pathway in Scheme 3.2) leads to carbocation 3.19 and then to pisiferin 
(3.1) upon deprotonation; (2) and (3) the C10-C1 or C10-C5 bonds migration (blue 
and green pathway, respectively) would generate carbocations 3.20 or 3.21, 
respectively, which are both tertiary and benzylic carbocations and therefore more 
stable than 3.19 (if the conformational energy difference induced by the newly formed 
sp2 C+ is ignored). However, only structures featuring the icetexane skeleton were 
isolated, showing the prevalence of the C-aryl bond to undergo migration. This could 
be rationalized by a partial interaction of the empty p-orbital of the primary 
carbocation 3.22 with the partial negative charge, built up by the π electrons of the 
electron rich aryl group, therefore directing this p-orbital parallel to the electron rich 
C10-C9(aryl) σ-bond allowing an optimal orbital overlap for a nucleophilic attack 
(see box in Scheme 3.2). 
 
                                               
82 (a) Yatagai, M.; Takahashi, T. Phytochemistry 1980, 19, 1149−1151;  Kelecom, A. 
Tetrahedron 1983, 39, 3603−3608; (b) Hasegawa, S.; Hirose, Y.; Yatagai, M.; 
Takahashi, T. Chem. Lett. 1984, 1837−1838; (c) Kametani, T.; Kondoh, H.; 
Tsubuki, M.; Honda, T. J. Chem. Soc., Trans. 1 1990, 5−10. 
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Scheme 3.2: Possible ring expansion of a ferruginol C20 carbocation toward pisiferin.71,72 
3.1.4.! Previous syntheses of icetexanes members 
 
 The rare fused 6-7-6 ring system skeleton of icetexanes coupled with their 
wide-range of stereochemical and functional groups, their rich biological activity and 
intriguing biogenetic origin, make these compounds challenging targets for synthetic 
chemists. Indeed, the first total synthesis of racemic pisiferin (3.1) was accomplished 
in 1986 by Matsumoto and co-workers using a A + C " ABC strategy.83 During the 
last three decades, this predominant strategy for the synthesis of icetexanes was 
achieved through the coupling of the A ring with the C ring followed by the 
construction of the B ring. Six different variants of this strategy are shown in Scheme 
3.3 to Scheme 3.7, whereat the synthetic precursors will be linked to the 
corresponding retrosynthetic synthons. One example of an icetexane total synthesis 
will be given for each strategy. The syntheses of the B ring could be further classified 
into a top-down or a bottom-up approach whether the coupling of the A and C ring 
forms the top of the B ring or the bottom of this ring, respectively. The latter 
perspective will be discussed first.  
 The first variant (Scheme 3.3) to be employed for the synthesis of icetexanes 
was disclosed in the Matsumoto83 synthesis of pisiferin where aldehyde 3.23 and 
phosphonium salt 3.24, corresponding to synthons 3.25 and 3.26, were coupled via a 
Wittig olefination to give the attached A and C ring in which the bottom part of the B 
                                               
83 Matsumoto, T.; Imai, S.; Yoshinari, T.; Matsuno, S. Bull. Chem. Soc. Jpn. 1986, 59, 
3103−3108. 
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ring is formed. A successive double bond reduction, epoxidation, base catalyzed 
epoxide opening and allylic alcohol oxidation delivered enone 3.27 corresponding to 
synthon 3.28. Formation of the B ring of 3.29 was accomplished through an acidic 
intramolecular cyclization. Final steps include reduction and elimination reactions, 
which delivered the (±)-pisiferin. 
  
 
Scheme 3.3: Total synthesis of pisiferin by Matsumoto through variant A:83 1) n-BuLi, then 3.23; 2) H2, Pd/C; 3) 
m-CPBA; 4)LiNEt2; 5) PCC; 6) PPA. 
 The second variant used by Pan and co-workers, starts with enone 3.30 and 
alkyl iodide 3.31 (Scheme 3.4) corresponding to synthons 3.32 and 3.33 that were 
joined via a base catalyzed alkylation to furnish the attached A and C rings product 
3.34 corresponding to synthon 3.35.84 A sequence protocol consisting of a double 
bond reduction, a keto group protection, a formylation, a bromination of a primary 
alcohol and a keto deprotection furnished the alkyl bromide 3.36. The formation of 
the B ring was accomplished through an intramolecular Barbier reaction. Final 
dimethyl deprotection delivered the (±)-demethylsalvicanol 3.37. 
 
Scheme 3.4: Total synthesis of demethylsalvicanol by Pan through variant B:84 1) LDA then 3.31; 2) Li, NH3; 3) 
BF3!OEt2, (OHCH2)2; 4) n-BuLi, then PFA; 5) PBr3; 6) aq. HCl; 7) Zn; 8) NaH, EtSH. 
                                               
84 Wang, X.; Pan, X.; Cui, Y.; Chen, Y. Tetrahedron 1996, 52, 10659−10666. 
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 The third variant used by Shia and co-workers, starts with aldehyde 3.38 and 
aryl bromide 3.39, corresponding to synthons 3.40 and 3.41 (Scheme 3.5), which 
were coupled through a bromo-lithium exchange of 3.39 followed by an alkylation of 
3.38.85 A subsequent acidic dehydration furnished the alkene 3.42 corresponding to 
synthon 3.43. Double bond hydrogenation followed by an I/Li exchange/acylation 
sequence, generated ester 3.44, which displays the complete icetexane structural core. 
A five steps protocol consisting of a saponification, acidic intramolecular 
Friedel-Crafts acylation forming the icetexane skeleton, ketone reduction, 
dehydration, C1-C2 double bond reduction and deprotection, provided the 
(−)-isopisiferinc (3.45). 
 
 
Scheme 3.5: Total synthesis of (−)-isopisiferin by Liu and Shia through variant C:85 1) n-BuLi, then 3.38; 2) p-
TsOH; 3) n-BuLi, then ClCO2Me; 4) H2, Pd/C; 5) KOH; 6) TFAA, TFA; 7) NaBH4; 8) Et3N, MsCl; 9) H2, Pd/C; 
10) NaH, EtSH. 
 The fourth variant used by Jennings and co-workers,86 a top-down approach, 
starts with ketone 3.46 and aryl 3.47 (Scheme 3.6) corresponding to synthons 3.48 
and 3.49. Benzylic lithiation of 3.47 followed by addition of 3.46 furnished the 
tertiary alcohol 3.50 corresponding to the synthon 3.51. A sequence protocol 
consisting of an ozonolysis and Marson type cyclization delivered the B ring of the 
cyclic ether 3.52, displaying the icetexane skeleton. Final dimethyl deprotection 
delivered (±)-brussonol (3.7).81d 
 
                                               
85  Jan, N.-W.; Liu, H.-J.; Hsieh, M.-T.; Shia, K.-S. Eur. J. Org. Chem. 2010, 
4271−4275. 
86 Martinez-Solorio, D.; Jennings, M. P. Org. Lett. 2009, 11, 189−192. 
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Scheme 3.6: Formal total synthesis of brussonol dimethyl ether by Jennings through variant D:86 1) n-BuLi, then 
3.46; 2) O3, then PPh3; 3) BF3!OEt2. 
 The variant described by Pan and co-workers, starts with ketone 3.53 and aryl 
bromide 3.54, corresponding to synthons 3.55 and 3.56 (Scheme 3.7), which were 
combined through a base catalyzed alkylation to furnish 3.57 in line with synthon 
3.58.87 The ketone 3.57 was treated with vinyl magnesium bromide to form a tertiary 
alcohol that was directly transformed using chromic(VI) acid to yield the carboxylic 
acid 3.59. A sequence protocol consisting of a Friedel-Crafts acylation forming the 
icetexane skeleton succeeded by a A and B ring DDQ oxidation. Finally a selective 
reduction of a conjugated isopropene unit furnished the natural product taxamairin B 
(3.60). 
 
Scheme 3.7: Total synthesis of taxamairin (3.60) by Pan through variant E:87 1) KH, then 3.54; 2) H2C=CHMgBr; 
3) CrO3 in aq. H2SO4; 4) PPA; 5) DDQ; 6) H2, Pd/C. 
 Alternatively to the A + C " ABC approach, Sarpong and co-workers81d 
developed an elegant and efficient C (3.61) " ABC strategy towards the synthesis of 
icetexanes via an impressive Lewis acid mediated cycloisomerization of 3.62 to 
furnish the icetexane skeleton 3.63 that was further functionalized to form several 
                                               
87  Jan, N.-W.; Liu, H.-J.; Hsieh, M.-T.; Shia, K.-S. Eur. J. Org. Chem. 2010, 
4271−4275. 
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natural products such as the coulterone family member abrotanone (3.64, Scheme 
3.8). 
 
 
Scheme 3.8: Total synthesis of abrotanone (3.64) by Sarpong through a C " ABC strategy.81d 
Furthermore, strategies towards the icetexane tricyclic core structure were 
developed without forming the complete icetexane skeletons. In 1998, Whitby and co-
workers 88  developed a rapid access to the tricyclic 3.65 through an efficient 
intramolecular Diels-Alder reaction to form the B and C ring starting from the 
substituted A ring 3.66 (Scheme 3.9, A). The tandem cyclization-cycloaddition of 
rhodium (II) stabilized carbenes, providing an entry to the synthesis of diverse 
tetrahydrofurans, was developed by Padwa and co-workers89 and used towards the 
synthesis of icetexanes.90 The diazoketone 3.67 was able to generate the carbonyl 
ylide 3.68, which under the effect of either a rhodium(II) catalyst or heating, was able 
to undergo an impressive [3+2] cycloaddition thereby forming the desired tricyclic 
core of komaroviquinone (3.11) and the required β C10−O ether bond (3.69). 
 
 
Scheme 3.9: A) Whitby88 and B) Padwa89,90 strategies for the synthesis of 6-7-6 tricyclic core. 
                                               
88  Tuckett, M. W.; Watkins, W. J.; Whitby, R. J. Tetrahedron Lett. 1998, 39, 
123−126. 
89 Padwa, A.; Fryxell, G. E.; Zhi, L. J. Am. Chem. Soc. 1990, 112, 3100−3109. 
90 Padwa, A.; Chughtai, M. J.; Boonsombat, J.; Rashatasakhon, P. Tetrahedron 2008, 
64, 4758−4767. 
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3.1.5.! Target motivations and synthetic strategies 
3.1.5.1.! Goal of the study 
 
 In chapter 2, we reported the photolysis of taiwaniaquinone F (2.3) to 
taiwaniaquinol A (2.9) (Scheme 3.10, A) through which we proposed a hypothesis 
where such a methylenedioxy bridge bearing a 1,2,4-hydroxylated aryl moiety could 
be biosynthetically generated via a light promoted remote C−H activation. In 
biosynthesis, this postulate would then be complementary to the already accepted and 
established cytochrome P450 mechanism to produce methylenedioxy bridge (like 
cheilanthifoline), especially in the plant kingdom where the use of light as a source of 
energy is omnipresent. We also postulated that other natural products such as 
cyclocoulterone (3.10) and ET-743 (2.101, Scheme 3.10, B) could be formed via a 
similar mechanism. Therefore, the goal of this chapter is to demonstrate that the 
previously discovered photolysis of taiwaniaquinone F (2.3) is not limited to this 
substrate but in contrary, presents general validity to many other natural products 
displaying such motifs. In order to support this proposed, we envisaged to synthesize 
an additional natural product quinone with the general formula 3.70 to perform its 
photolysis to the methylenedioxy congener 3.71. Ideally, both natural products would 
be co-isolated from the same plant and therefore give further confirmation of our 
hypothesis. As already mentioned above, komaroviquinone (3.11) was isolated from 
D. komarovi (the whole plant) besides cyclocoulterone (3.10), indicating a possible 
biogenetic connection between both natural products. Furthermore, having obtained 
experience in diterpenoids natural products, komaroviquinone (3.11) was chosen as 
the target molecule, which could generate cyclocoulterone (3.10) under sunlight 
irradiation, and through this would validate our hypothesis. Although a previous 
report of Majetich and co-workers91 on the photolysis of komaroviquinone (3.11) in 
cyclohexane, which furnished komarovispirone (3.12) in high yield, we expected that 
the use of the conditions developed for the photolysis of taiwaniaquinone F (2.3) 
would change the course of the photolysis of komaroviquinone (3.11) in favor of 
cyclocoulterone (3.10). 
 
                                               
91 Majetich, G.; Jianhua, Y. Org. Lett. 2008, 10, 89−91. 
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Scheme 3.10: A) Remote C−H activation of taiwaniaquinone F (2.3) to taiwaniaquinol A (2.9); B) Possible 
methylenedioxy candidates biosynthesized via a quinone photolysis precursors. 
 As described in section 3.1.2, komaroviquinone (3.11) was found as an 
exceptionally efficient antichagasic agent.76 Chagas disease is a chronic and 
potentially mortal disease affecting about 8 million people mainly in Central and 
South America caused by the parasite Trypanosoma cruzi, which has a complex life 
cycle,92 therefore rendering treatments difficult. Indeed, the kissing bugs carrying the 
trypomastigotes, the infectious form of the parasite, bites the victim and defaces close 
to the wound provoking an infection. After cell penetration, the trypomastigotes 
transform to amastigotes, which duplicate and transform back to the infectious form. 
This phenomena causes the cell to burst and liberates the trypomastigotes into the 
blood stream, therefore causing tissues lesions. The mechanism of action of 
komaroviquinone (3.11) as trypanocidal active ingredient was elucidated by 
Uchiyama et al., 93 the same group that isolated most of the coulterones including 
komaroviquinone (3.11) and cyclocoulterone (3.10). The potency of komaroviquinone 
(3.11) as an antichagasic agent is attributed to a one electron reduction to the 
semiquinone radical anion 3.72 (under O2 free conditions and in presence of NADPH) 
by the reductase TcOYE, presents in all parasite forms (Scheme 3.11). The radical 
anion could be characterized by Electron Paramagnetic Resonance (EPR) 
                                               
92 Rassi Jr, A.; Rassi, A.; Marin-Neto, J. A. Lancet 2010, 375, 1388−1402. 
93 Uchiyama, N.; Kabututu, Z.; Kubata, B. K.; Kiuchi, F.; Ito, M.; Nakajima-Shimada, 
J.; Aoki, T.; Ohkubo, K.; Fukuzumi, S.; Martin, S. K.; Honda, G.; Urade, Y.)
Antimicrob. Agents Chemother. 2005, 49, 5123−5126. 
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spectroscopy. Once the reaction conditions were switched to aerobic, the quinone 
could be regenerated by oxidation with oxygen and produce a reactive oxygen 
species, the superoxide radical anion O2!−. Superoxide radical anion was therefore 
detected by EPR and is perhaps responsible to the parasite death.  
 
 
Scheme 3.11: Redox cycle of komaroviquinone (3.11) in presence of TcOYE, NADPH in aerobic conditions.93 
 The first total synthesis of (±)-komaroviquinone (3.11) was achieved by 
Banerjee and co-workers in 2005 using an approach corresponding to the previously 
described strategy D (Scheme 3.6) via an intramolecular Heck reaction.94 Two years 
later, Majetich and co-workersreported a racemic and an enantioselective total 
synthesis of komaroviquinone this time based on strategy E (Scheme 3.7).95 Recently, 
Iwasaki and co-workers, published a short and efficient enantioselective total 
synthesis of komaroviquinone (3.11) via strategy D (Scheme 3.6) with an elegant 
introduction of the C10-OH group through an acidic lactonization.96 
3.1.5.2.! Retrosynthetic Analysis  
 
As discussed in the previous section, the biosynthetic abietane origin of 
icetexanes was determinant for choosing an abietane as starting material. Ideally this 
                                               
94 Sengupta, S.; Drew, M. G. B.; Mukhopadhyay, R.; Achari, B.; Banerjee, A. K. J. 
Org. Chem. 2005, 70, 7694−7700. 
95 (a) Majetich, G.; Li, Y.; Zou, G. Heterocycles 2007, 73, 217−225; (b) Majetich, G.; 
Yu, J.; Li, Y. Heterocycles 2007, 73, 227−235. 
96 Suto, Y.; Kaneko, K.; Yamagiwa, N.; Iwasaki, G. Tetrahedron Lett. 2010, 51, 
6329−6330. 
O
O
OMe
OHH
O
O
O
OMe
OHH
O
1/2 NADPH
1/2 (NADP+ + H+)
TcOYE
O2
O2.-
EPR active
komaroviquinone (3.11)
3.72
!Chapter 3 54 
abietane should be commercially available, or naturally abundant and possess the 
optimal structural features for a redox and a protecting group economy synthetic 
route. With these objectives in mind, the commercially available and naturally 
abundant carnosic acid (3.73), which is used as an antioxidant and food 
preservative,97 was chosen as the starting material. The chirality of this material offers 
the advantage that no enantioselective step is necessary. 
 
 
Scheme 3.12: Retrosynthetic analysis of cyclocoulterone (3.10). 
 The methylenedioxy bridge formation, described in Scheme 3.12, was 
envisioned to occur via a remote C−H functionalization of komaroviquinone (3.11), 
as observed in chapter 2 for the synthesis of taiwaniaquinol A (2.9). The C14 
hydroxyl group was envisaged to be installed via an aromatic aerobic oxidation of the 
phenol 3.74 as already encountered for the synthesis of intermediate 2.84. A benzylic 
oxidation of the natural product salvicanol (3.6), which could be challenging due to 
the presence of several benzylic positions was required to introduce the C7 ketone in 
                                               
97 Aguilar, F.; Autrup, H.; Barlow, S.; Castle, L; Crebelli, R.; Dekant, W.; Engel, K.-
H.; Gontard, N.; Gott, D.; Grilli, S.; Gürtler, R.; Larsen, J. C.; Leclercq, C.; Leblanc, 
J.-C.; Malcata, F. X.; Mennes, W.; Milana, M. R.; Pratt, I.; Rietjens, Y.; Tobback, 
P.; Toldrá, F. The EFSA Journal 2008, 721, 1−29. 
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3.74.98 An acid catalyzed ring expansion of dimethoxy abietane (3.75) was anticipated 
to yield the seven membered ring as well as the β-C10 angular hydroxyl group of 
methylsalvicanol (3.76) as depicted in Scheme 3.1. A selective demethylation of 3.76 
should afford salvicanol (3.6). Finally, methylation and reduction of the carnosic acid 
(3.73) would allow the formation of 3.77 and 3.75, respectively. 
3.2.! Results and Discussion 
3.2.1.! Isolation and derivatization of Carnosic Acid 
 
Carnosic acid99  (3.73) is found in significant amount in Lamiaceae (mint 
family) and particularly in Rosmarinus officinalis (common rosemary, Figure 3.4) and 
Salvia officinalis (common sage). The content of 3.73 in the dried leaves is varying in 
proportion from 1% to 10% (on weight basis), depending on the species, the plant age 
and the environmental stress. 100  The European Commission approved rosemary 
extracts with high content of carnosic acid (3.73) as food additives (E392) in 2010, 
although such extracts were already used in food industry for more than 20 years. 101 
Four different extraction methods are regulated by the European Commission for the 
production of rosemary extracts as food additives (acetone, supercritical CO2, ethanol 
and hexane followed by ethanol)102. The method developed by Albu et al.103 using 
ethanol as extraction solvent combined with sonication was chosen for its simple 
operation and extraction efficiency. Ultrasounds enhance significantly the extraction 
efficiency due to the cavitation bubbles, which are able to break the cell walls of the 
plant, allowing the solvent to dissolve the internal components, such as carnosic acid 
(3.73). This method has the advantage to be fast and requires lower extraction 
temperature, which is crucial for carnosic acid (3.73) due to its temperature but also 
oxygen and light sensitivity.104 
                                               
98 Majetich, G.; Li, Y.; Zou, G. Heterocycles 2007, 73, 217−225. 
99 For a review on carnosic acid see: Birtic ,́ S.; et al. Carnosic acid. Phytochemistry 
2015, http://dx.doi.org/10.1016/j.phytochem.2014.12.026. 
100 Munné-Bosch, S.; Alegre, L. Planta 2000, 210, 925−931. 
101 http://www.astro-verl.com/de/wurst-abc/216-Carnosolsaeure 
102 Commission Regulation (EU) No 231/2012. 
103  Albu, S.; Joyce, E.; Paniwnyk, L.; Lorimer, J. P.; Mason, T. J. Ultrason. 
Sonochem. 2004, 11, 261−265. 
104 Zhang, Y.; Smuts, J. P.; Dodbiba, E.; Rangarajan, R.; Lang, J. C.; Armstrong, D. 
W. J. Agric. Food Chem. 2012, 60, 9305−9314. 
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Figure 3.4: Common rosemary (Italy). 
 The purification and isolation of carnosic acid (3.73) from crushed and dried 
leaves of rosemary (Rosmarinus officinalis, origin: Portugal) was achieved by HPLC 
as reported by Albu et al.103  However, due to the high sensitivity of carnosic acid 
(3.73), long storage of the extracted product was difficult as 3.73 has to be pure, 
protected from light, under argon at low temperature (-20 °C). The triple methylation 
of pure carnosic acid (3.73) using the modified conditions of Theoduloz et al.105 
(NaH, Me2SO4, THF, then MeOH) gave only a moderate yield of 3.77 (66%). 
Evidence in literature of the different constituents of rosemary (Figure 3.5), we 
changed our strategy in order to obtain higher quantities of 3.77. Indeed, these natural 
products (3.70, 3.78-3.81), could be converted to 3.77 through one step (methylation, 
3.78-3.79) or two steps (methylation and hydrogenation, 3.80-3.81), whereby 
carnosol106 (3.80) was also found as a major constituent of rosemary extracts. These 
findings increased the potential to obtain 3.77 in high amounts from rosemary extracts 
containing all the natural products. 
                                               
105 Theoduloz, C.; Pertino, M. W.; Rodríguez, J. A.; Schmeda-Hirschmann, G. Planta 
Med. 2011, 77, 882−887. 
106 Doolaege, E. H. A.; Raes, K.; Smet, K.; Andjelkovic, M.; Van Poucke, C.; De 
Smet, S.; Verhé, R. J. Agric. Food Chem. 2007, 55, 7283−7287. 
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Figure 3.5: Different phenolic compounds isolated from rosmarinus officinalis.106 
 In this regard, the dried ethanolic extract of rosemary, which was dissolved in 
Et2O (Scheme 3.13) was extracted with NaOH (1 M) in order to form the aqueous 
soluble sodium salt of phenols 3.70 and 3.78-3.81. Acidification (1 M aq. HCl) and 
ethereal extraction of the aqueous phase yielded an phenolic abietane enriched 
extract, which was subjected to the previously mentioned methylation conditions to 
yield a mixture of trimethylated carnosic acid (3.77), trimethylated 3.81 and 
dimethylated 3.82. The mixture was dissolved in MeOH, the undesired dimethylated 
3.82 precipitated and filtrated to leave an inseparable mixture of 3.77 and 
trimethylated 3.81 (1.46:1.00). This mixture was hydrogenated using Pd(OH)2 on 
charcoal under hydrogen atmosphere for 1 h to yield pure 3.77 (1.3% from dried and 
crushed rosemary). 
 
 
Scheme 3.13: Isolation and derivatization of carnosic acid (3.70). 
3.2.2.! Reduction of a congested angular ester  
 
Reduction of the angular methoxy ester group of 3.77 was necessary to access 
the primary alcohol 3.75 (Scheme 3.14), set up for a ring expansion towards the 
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icetexane skeleton (see following section). The known procedure,107  consisting of 
treating 3.77 with LiAlH4 (LAH) in refluxing THF in 3 h, furnished the desired 
primary alcohol 3.75 in moderate yields (40−60%) with side-product 3.83 (20−30%) 
and unreacted starting material (3.77). As reported by Kelecom and co-workers107, 
3.83 could not be converted to 3.75, even is if higher temperature were employed. 
 
 
Scheme 3.14: Reduction of trimethylcarnosic acid (3.77). 
The use of alternative reducing agent, such as LiBH4 (with or without Lewis 
acid), 108  Superhydride,109  BH3.DMS,110  BH3.THF111  or SmI2 (with pyrrolidine and 
water),112 lead to no or small conversion to the desired primary alcohol. The inertness 
of this reduction was attributed to the congested nature of the ester group. Finally, 
refluxing a solution of 3.77 in Et2O in presence of excess of LAH for 6 h furnished 
the desired 3.75 in excellent yield (89%). Astonishingly, if the reaction was 
performed in THF in a closed vessel, a similar conversion could be observed (TLC 
analysis) after 12 h at 60 °C, however, NMR, and mass data analysis revealed that the 
major product of the reaction was actually the Ar-OMe hydrogenolysis product 3.84, 
which was formed in high yield (83%).  
                                               
107 Kelecom, A. Tetrahedron 1983, 39, 3603−3608. 
108 Brown, H. C.; Narasimhan, S. J. Org. Chem. 1984, 49, 3891−3898. 
109 Brown, H. C.; Kim, S. C.; Krishnamurty, S.  J. Org. Chem. 1980, 45, 1−12. 
110 Truong, A. P.; Tóth, G.; Probst, G. D.; Sealy, J. M.; Bowers, S.; Wone, D. W. G.; 
Dressen, D.; Hom, R. K.; Konradi, A. W.; Sham, H. L.; Wu, J.; Peterson, B. T.; 
Ruslim, L.; Bova, M. P.; Kholodenko, D.; Motter, R. N.; Bard, F.; Santiago, P.; Ni, 
H.; Chian, D.; Soriano, F.; Cole, T.; Brigham, E. F.; Wong, K.; Zmolek, W.; 
Goldbach, E.; Samant, B.; Chen, L.; Zhang, H.; Nakamura, D. F.; Quinn, K. P.; 
Yednock, T. A.; Sauer, J.-M. Bioorg. Med. Chem. Lett. 2010, 20, 6231−6236. 
111 Brown, H. C.; Stocky, T. P. J. Am. Chem. Soc. 1977, 99, 8218−8226. 
112 Fazakerley, N. J.; Helm, M. D.; Procter, D. J. Chem. Eur. J. 2013, 19, 6718−6723. 
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Hydrogenolysis of Ar-OAlkyl bond can be carried out in a limited number of 
ways with a prevalence use of Ni113 and Ir114 catalysts under relatively harsh (1 atm 
H2, 120 °C, 48 h and 1 atm H2, 200 °C, 20 h, respectively). A possible mechanism is 
shown in Scheme 3.15. A metal oxidative insertion of an aryl methoxy substrate (A), 
followed by a β-hydride elimination would generate formaldehyde and an aryl metal-
hydride (B). Reductive elimination of this metal hydride would release the 
hydrogenolyzed aryl and the metal center (C), which under H2 conditions reduces 
formaldehyde to methanol (D).115 
 
 
Scheme 3.15: Possible metal catalysed hydrogenolysis of aryl-OMe.115 
A selective reductive aryl methyl ether bond cleavage was achieved very 
recently with the help of LAH as reducing agent, however, based on iron catalysis.116 
To the best of our knowledge, the only example showing a Aryl-OAlkyl 
                                               
113 Sergeev, A. G.; Hartwig, J. F. Science 2011, 332, 439−443. 
114  Kusumoto, S.; Nozaki, K. Nature Communications 2015, 6, 1–7. DOI: 
10.1038/ncomms7296. 
115 Zaheer, M.; Kempe, R. ACS Catalysis 2015, 5, 1675−1684. 
116 Ren, Y.; Yan, M.; Wang, J.; Zhang, Z. C.; Yao, K. Angew. Chem. Int. Ed. 2013, 
52, 12674−12678. 
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hydrogenolitic reactivity with the sole use of LAH was reported by Tweedie117 et al. 
in 1956. However, only 12% conversion was observed and the major compound of 
the reaction was the ArylO−Alkyl bond hydrogenolysis product and not the desired 
Aryl−OAlkyl bond. 
In order to rationalize this unexpected result, we performed various 
experiments to determine the reaction intermediate, the active species responsible for 
this over-reduction product (Scheme 3.14), and finally the origin of the installed 
hydrogen atom at C11. The early formation of 3.75, observed using the Kelecom 
conditions, strongly supports our theory that the ester reduction happened first, which 
further emphasized that the second reduction would be achieved via a OH 
deprotonated 3.75. Indeed, treatment of 3.75 with the best reaction conditions (LAH, 
THF, 50 °C, 7 h, closed vessel) smoothly furnished methylpisiferol (3.84) in high 
yield (80%). Longer reaction time (48 h) lead to an efficient formation of pisiferol 
(68%) via a hydride promoted demethylation118 or via ArO-CH3 hydrogenolysis. 
As no precedence of such efficient reactions could be found in literature using 
solely LAH, we aimed to investigate the possibility that this process could be 
facilitated by a degradation product of LAH (Li3AlH6, LiH, Al, H2) 119  or trace 
amounts of a metallic residue. With this intention, the hydrogenolysis of 3.75 was 
undertaken with freshly purified LAH (see SI for experimental details, THF, 70 °C, 
15 h, under Ar atmosphere) only as well as in combination of one of the different 
thermal decomposition products of LAH, and finally in combination of all of them 
(Table 3.1). The first general observation made, was a slower reaction rate. Indeed, 
the conversion with commercially available LAH was completed within 7 h at 50 °C. 
The hydrogenolysis product/starting material ratio (3.84/3.75) was higher for entry 1, 
3, and 5. These results were not sufficient to identify a thermal degradation product as 
the key component for the reactivity of the hydrogenolysis. Moreover, the generally 
lower reaction rate indicated that the commercially available reagent contains an 
additional additive (or in higher amount), necessary for a faster hydrogenolysis. 
                                               
117 Tweedie, V. L.; Cuscurida, M. J. Am. Chem. Soc. Chem. 1956, 79, 5463−5466. 
118 Majetich, G.; Zhang, Y.; Wheless, K. Tetrahedron Lett. 1994, 35, 8727−8730. 
119 Dilts, J. A.; Ashby, E. C. Inorg. Chem. 1972, 11, 1230−1236. 
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Table 3.1: Scope of additives to LAH hydrogenolysis. 
 
 
a Reaction conditions: LAH (6.4 eq.), Li3AlH6 (1.7 eq), LiH (4.3 eq), Al (2.3 eq.), 70 °C, 15 h. b Ratio 
determined by 1H-NMR. 
 
 We then explored the role of H2 (either produced by the reaction of the alcohol 
substrate or by thermal degradation of LAH) by changing the Ar to a H2 or a D2 
atmosphere. The reaction still proceeds as usual, however no rate enhancement, 
neither deuterium incorporation (with D2) was observed. 
 Preliminary studies (GC analysis of the reaction mixtures) of the reduction of 
three model substrates to analyze the substrate scope of this reaction were undertaken. 
Reduction of compound 3.85, showed Aryl−OMe hydrogenolysis products (3.86, 
3.87). However, ArylO−Me hydrogenolysis product (3.88, Scheme 3.16) could also 
be detected. The same conclusion could be made for the hydrogenolysis of the lignin 
model compound 3.89. Reduction of 3.90 showed, only traces of ArylO−Me 
hydrogenolysis product 3.91. This emphasizes the importance of the δ-position of the 
−OH group to the Aryl−OMe as well as the necessary conformation. 
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Scheme 3.16: Hydrogenolysis of various model substrate. In red are the Aryl−OMe hydrogenolysis product. In 
blue are the ArylO−Me hydrogenolysis product. 
 Finally, the LAH origin of the C11 hydrogen atom in 3.84 was confirmed by a 
LAD reduction of ester 3.77 (THF, 60 °C, 48 h), which delivered the C20 and C14 
deuterated product 3.92 in high isolated (72%) and isotopic yield (93%, Scheme 
3.17).  
 
 
Scheme 3.17: LAD reduction of trimethylcarnosic acid (3.77). 
 From these preliminary results and literature precedences, a mechanism could 
be suggested where the alkoxyhydroxyaluminate 3.93, formed after LAH treatment of 
the alcohol 3.75, undergoes an intramolecular hydride transfer to an eventual Lewis 
acid coordinated C11-OMe (Scheme 3.18). Indeed, alkoxyhydroaluminates are known 
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to possess enhanced hydride delivery abilities.120,121 Furthermore, coordination of the 
methoxy group to a Lewis acid, such as Li+, or some metallic residues from 
commercially available LAH, would decrease the electron density in the aromatic ring 
and therefore facilitate the hydride transfer. 
 
  
Scheme 3.18: Proposed mechanism for the hydrogenolysis of 3.77. LA = Lewis acid. 
 Further mechanistic experiments such as NMR studies are required to support 
this proposed mechanism. Treatment of alcohol 3.75 with LAH in fully deuterated 
THF should show the formation of the alkoxyhydroaluminate 3.93 and any 
coordination of a Lewis acid to the C11-OMe would display a clear methoxy 
downfield signal. Finally, increasing the measurement temperature could reveal the 
existence of transition states and/or other intermediates. 
3.2.3.! Ring expansion based on a biogenetic hypothesis and first 
synthesis of salvicanol 
 
The B ring expansion of 3.75 based on the previously described hypothesis 
was addressed next. Thus, we aim to follow the strategy described in section 3.1.3 via 
the formation of carbocation, such as 3.15, and its selective β-trapping with a water 
molecule. Although all reported examples showed a ring expansion followed by 
deprotonation yielding alkenes such as 3.16, no example of icetexane synthesis 
showed an introduction of a C10 hydroxyl group throughout the numerous successful 
ring expansions. The trapping of carbocation such as 3.15 would experimentally 
validate the reported biosynthetic hypothesis of icetexanes bearing a β-C10 angular 
hydroxyl group like salvicanol (3.6). Previous installations of C10 hydroxyl group on 
already constructed icetexane skeletons were performed over two steps from an 
                                               
120 Baudouy, R.; Goré, J. Tetrahedron Lett. 1974, 1593−1596. 
121 Breeden, W. B.; Coop, A.; Husbands, S. M.; Lewis, J. W. Helv. Chim. Acta 1999, 
82, 1978−1980. 
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alkene 3.94 or 3.95 through an epoxidation followed by a hydride epoxide opening122 
or, via an aqueous alkene bromination followed by a radical dehalogenation, 123 
respectively (Scheme 3.19). 
 
 
Scheme 3.19: Precedent strategies to install C10-OH group.122,123 
 A different approach by Corey and co-workers demonstrated that such 
transformations were feasible with a similar 6-6-6 ring system by treating the primary 
amine 3.96 with NaNO2, which forms the diazonium species 3.97 (Scheme 3.20).124 
Cationic ring expansion of the latter produced the tertiary carbocation 3.98, which 
upon water trapping, leads to the formation of the ring-expanded product 3.99 bearing 
an angular hydroxyl group. 
 
 
Scheme 3.20: Corey's ring expansion towards cortistatins.124 
                                               
122 Majetich, G.; Zou, G. Org. Lett. 2008, 10, 81−83. 
123 Majetich, G.; Yu, J.; Li, Y. Heterocycles 2007, 73, 227−235. 
124 Kürti, L:; Czakó, B.; Corey, E. J. Org. Lett. 2008, 10, 5247−5250. 
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Studies towards the ring expansion of the primary alcohols 3.75 or 3.84 were 
initiated under acidic conditions (Table 3.2, entry 1−6) in aqueous solution in order to 
trap the postulated formed carbocation to install the C10 hydroxyl group. However, 
none of the described conditions were able to provide the C10-OH icetexane. 
Nevertheless, treatment of 3.75 with either HPF6 (entry 3) or Amberlite 15 (entry 6) 
delivered an inseparable mixture of ring expanded icetexane alkenes 3.100. To the 
best of our knowledge, this is the first Brønsted acid mediated ring expansion of a 
non-activated primary alcohol like 3.75 to icetexanes. 
 
Table 3.2: Ring expansion studies towards icetexane skeleton. 
 
Entry Substrate Conditions Observationsa 
1 3.84 HCO2H, 50 °C formylated SM 
2 3.84 or 3.75 Conc. H2SO4 Complex mixture 
3 3.75 HPF6, aq. CH3CN 3.100 
4 3.75 Wet SiO2, 50 °C (MW) No reaction 
5 3.75 Amberlite IR120 No reaction 
6 3.75 Amberlite 15 3.100 
7 3.75 MsCl, Et3N, CH2Cl2 3.100 
8 3.84  MsCl, Et3N, CH2Cl2 3.101  
a SM: Starting material 
 
 The earlier employed harsh conditions that promoted the ring expansion of 
3.75 to 3.100 (entry 3 and 6) did not allow the formation of a C10 hydroxyl product. 
Indeed, such acidic conditions induce dehydration of tertiary alcohols. To prevent this 
side reaction, higher pH conditions were necessary. Therefore 3.75 and 3.84 were 
subjected to mesylation under basic conditions (MsCl, Et3N, DCM, entries 7 and 8) to 
form the corresponding mesylate esters. After work-up, during solvent evaporation at 
40 °C, the activated mesylate ester of 3.75 underwent a fast ring expansion to the 
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R R
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3.100
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corresponding alkenes 3.100. Absorption on silica gel was sufficient in promoting the 
rearrangement at rt. The mesylate ester of 3.84 was less heat sensitive but underwent 
a ring-expansion to 3.101 when absorbed on silica gel. Taking advantage of this silica 
gel mediated ring expansion, we decided then to combine both Kelekom and Corey’s 
strategies to obtain a ring-expanded icetexane with a C10 tertiary alcohol. To this end, 
the mesylation reaction mixture containing the mesylate ester 3.75 was absorbed on 
freshly prepared wet silica gel (1.5 mL H2O for 4.0 g of SiO2). The ring expanded 
tertiary alcohol 3.75 was obtained in this manner after five days at rt (Scheme 3.21) in 
acceptable yield (29%) along with an inseparable mixture of alkenes 3.100 (31%) and 
unreacted starting material (3.75, 7%). This ring expansion is the first experimental 
study that allows a water mediated trapping of a tertiary carbocation like 3.15. This 
constitutes the first experimental confirmation that validates the biosynthetic 
hypothesis of icetexane bearing a C10 tertiary alcohol, shown earlier (Scheme 3.1). 
The attack of water of such a carbocation was suggested to be disfavored from the 
β-face according to Dreiding’s model and therefore supporting an enzymatically 
guided attack.125 However, our exclusive β-selectivity challenges this hypothesis and 
thus supports a non-enzymatic mechanism. 
 
 
Scheme 3.21: Optimized ring expansion and first synthesis of salvicanol (3.6). 
                                               
125 Gonzales, A. G.; Andres, L. S.; Luis, J. G.; Ravelo, A. G. Phytochemistry 1991, 
30, 4067−4070. 
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An optimized protocol for the ring expansion was developed by changing the 
reaction solvent to THF, quenching the reaction mixture with water (0.80 mL for 1.0 
mL of THF) and heating the monophasic mixture to 40 °C for 12 h, allowing a 
combined yield increase to 94% for a lower reaction time (Scheme 3.21).  A selective 
hydride mediated demethylation (L-selectrive in THF, 80 °C, 2 h) developed by 
Majetich et al.126 on alkene 3.94 was successfully applied to the tertiary alcohol 3.76. 
Indeed, the less congested C11 methoxy was selectively demethylated with complete 
regioselectivity in high yield (80%) and shorter reaction time, leading to the first 
synthesis of salvicanol (3.6). All spectroscopic data is in agreement with the natural 
sample. The significant reaction rate enhancement could be explained by coordination 
effect attributed to the additional hydroxyl group of 3.76 with the bulky borane 
reagent as well as a C11-OMe-Li+ coordination. The alkenes 3.100, obtained in the 
course of the ring expansion of 3.75, could be converted to salvicanol in two 
consecutive steps consisting of an epoxidation carried out using a known procedure 
with m-CPBA,122 and a well established one-pot hydride (L-selectride) mediated 
epoxide opening / demethylation118 in 42% yield over two steps. Salicanol (3.6) could 
also be acetylated127 in high yield (90%) to afford salvicanol acetate (3.102), which 
was used for later studies. 
3.2.4.! Benzylic oxidation of salvicanol and its derivatives 
 
Having salvicanol (3.6) and its methyl and acetate derivatives (3.76 and 3.102, 
respectively) in hand, the C7 benzylic oxidation as well as the aromatic oxidation 
were the missing steps to accomplish the synthesis of komaroviquinone (3.11). As 
described previously, Majetich and co-workers95a reported an unsuccessful C7 
selective benzylic oxidation of a similar substrate 3.103 using the CrO3 (Scheme 
3.22). They conclude that the tertiary alcohol 3.103 would not allow oxidative 
conditions. Indeed, the tertiary alcohol was believed to form a free radical, 
responsible for the C10-C20 oxidative cleavage forming 3.104. 
 
                                               
126  Majetich, G.; Zhang, Y.; Tian, X.; Briton, J. E.; Li, Y.; Phillips, R. 
Tetrahedron 2011, 67, 10129−10146. 
127  Fraga, B. M.; González, A. G.; Herrera, J. R.; Luis, J. G.; Ravelo, A. G. 
Phytochemistry 1986, 25, 269−271. 
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Scheme 3.22: Attempted selective C7 benzylic oxidation of 3.103 by Majetich.95a 
 Due to the expected challenging benzylic oxidation, the aromatic oxidation of 
salvicanol (3.6) was first performed under aerobic conditions as described in chapter 2 
(O2, salcomine, MeCN) for the synthesis of 2.60 (see chapter 2). We were pleased to 
see that the same reaction condition furnished quinone 3.105 in 73% yield (Scheme 
3.23). Different oxidation strategies were investigated to install a keto-group at the C7 
position, which would result in the natural product komaroviquinone (3.11) (Table 
3.3, entry 4-7). Quinone 3.105 did not react with SeO2 oxidation in various solvent 
(dioxane, MeOH, AcOH, entry 4) although this method was known to efficiently 
oxidize this position in a very similar quinone system.128 The same findings could be 
made for the allylic oxidation approach using Co(acac)2 and TBHP (entry5). 129 
However, complete conversion of 3.105 was observed after reacting with CrO3 in 
AcOH (entry 6), yet the isolated product, which could not be structurally identified, 
showed to be different from komaroviquinone (3.11). A complex mixture was 
obtained when 3.105 was subjected to Sulikowski conditions (nPr4NRuO4, NMO, 
entry 7).130 
 
 
Scheme 3.23: Aromatic oxidation of salvicanol (3.6). 
As the standard procedures to oxidized 3.105 were unsuccessful to give the 
desired natural product, we next tried the direct benzylic oxidation of salvicanol (3.6), 
the corresponding methyl ether (3.76) and acetate (3.102) derivatives (Table 3.3). 
                                               
128 Yokoya, M.; Ito, H.; Saito, N. Tetrahedron 2011, 67, 9185−9192. 
129 Han, X.; Zhou, Z.; Wan, C.; Xiao, Y.; Qin, Z. Synthesis 2013, 45, 615−620. 
130  Boyd, V. A.; Reibenspies, J.; Sulikowski, G. A. Tetrahedron Lett. 1995, 36, 
4001−4004. 
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Selective functionalization of the benzylic positions, especially benzylic oxidation, is 
a long-established objective in organic synthesis. However, it was difficult to find the 
appropriate conditions for our substrates, due to the tremendous number of existing 
methods and the limiting substrate scope. Nevertheless, a long and careful screening 
was performed to obtain a method, which would provide reasonable yields of a 
selective benzylic oxidized product. 
 
Table 3.3: Benzylic oxidation screening. 
 
Entry Conditions Substrate Observations 
1 DDQ, aq. acetone (or AcOH) 3.6 3.106 (96%) 
2 RuCl3!xH2O, TBHP 3.6  3.105a 
3 Bi(0), picolinic acid, TBHP 3.6  Complex mixture 
4 SeO2 3.6, 3.76 
or 3.105 
No conversion 
5 TBHP, Co(acac)2 3.105 No conversion 
6 CrO3 3.105 Unknown compound 
7 nPr4NRuO4, NMO 3.105 Complex mixture 
8 KBr, Oxone, DCM/H2O 3.76 3.108a 
9 NaOCl2, NHPI, CH3CN/H2O 3.76 No conversion 
10 NaOCl, TEMPO, Co(OAc)2, DCM 3.76 Complex mixture 
11 DDQ, aq. acetone (or AcOH) 3.76 or 
3.102 
No conversion 
12 DCN, THF/H2O 3.76 or 
3.102 
No conversion 
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13 NaN3, PhI(OAc)2 3.102 Low conversion 
14 I2, pyr., TBHP 3.102 Low conversion 
15 Bu4NI, TBHP 3.102 Low conversion 
16 IBX 3.102 No conversion 
17 TBHP, MW 3.102 3.109a 
18 CrO3 3.76 Ea  
19 CrO3 3.102 Fa 
20 KMnO4, MgSO4, NaOH, t-BuOH 3.76 No conversion 
21 TBHP, Co(acac)2 3.76 No conversion 
22 Cr(CO)6, TBHP 3.76 No conversion 
23 Cr(CO)6, TBHP 3.102 3.109: 10% 
24 CrO3, TBHP 3.102 No conversion 
25 Co(OAc)2, TBHP 3.102 Low conversion 
26 FeCl3!6H2O, TBHP 3.102 Complex mixture 
27 Bi(OTf)3, picolinic acid, TBHP 3.102 Low conversion 
28 Rh2(cap)4, TBHP 3.102 3.109a 
29 Ru(Cl)2(PPh3)2, TBHP 3.102 3.109: 10%, 3.102: 40% 
30 ReOCl3(OPPh3)(SMe)2, TBHP 3.102 3.109a 
31 VCp2Cl2, TBHP 3.102 No conversion 
32 Bi(0), picolinic acid, TBHP 3.102 3.109: 17%, 3.102: 13% 
33 RuCl3!xH2O 3.102 3.109: 31%, 3.102: 19%  
34 Fe(OTf)2, ligands, H2O2 3.102 3.109a 
35 CuSO4!5H2O, K2S2O8 3.102 Complex mixture 
36 NaIO4, RuCl3!xH2O 3.102 Complex mixture 
37 KMnO4/CuSO4!5H2O 3.102  3.109a 
38 KMnO4/CuSO4!5H2O 3.76  3.110a  
Cond.: Conditions; NHPI: N-hydroxyphthalimide; TBHP: t-butyl hydroperoxide; DDQ: 2,3-dichloro-
5,6-dicyano-p-benzoquinone; DCN: 1,4-dicyanonaphtalene; NMO: N-methyl morpholine-N-oxide; a 
trace amounts 
 
 Salvicanol (3.6) was the first substrate that was subjected to benzylic 
oxidation conditions (Table 3.3, entries 1-4). DDQ oxidation (entry 1) in aqueous 
acetone failed to yield the desired ketone 3.74. Instead, the orthoquinone 3.106 was 
obtained in excellent yield (96% crude)122 perhaps through an aromatic oxidative 
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demethylation. Compound 3.106, very recently isolated from Perovskia 
atriplicifolia,131 has already been synthesized by Takeya132 and Majetich122 and our 
spectral data was in good agreements with both natural and synthetic samples. To the 
extent of our knowledge, this unexpected oxidation of monomethoxy catechol in 
presence of DDQ was reported only three times in poor to moderate yield (15-52%) 
and has received little attention.133 We believe that the importance of water as co-
solvent is the key to this high yielding reaction. Indeed, such a reaction could proceed 
via hydride transfer from the methoxy phenol 3.6 to DDQ, resulting in the formation 
of the reactive species 3.107 (Scheme 3.24). Nucleophilic attack of water on the 
oxonium methyl (red pathway) or on the C12 carbonyl atom (green pathway) would 
give the orthoquinone 3.106. To determine which pathway is preferred, the reaction 
should be performed in isotopically labeled water (18OH2). An investigation of the 
substrate scope could also be of interest. Another aromatic oxidation occurred when 
salvicanol (3.6) was treated with RuCl3 in presence of aqueous TBHP134 (entry 2) 
yielding trace amount of 3.105 without detection of the desired product 3.11. 
Moreover the use of Bi(0) catalyst in presence of TBHP (entry 3) or utilization of 
SeO2 (entry 4) lead to a complex mixture or no reaction conversion respectively. 
 
                                               
131 Jiang, Z.-Y.; Yu, Y.-J.; Huang, C.-G.; Huang, X.-Z.; Hu, Q.-F.; Yang, G.-Y.; 
Wang, H.-B.; Zhang, X.-Y.; Li, G.-P. Planta Med. 2015, 81, 241−246. 
132 Aoyagi, Y.; Takahashi, Y.; Fukaya, H.; Takeya, K.; Aiyama, R.; Matsuzaki, T.; 
Hashimoto, S.; Kurihara, T. Chem. Pharm. Bull. 2006, 54, 1602−1604. 
133 (a) Boldt, P.; Paul, K.-P. Chem. Ber. 1966, 99, 2337−2344; (b) Cimino, G.; De 
Luca, P.; De Stephano, S.; Minale, L. Tetrahedron 1975, 31, 271−275; (c) Magauer, 
T.; Martin, H. J.; Mulzer, J. Chem. Eur. J. 2010, 16, 507−519. 
134 Amaya, T.; Hifumi, M.; Okada, M.; Shimizu, Y.; Moriushi, T.; Segawa, K.; Ando, 
Y.; Hirao, T. J. Org. Chem. 2011, 76, 8049−8052. 
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Scheme 3.24: Possible mechanism for the DDQ oxidation of salvicanol (3.6). 
 The benzylic oxidation of the ring expanded alcohol 3.76 and salvicanol 
acetate (3.102) was explored as next. All benzylic oxidation attempts imply the 
possible formation of benzylic radicals. Among them, the use of halogenated species 
to generate these radicals (entries 8-10) resulted in either the formation of the 
side-product 3.108 (entry 8, presumably via the bromination with a Br+ species),135 no 
conversion (entry 9),136 or a complex mixture (entry10).137 The use of transition metal 
free conditions (entries 11-16)138 lead to low or no conversion with the exception of 
using of TBHP under microwave conditions (180 °C, CH3CN, entry 17)139 where the 
desired benzylic oxidized product 3.109 could be detected by 1H-NMR. Similar 
C10-C20 oxidative cleavage product, described by Majetich and co-workers (see 
Scheme 3.22), could be detected 1H-NMR when substrates 3.76 (entry 18) and 3.102 
(entry 19) were treated with CrO3 in acidic medium. Substrate 3.76 remained 
unreactive when treated with KMnO4 under basic conditions (entry 20). 
The successful formation of 3.109 motivated us to investigate additional 
combinations of transition metal catalysts in TBHP (entries 21-33). Indeed, the 
                                               
135 Moriyama, K.; Takemura, M.; Togo, H. Org. Lett. 2012, 14, 2414−2417. 
136 Silvestre, S. M.; Salvador, J. A. R. Tetrahedron 2007, 63, 2439−2445. 
137 Jin, C.; Zhang, L.; Su, W. Synlett. 2011, 11, 1435−1438. 
138  (a) Amemiya, T.; Yasunami, M.; Takase, K. Chem. Lett. 1977, 587−590; (b) 
Pandey, G.; Pal, S.; Laha, R. Angew. Chem. Int. Ed. 2013, 52, 5146−5149; (c) PhD 
thesis of Sasane, Kulbhushan A. Novel Synthetic Methodologies for Bioactive 
Molecules 2013, Chapter 3, p 96−126; (d) Zhang, J.; Wang, Z.; Wang, Y.; Wan, C.; 
Zheng, X.; Wang, Z. Green Chem. 2009, 11, 1973−1978; (e) Majji, G.; Guin, S.; 
Gogoi, A.; Rout, S. K.; Patel, B. K. Chem. Comm. 2013, 49, 3031−3033; (f) 
Nicolaou, K. C.; Montagnon, T.; Baran, P. S.; Zhong, Y.-L. J. Am. Chem. Soc. 2002, 
124, 2245−2258. 
139 He, H.; Pei, P.-J.; Lee, A. W. N. Green Chem. 2009, 11, 1857−1861. 
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formation of the desired product 3.109 was observed for several transition metals 
(entries 23, 28-30, 32 and 33) 140 . The optimal conversion was identified while 
reacting acetate 3.102 with modified conditions of the Hirao protocol (RuCl3!xH2O, 
TBHP, entry 33).140k The benzylic oxidation product was obtained in moderate yield 
(31%) along with starting material (19%). NMR analysis of this compound was 
difficult due to the keto-hemiketal tautomerism equilibrium between the open (3.109) 
and the closed form (3.111) (Scheme 3.25), as already observed on a similar hydroxy-
ketone by Suto and co-workers.96 
Conditions using transition metals without TBHP were also investigated 
(entries 34-38).141 However, compounds 3.110 (entry 38) or 3.109 (entries 34 and 37), 
were produced only in trace amounts. 
 
 
Scheme 3.25: Optimized benzylic oxidation conditions of 3.102 and product keto-hemiketal tautomerism. 
                                               
140 (a) Han, X.; Zhou, Z.; Wan, C.; Xiao, Y.; Qin, Z. Synthesis 2013, 45, 615−620; (b) 
Pearson, A. J.; Chen, Y.-S.; Hsu, S.-Y.; Ray, T. Tetrahedron Lett. 1984, 25, 
1235−1238; (c) Modica, E.; Bombieri, G.; Colombo, D.; Marchini, N.; Ronchetti, 
F.; Scala, A.; Toma, L. Eur. J. Org. Chem. 2003, 2964−2971; (d) Nakanishi, M.; 
Bolm, C. Adv. Synth. Catal. 2007, 349, 861−864; (e) Bonvin, Y.; Callens, E.; 
Larrosa, I.; Henderson, D. A.; Oldham, J.; Burton, A. J.; Barret, A. G. M. Org. Lett. 
2005,  7, 4549−4552; (f) Catino, A. J.; Nichols, J. M.; Choi, H.; Gottipamula, 
S.; Doyle, M. P. Org. Lett. 2005, 7, 5167−5170; (g) Murahashi, S.-I.; Komiya, N.; 
Oda, Y.; Kuwabara, T.; Naota, T. J. Org. Chem. 2000, 65, 9186−9193; (h) Peng, H.; 
Lin, A.; Zhang, Y.; Jiang, H.; Zhou, J.; Cheng, Y.; Zhu, C.; Hu, H. ACS Catal. 2012, 
2, 163−167; (i) Xia, J.-B.; Cormier, K. W.; Chen, C. Chem. Sci. 2012, 3, 
2240−2245; (j) Bonvin, Y.; Callens, E.; Larrosa, I.; Henderson, D. A.; Oldham, J.; 
Burton, A. J.; Barrett, A. G. M. Org. Lett. 2005, 7, 4549−4552; (k) Amaya, T.; 
Hifumi, M.; Okada, M.; Shimizu, Y.; Moriushi, T.; Segawa, K.; Ando, Y.; Hirao, T. 
J. Org. Chem. 2011, 76, 8049−8052. 
141 (a) Olivo, G.; Arancio, G.; Mandolini, L.; Lanzalunga, O.; Di Stephano, S. Catal. 
Sci. Technol. 2014, 4, 2900−2903; (b) Bhatt, M. T.; Perumal, P. T. Tetrahedron Lett. 
1981, 22, 2605−2608; (c) Ghosh, S.; Ghatak, U. R. Tetrahedron 1992, 48, 
7289−7296; (d) Noureldin, N. A.; Zhao, D.; Lee, D. G. J. Org. Chem. 1997, 62, 
8767−8772. 
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The problems encountered in the benzylic oxidations of salvicanol derivatives 
could be explained by the three benzylic C-H present at C7, C15 and C20, which are 
prone to oxidation in substrates 3.6, 3.76 and 3.102. The improved results obtained 
with salvicanol acetate (3.102) are due to the electronic effect of the acetate group,142 
which deactivates the ortho position (C20) for oxidation and therefore directs the 
course of the reaction preferably to the para position (C7) of the methoxy substituent. 
The second explanation would associate the ring size fused to the aromatic ring, with 
the efficiency of the benzylic oxidation. Indeed, a former study by Miller addressing 
the problematic benzylic oxidation of a seven membered ring system, suggested a 
greater ring strain to force the orbital occupied by the unpaired electron of the newly 
formed radical (or the empty p-orbital in case of a newly formed carbocation) in the 
same plane as the aromatic ring (to maximize the overlap of the p-orbital with the 
π-system for radical or carbocation stabilization, Figure 3.6).143 
 
 
Figure 3.6: Benzylic radical or carbocation stabilization. 
This interpretation was supported with the construction of a space-filling 
model of compound 3.112 and 3.113, whereby the benzylic carbon, in para position 
to the methoxy substituent (C6) was sp2 hybridized (to mimic the radical or 
carbocation character, Figure 3.6). A bigger ring strain was observed in a seven 
membered ring than in a six membered system, when the sp2 C7 was forced to be in 
the phenyl plane. Besides what, the chemical shift of the vinyl proton Ha and Hb of 
compounds 3.114 and 3.115, both having an exocyclic sp2 C6 methylidene group, 
were compared in NMR studies (Figure 3.7). In the case of the six membered ring 
3.114, it was found that the chemical shift of Ha was significantly higher than Hb, 
indicating the relative planarity of the C6 center, Ha being closer to the deshielding 
region of the aromatic ring. Regarding the seven membered ring of 3.115, the 
chemical shifts of both, Ha and Hb, were identical and lower, resulting from a 
                                               
142  Ramdayal, F. D.; Kiemle, D. J.; Lalonde, R. T. J. Org. Chem. 1999, 64, 
4607−4609. 
143 Miller, R. B.; Gutierrez, C. G. J. Org. Chem. 1978, 43, 1569−1573. 
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deviation out of the plane of the sp2 C6 methylidene group as depicted in Figure 3.7. 
For stabilization of any radical or carbocation, the sp2 C6 atom of a seven membered 
ring system has to be in the plane of the aromatic ring, thus requiring higher torsional 
strain than for the six membered ring. 
 
 
 
 
 
 
 
 
Figure 3.7: Space-filling model and NMR studies of different ring system C6 benzylic positions reported by 
Miller.143 
3.2.5.! Synthesis and photolysis of komaroviquinone 
 
For the completion of the synthesis of komaroviquinone (3.11, Scheme 3.26), 
the benzylic oxidized acetate was first deacetylated using KOH in methanol at rt for 
12 h. The crude mixture was subsequently submitted to aromatic oxidation of phenol 
3.74 using Salcomine in an O2 atmosphere with strict exclusion from light to yield the 
synthetic komaroviquinone (3.11) in 56% yield over two steps. However, longer 
reaction time (12 h) and high oxygen pressure (5 bar) were necessary in this case. 
These required condition adjustments could be explained by the C7 keto group, which 
lowers the electron density of the aromatic ring and therefore decreases the reactivity 
towards an aromatic oxidation. Furthermore, komaroviquinone (3.11) was obtained as 
the sole tautomer, which could be explained by the newly formed H-bond at the C14-
keto group, and by the increased electrophilicity of the C7-vinylogous ketone 
compared to the benzylic ketone in structure 3.109. 
Next, the photolysis of komaroviquinone (3.11), applying similar conditions as 
used for the synthesis of taiwaniaquinol A (2.9) (Et2O, sunlight, rt), was successfully 
carried out. We were delighted to observe the formation of the first synthetic 
cyclocoulterone as well as the known komarovispirone (3.12) in nearly equimolar 
ratio with an overall yield of 63%.  
Compound δ Ha (ppm) δ Hb (ppm) 
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3.115 4.91 4.91 
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Additionally, quinone 3.11 in an ethereal solution was reduced using an 
aqueous solution Na2S2O4 in a separatory funnel at rt for 1 min, which affords the first 
synthesis of coulterone (3.9) in high yield (82%). Finally, we could confirm the 
relative configuration of coulterone (3.9) by its chemical synthesis from the precursor 
salvicanol (3.6). To this point the relative configuration of 3.9 was previously 
assigned by 1H-NMR chemical shifts comparisons with salvicanol (3.6), which 
absolute configuration was determined by X-ray diffraction.125 
 
 
Scheme 3.26: Synthesis, photolysis and reduction of komaroviquinone, first synthesis of cyclocoulterone (3.10) 
and coulterone (3.9). 
As mentioned before, the previous photolysis of komaroviquinone (3.11), 
achieved with a low-pressure mercury lamp by Majetich and co-workers91 in 
cyclohexane, lead to the formation of komarovispirone (3.12) as the sole product. 
However, under sunlight irradiation, the authors reported the formation of an 
additional unknown compound in a CDCl3 solution. This could correspond to 
cyclocoulterone, but no analytical data was reported to verify this hypothesis. 
A possible mechanism, in accordance with the suggested proposal for the 
formation of komarovispirone (Majetich et al.91), is depicted in Scheme 3.27 to 
rationalize the formation of cyclocoulterone (3.10) using our established conditions. 
Light excitation of the n " π* transition of the quinone 3.11 generates the quinol 
diradical 3.116 that can undergo a 1,5-HAT between the alkoxy radical at C14 and the 
hydroxyl group at C7 to give 3.117. At this point, the compound 3.117 can either 
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fragment at the C6-C7 bond to form the biradical 3.118, which recombined to 
komarovispirone (3.12), or at the C7-O(C10) ether bond, which after a second 
1,5-HAT, recombine to yield cyclocoulterone (3.10). 
 
 
Scheme 3.27: Suggested mechanism for the co-formation of cyclocoulterone (3.10) and komarovispirone (3.12) 
through the photolysis of komaroviquinone (3.11). 
3.2.6.! Synthesis of barbutasol family members 
 
 As the direct benzylic oxidation of salvicanol (3.6) with DDQ generated the 
aromatic oxidized orthoquinone 3.106 in excellent yield (96%), which could not be 
purified by column chromatography on silica gel due to stability issues, we decided to 
investigate the outcome of a prolonged exposure of 3.106 on silica gel upon 
absorption. After 48 h at rt, the purification of the mixture by column chromatography 
on silica gel afforded two main products, identified as przewalskin E (3.8) and 
brussonol (3.7, Scheme 3.28). Interestingly, when the absorbed orthoquinone (3.106) 
was left in an open flask with frequent mixing (every 4 hours), higher yields of 
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przewalskin E (3.8, 50%) were obtained and no formation of brussonol (3.7) was 
observed.  
 
 
Scheme 3.28: Synthesis of przewalskin E (3.8), brussonol (3.7) and first synthesis of obtusinone D (3.124) and 
E (3.125). 
 The outcome of this reaction could be rationalized by a silica gel acid 
catalyzed tautomerization, forming the reactive quinone-methide intermediate 3.119 
(Scheme 3.29), which upon nucleophilic attack of the angular C10-OH on the 
electrophilic C7, delivers the natural brussonol (3.7). Upon aerobic condition, 3.7 
converts into its natural congener przewalskin E (3.8). Majetich and co-workers 
already reported such synthesis of brussonol (3.7) from 3.106 through heating a 
concentrated solution of 3.106 in Et2O (60 °C, 40 h, 70%).122 Similarly, Takeya and 
co-workers132 described the same transformation by heating 3.106, absorbed on 
magnesium silicates (Florisil®) in a microwave oven (150 °C, 5 min, 37%). However, 
none of these methods were suitable to produce przewalskin E (3.8) directly from 
3.106. Interestingly, only very few reports of catechols oxidation to orthoquinone 
were described on silica gel under aerobic conditions.144 Futhermore, the crucial role 
                                               
144 (a) Takuwa, A.; Ryoji, K. Bull. Chem. Soc. Jpn. 1990, 63, 623−625; (b) Vol’eva, 
V. B.; Belostotskaya, I. S.; Bundel’, A. Y.; Komissarova, N. L.; Ershov, V. V. Russ. 
Chem. Bull. 1997, 46, 385−386; (c) Vol’eva, V. B.; Prokof’ev, A. I.; Karmilov, A. 
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of silica gel was emphasized, when an acetonitrile or acetone solution of brussonol 
was stirred under oxygen atmosphere and only trace amounts of przewalskin E (3.8) 
could be observed after several days. 
 
 
Scheme 3.29: Mechanistic proposal for the formation brussunol (3.7) und przewalskin E (3.8). 
 Formation of such a reactive quinone methide from orthoquinone 3.119 under 
comparable reaction conditions, was reported by Burnell and co-workers.145 In their 
study, they synthesized paraquinone methide 3.120 from orthoquinone 3.121, which 
was obtained from the silver(I) oxide oxidation of catechol 3.122. Prolongated 
exposure of 3.120 to silica gel and air, produced the autooxidized maytenoquinone 
3.123 (Scheme 3.30). 
 
 
Scheme 3.30: Aerobic silica gel tandem tautomerization/oxidation of orthoquinone 3.121 by Burnell.145 
 The spectral data of brussonol (3.7), first isolated from Salvia brussonetii and 
showing insecticidal81c and anti-P388 leukemia cell acitivity,132 were in good 
agreement with those reported for the natural and synthetic products. The spectral 
data of przewalskin E (3.8), first synthetically prepared from natural 
                                                                                                                                      
Y.; Komissarova, N. L.; Belostotskaya, I. S.; Prokof’eva, T. I.; Ershov, V. V. Russ. 
Chem. Bull. 1998, 47, 1920−1923; (d) Vol’eva, V. B.; Prokof’eva, T. I.; 
Belostotskaya, I. S.; Komissarova, N. L.; Ershov, V. V. Russ. Chem. Bull. 1997, 46, 
385−386. 
145 Burnell, R. H.; Jean, M.; Marceau, S. Can. J. Chem. 1987, 66, 227−230. 
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demethylsalvicanol,132 and subsequently isolated from Salvia przewalskii MAXIM,146 
corresponds perfectly to the synthetic material, but significantly deviates from the 
natural sample. Although the 13C-NMR chemical shifts (0.1-0.4 ppm) and the optical 
activity of the isolated sample reasonably matches with our synthetic substance, the 
1H-NMR chemical shifts (0.01-0.08 ppm) and FT-IR absorption bands (the main 
signal at 1660 cm-1 was not reported, and signals at 1722, and 1680 cm-1 were found 
with much lower intensity) significantly diverges from the synthesized samples. 
Moreover, the natural compound was isolated as a white powder and our synthetic 
sample as a red amorphous solid, the typical color of orthoquinones. Unfortunately, 
the authors did not compare their sample with the synthetic compound of Takeya. 
However, the structure of przewalskin E (3.8) could be verified by interconverting it 
to brussonol (3.7) by reduction with aqueous Na2S2O4 in excellent yield (94%, 
Scheme 3.28). The resulting brussonol (3.7) was then oxidized back to przewalskin 
E (3.8) following the Takeya protocol (DDQ, dioxane).132 
 Having confirmed the structure of our synthetic 3.8, the synthesis of the rarely 
found dimeric icetexanes obtusinones D (3.124) and E (3.125) was addressed next 
(Scheme 3.28). The first example of such icetexane dimers is grandione, which was 
isolated by Riccio et al. 147 in 1999 from Toreya grandis and synthesized  by Takeya 
and co-workers in 2005 (the structure was reassigned later) via a solid state 
hetero-Diels-Alder dimerization of orthoquinone 3.106.148 Obtusinone D (3.124) and 
E (3.125), which were recently isolated by Salae and Boonnak,149 were suggested to 
biogenetically originate from a similar Diels-Alder dimerization of 
przewalskin E (3.8). Having 3.8 in hand, modified Takeya conditions (neat, 100 °C, 6 
h) were applied to achieve the first synthesis of both obtusinone D (3.124) and 
E (3.125) (1.7 : 1.0), in high overall yield (69%). The separation of both synthesized 
natural products proved to be difficult, using either column chromatography or pTLC 
on silica gel utilizing the eluent reported in the isolation study.149 We expected that 
                                               
146 Xu, G.; Peng, L.-Y.; Tu, L.; Li, X.-L.; Zhao, Y.; Zhang, P.-T.; Zhao, Q.-S. Helv. 
Chim. Acta 2009, 92, 409−413. 
147 Galli, B.; Gasparrini, F.; Lanzotti, V.; Misiti, D.; Riccio, R.; Villani, C.; Guan-Fu, 
H.; Zhong-Wu, M.; Wan-Fen, Y. Tetrahedron 1999, 55, 11385−11394. 
148  Aoyagi, Y.; Takahashi, Y.; Satake, Y.; Fukaya, H.; Takeya, K.; Aiyama, R.; 
Matsuzaki, T.; Hashimoto, S.; Shiina, T.; Kurihara, T. Tetrahedron Lett. 2005, 46, 
7885−7887. 
149 Salae, A.-W.; Boonnak, N. Tetrahedron Lett. 2013, 54, 1356−1359. 
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the π-stacking of both natural products could be responsible for the same retention 
time. Consequently, we decided to change our eluent system by adding toluene to our 
solvent mixture, to break the π-stacking between 3.124 and 3.125. Fortunately, the 
natural products were then successfully separated by pTLC with the optimized eluent 
(pentane/toluene/Et2O, 5/5/1). The spectral data of both synthetic natural products 
was in perfect agreements with the natural samples. However, an X-ray analysis of a 
single crystal of obtusinone D (3.124, Figure 3.8) could be obtained and the structure 
shows an opposite C13 and C14 configuration as reported by Salae and Boonnak.149 
Indeed, these authors established the C13 and C14 stereochemical assignement of 
3.124 based on a NOESY correlation between H7 and H14 and between H14 and 
Me16. The close proximity of H7 and H14 revealed by the X-ray crystallographic 
analysis of 3.124 (Figure 3.8), could explain the NOESY correlation measured by 
Salae and Boonnak149 between these two centers. This NOESY correlation was later 
confirmed by us, therefore further supporting the authenticity of our synthetic 
obtusinone D.  
 
 
Figure 3.8: X-ray crystallographic analysis of 3.124. Red = oxygen, grey = carbon, white = hydrogen. 
 The synthetic X-ray crystallographic analysis of 3.124 (Figure 3.8) 
unambiguously leads to the structural reassignment of the natural product 
obtusinone D (3.124), represented by the revised structure R3.124 (Figure 3.9, B). 
Consequently, the C13 and C14 configuration of obtusinone E (3.125) is suggested to 
be identical with obtusinone D (3.124), shown in the revised structure R3.125 (Figure 
3.9, B). 
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Figure 1. Examples of subclasses of icetexanes according to Sarpong. 
 
Figure 3.9: A) Originally proposed and B) revised structure of obtusinones D and E. 
 The different regioselectivity ratio of the isolated natural products 
(3.124:3.125, 4:1) compared to the synthetic study (3.124:3.125, 1.7:1.0) could be 
explained by the higher temperature needed to achieve the Diels-Alder reaction in 
high yield and reasonable reaction time. Indeed, the authors justified their ratio by 
steric arguments. When the reaction was performed at 55 °C, the reaction conversion 
was only 43% after 18 h (instead of 6 h at 100 °C, see above), therefore, at 
physiological conditions, the thermal Diels-Alder does not appeared realistic. 
Consequently, the higher selectivity achieved by nature, could be explained by an 
acid catalyzed Diels-Alder that would lower the energy the LUMO of the dienophile 
and therefore increasing the reactivity. The difference in orbital coefficients of the 
LUMO would also be increased, thus increasing the regioselectivity. To test our 
hypothesis, przewalskin E (3.8) was stirred at rt in DCM in presence of AlCl3. 
However, this resulted only in a complex mixture. Due to limitation of material we 
could not further investigate additional acids such as TFA or boronic acids. 
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3.2.7.! Synthesis of pisiferin family members 
 
 Since methylpisiferol (3.84) was accessible from the hydrogenolysis of 
hydroxyl compound 3.77 in substantial amounts, we decided to continue our effort 
with the synthesis of pisiferin family members such as euolutchuol E (3.3) using our 
aqueous ring expansion strategy. Consequently, 3.84 (Scheme 3.31) was subjected to 
the ring expansion conditions developed earlier (MsCl, Et3N, THF, −10 °C, 20 min; 
then H2O, 40 °C, 12 h). To our delight, these conditions afforded the ring expanded 
tertiary alcohol methylpisiferanol (3.4, 29%), which spectral data being in excellent 
agreement with the natural sample isolated from the leaves of Chamaecyparis 
formosensis.150 Additionally, an inseparable mixture of ring expanded alkenes 3.126 
was isolated in 62% yield, therefore giving an excellent overall yield (92%) of the 
ring expansion (Scheme 3.31). Interestingly, the methoxy hydrogenolysis of 
methylsalvicanol (3.76) was also possible, using commercial LAH (detected by 1H-
NMR). However, a complete conversion could not be achieved (starting material and 
product were inseparable), and longer reaction time, lead to decomposition of both 
starting material and product. This emphasizes once again the importance of the 
conformational bias of the hydroxyl group to achieve an efficient hydrogenolysis. 
 
                                               
150 Lin, T.-C.; Fang, J.-M.; Cheng, Y. S. Phytochemistry 1999, 51, 793−791. 
!Chapter 3 84 
 
Scheme 3.31: Synthesis of 12-O-methylpisiferanol, pisiferanol (3.2). 
 Demethylation of 3.4 using the previously applied conditions (L-Selectride in 
THF, 80 °C, 3 h, Table 3.4, entry 1) resulted only in a complex mixture without traces 
of the desired pisiferanol (3.2). The use of BBr3 in DCM or AlCl3 in combination with 
EtSH (entry 2 and 3), lead to similar results. In contrast, basic conditions using EtSNa 
in DMF at 140 °C for 12 h (entry 4), lead to a low conversion of starting material and 
traces of psiferanol (3.2). Encouraged by these results, the reaction was repeated with 
slight modifications utilizing in situ prepared EtSNa (from NaH and EtSH in DMF, 
entry 5). In this regard, 3.2 was obtained in excellent yield (97%). Part of the spectral 
data was in excellent agreement (FTIR, [α]) with the natural sample isolated from 
Chamaecyparis pisifera.151 Unfortunately, the 1H-NMR and the 13C-NMR chemical 
shifts showed significant deviation, especially concerning the aromatic signals. 
Extensive literature research revealed only one set of NMR data of pisiferanol (3.2) 
(here named lanigerol), re-isolate of from Salvia lanigera.152 Also here, our spectral 
data did not match the reported one, although the spectral data varied from the one of 
                                               
151 Hasegawa, S.; Kojima, T.; Hirose, Y. Phytochemistry 1985, 24, 1545−1551. 
152 El-Lakany, A. M.; Abdel-Kader, M. S.; Sabri, N. N.; Stermitz, F. R. Planta Med. 
1995, 61, 559−560. 
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Hasegawa. In order to confirm the structure of our synthetic pisiferanol (3.2), a full 
spectroscopic characterization was performed, which confirmed the structure of our 
synthetic sample.  
Table 3.4: Aromatic demethylation of methylpisiferanol (3.4). 
 
Entry Conditions Observation 
1 L-Selectride in THF, 80 °C, 3 h Complex mixture 
2 BBr3, DCM, −78 °C to 0 °C, 20 min. Complex mixture 
3 AlCl3, DCM, EtSH, 0 °C to rt, 20 min. Complex mixture 
4 NaSEt, DMF, 140 °C, 12 h Low conversion, traces of 3.2 
5 NaH, EtSH, DMF, 140 °C, 12 h 3.2 (97%) 
 
 With pisiferanol (3.2) in hand, the synthesis of euolutchuol E (3.3), an 
icetexane isolated from Euonymus lutchuensis,153 was attempted with the objective to 
form the intermediate orthoquinone methide 3.125 (Scheme 3.32). This reactive 
species should deliver euolutchuol E (3.3) upon nucleophilic attack on C7, via an 
analogous approach used for the synthesis of brussonol (3.7). Consequently, 
pisiferanol (3.2) was treated with an excess of DDQ in dioxane at rt for 16 h and an 
aqueous workup with brine followed by a fast pTLC purification resulted in the first 
synthesis of the natural product euolutchuol E (3.3) in moderate yield (45%) along 
with recovered unreacted pisiferanol (3.2, 17%). It is noteworthy to mention that the 
typical workup procedure for such reaction conditions, including filtering of the 
reaction mixture through a pad of silica gel or celite, gave only complex mixtures. 
Such a decomposition was observed by TLC analysis when the starting material 
and/or the product was in a simultaneous contact with silica gel (on the TLC) and 
DDQ (in excess in the reaction mixture). This process could be observed by a color 
change of the absorbed sample from orange to dark brown within a minute. To 
improve the yield of the reaction, different oxidants such as Ag2O, or K3Fe(CN)6 were 
                                               
153 Inaba, Y.; Hasuda, T.; Hitotsuyanagi, Y.; Aoyagi, Y.; Fujikawa, N.; Onozaki, A.; 
Watanabe, A.; Kinoshita, T.; Takeya, K. J. Nat. Prod. 2013, 76, 1085−1090. 
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tested in different solvents. However, these experiments resulted only in complex 
mixtures. 
 
 
Scheme 3.32: First synthesis of euolutchuol E (3.3). 
3.2.8.! Synthetic studies toward the synthesis of dihydrolatifolionol 
and its congeners 
 
 Recently, Babu and co-workers reported the isolation of dihydrolatifolionol 
(3.128, Scheme 3.33) and two related icetexanes (3.129 and 3.130, Scheme 3.35) 
from Premna latifolia.154 These compounds showed cytotoxic activity against HT-29 
and Hep-G2 cancer cell lines. As these natural products are structurally related to the 
previously synthesized orthoquinone 3.106 and przewalskin E (3.8), and with our 
experience in the photolysis of paraquinone 3.11 and taiwaniaquinone F (2.3), the 
synthesis of the D ring of dihydrolatifolionol (3.128) might be achieved in similar 
manner. Indeed, the formation of the biradical species 3.131 via a light irradiation of 
3.106 would undergo a [1,5]-HAT to form the isopropyl biradical 3.132, which upon 
a successive [1,4]-HAT followed by radical recombination should form the D ring of 
dihydrolatiflionol (3.128). 
 
 
Scheme 3.33: Hypothetical photolysis of orthoquinone 3.106. 
                                               
154 Suresh, G.; Babu, K. S.; Rao, V. R. S.; Rao, M. S. A.; Nayak, V. L.; Ramakrishna, 
S. Tetrahedron Letters 2011, 52, 1273−1276. 
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 Previous photolysis of orthoquinones displaying such reactivity was described 
by Thomson and co-workers.155 Indeed, sunlight irradiation of quinone 3.133 in an 
acetonitrile solution yielded lactone 3.134 in high yield (76%). The suggested 
mechanism in Scheme 3.34 shows a 1,5-HAT of an excited state of quinone 3.133 
giving the biradical intermediate 3.135. A subsequent 1,4-H abstraction would 
generate the alkoxy radical 3.136, which upon recombination, furnishes the lactone 
3.134. 
 
 
Scheme 3.34: Photolysis of orthoquinone aldehyde 3.133 to lactone 3.134 by Thomson.155 
 Encouraged by these reported results, the photolysis of the orthoquinone 3.106 
was performed with the previously described conditions used for the synthesis of 
taiwaniaquinol A (2.9) and cyclocoulterone (3.10, Et2O, sunlight). A complete 
discoloration of the iniatially intense orange solution after 30 min. in direct sunlight 
was observed, along with complete conversion of the starting material. However, 
analysis of the reaction mixture showed an inseparable complex mixture, whereby 
NMR analysis did not show any traces of the desired natural product. The same 
observations were made when the reaction was performed in different solvents such 
as CHCl3, t-BuOH, benzene and aqueous MeOH. Due to these results, the photolysis 
of przewalskin E (3.8), a possible biogenetic precursor of dihydrolatifolionol (3.128) 
was addressed next. Sunlight irradiation of 3.8 would provide the cyclized product 
3.137, which upon exposure to reductive conditions (such as Pd(OH)2/C, H2, MeOH) 
would furnish dihydrolatifolionol (3.128). Moreover, acid treatment of 3.137 could 
generate a benzylic carbocation 3.138, which upon deprotonation would yield the 
alkene 3.129. Epoxidation of 3.129 would give the reactive epoxide 3.137 (although 
the stereoselectivity of this reaction is not clear), which under acidic or basic medium 
would tautomerize to the desired alcohol 3.130 via a Payne-like rearrangement 
mechanism. Furthermore, reduction of alkene 3.129 would also provide 3.128. 
                                               
155 Ferreira, M. A.; King, T. J.; Ali, S.; Thomson, R. H. J. Chem. Soc., Perkin Trans. 
1, 1980, 249−256. 
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Consequently, przewalskin E (3.8) was exposed to sunlight in an ethereal solution. 
Unfortunately, the fully converted reaction delivered an unstable product that could 
not be isolated nor characterized by NMR spectroscopy (thermally and silica gel 
sensitive). Reduction of the crude mixture using Pd(OH)2/C in the presence of one 
atmosphere of H2 in MeOH did not lead to the formation of the natural product. 
Instead, a complex mixture was obtained. 
 
 
Scheme 3.35: Photolysis of orthoquinone 3.106 and 3.8 as well as possible biogenetic connection of 
dihydrolatifolionol and its congeners. 
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3.2.9.! Conclusion and outlook 
 
 A divergent, elegant and short synthesis of thirteen members of the icetexane 
natural products was achieved in few steps from the abundant (+)-carnosic acid 
(3.73), isolated from Rosmarinus officinalis. Among these members, (+)-salvicanol 
(3.6), (−)-cyclocoulterone (3.10), (−)-coulterone (3.9), (−)-obtusinone D (3.122), 
(−)-obtusinone E (3.123), and (−)-euolutchuol E (3.3) were synthesized for the first 
time. A straightforward, inexpensive and efficient sequence, consisting of methylation 
and hydrogenation of rosemary ethanol extracts enriched with carnosic acid (3.73) 
was developed to obtain the desired trimethyl carnosic acid 3.77 in high yield. Salient 
features of the synthesis of salvicanol include a single step ring expansion of the 
abietane 3.75 to the icetexane 3.76, bearing an angular hydroxyl group at C10, which 
constitute the first experimental proof for a tertiary carbocation trapping such as 3.15 
by a water molecule, and a selective aromatic demethylation. (+)-Salvicanol (3.6) was 
used as a common intermediate to synthesize: (1) (−)-brussonol (3.7) and 
(−)-przewalskin E (3.8) in two steps via an aromatic oxidation to form the 
orthoquinone 3.106, followed by an aerobic silica gel based tautomerization and 
oxidation; (2) (−)-obtusinone D (3.124) and (−)-obtusinone E (3.125) through a 
hetero-Diels-Alder of (−)-przewalskin E (3.8); (3) (+)-komaroviquinone (3.11) via a 
selective benzylic oxidation and an aromatic oxidation; (4) (−)-cyclocoulterone (3.10) 
and (+)-komarovispirone (3.12) by a sunlight photolysis of (+)-komaroviquinone 
(3.11). This result supports our previous biogenetic hypothesis for the non-enzymatic 
formation of methylenedioxy catechol natural products; (5) (−)-coulterone (3.9) 
through hydrogenation of (+)-komaroviquinone (3.11). Furthermore, pisiferins such 
as (+)-pisiferanol (3.2), (+)-methylpisiferanol (3.4) and (−)-euolutchuol E (3.3) were 
synthesized via the discovery of an impressive methoxy hydrogenolysis of 3.75 using 
LAH. 
 An alternative strategy towards the difficult benzylic oxidation encountered 
earlier might be provided by the discovery of the silica gel tautomerization of 
orthoquinone 3.106 to brussonol (3.7). Indeed, oxidation reactions at this position 
might be more favored (Scheme 3.36). Therefore, a benzylic oxidation (DDQ, aq. 
acetone) of dimethylbrussonol (3.140) could deliver the ketone 3.141, which upon 
selective demethylation (tBuSNa, DMF) would give our already synthesized phenol 
3.74, a direct precursor of komaroviquinone (3.11). 
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Scheme 3.36: Brussonol (3.7) as a substrate candidate for the benzylic oxidation. 
 Further targets could be achieved following our synthetic route. Fokihodgin J 
(3.142), isolated from Fokienia hodginsii by Zhao and co-workers, 156  could be 
obtained through an oxidative dearomatization of the natural pisiferanol (3.2) using a 
hypervalent iodine source such as phenyliodine diacetate (PIDA, IIII) and a 
nucleophilic water attack para to the activated intermediate 3.143 (Scheme 3.37). 
 
 
Scheme 3.37: Oxidative strategy towards the synthesis of fokihodgin J (3.142). 
 Another accessible target via the direct transformation of one of our synthetic 
natural products could be the przewalskone A (3.144), which was isolated from Salvia 
przewalskii in 2012 by the Zhao group.157 It is noteworthy to mention that the same 
group isolated przewalskin E (3.8) from the same plant.146 Compound 3.144 could be 
obtained through a hetero-Diels-Alder cycloaddition of a przewalskin E (3.8) diene 
                                               
156 Wu, X.-D.;  He, J.; Li, X.-Y.; Dong, L.-B.; Gong, X.; Song, L.-D.; Li, Y.; Peng, 
L.-Y.; Zhao, Q.-S. J. Nat. Prod. 2013, 76, 1032−1038. 
157 Xu, G.; Yang, X.-W.; Wu, C.-Y.; Li, X.-N.; Su, J.; Deng, X.; Li, Y.; Qin, H.-B.; 
Yang, L.-X.; Zhao, Q.-S. Chem. Commun. 2012, 48, 4438−4440. 
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and a dienophile 3.145 (its enantiomer dehydrodanshenol A158 was isolated within the 
same plant, Scheme 3.38). This reaction would be analogous to the one implemented 
for the synthesis of obtusinones D (3.124) and E (3.125). 
 
 
Scheme 3.38: Hetero-Diels-Alder strategy towards the synthesis of przewalskone A (3.144)
                                               
158 Jiang, H.-L.; Wang, X.-Z.; Xiao, J.; Luo, X.-H.; Yao, X.-J.; Zhao, Y.-Y.; Chen, Y.-
J.; Crews, P.; Wu, Q.-X. Tetrahedron 2013, 69, 6687−6692. 
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4.!Synthetic studies towards the mechanistic 
elucidation of the remote C−H 
functionalizytion of taiwaniaquinone F and 
komaroviquinone 
 
4.1.!Introduction 
4.1.1.! Discovery and beginning of solar chemistry  
 
 Sunlight promoted photochemistry arose probably billion years ago on our 
planet. With photosynthesis arising on the planet, plants utilized sunlight to convert 
water and CO2 into solar fuels (e.g. sugars) and oxygen. The photolysis of oxygen 
produced ozone protecting terrestrial life from high energy UV light. These 
photochemical reactions remained unknown to humans before they started to observe 
that the appearance of many materials changed upon sunlight exposure.159  
 Three kinds of chemical alterations could be observed by mankind after 
sunlight exposure of various inorganic and organic compounds: 1) color change; 
2) evolution of gas; and 3) the precipitation of less soluble photolyzed products.  
 In 1886, Klinger observed the formation of a precipitate of an ether solution of 
benzil (4.1).160 This precipitate was characterized as a 2:1 complex of benzil (4.1) and 
benzoin (4.2), respectively. Initially, Klingler could not reproduce these results. 
Surprisingly, he described his frustration and the time consuming experiments, where 
the key reaction parameter was unknown. Finally, he recognized that the tubes 
containing a solution of 4.1 were exposed sunlight, inducing the ketone reduction. 
 
                                               
159 Roth, H. D. Angew. Chem. Int. Ed. 1989, 28, 1193−1207. 
160 Klinger, H. Ber. Dtsch. Chem. Ges. 1886, 19, 1862−1870. 
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Scheme 4.1: Sunlight mediated reduction of benzil diketone (4.1) by Klinger.160 
 Having recognized the potential of light to induce the reduction of ketones in 
solution, Klinger performed the reduction of other ketones such as 
phenanthrenequinone (4.3),160 to obtain the reduced catechol 4.4. Two years later, he 
reported the same photolysis, this time in acetaldehyde, and to his own surprise he 
observed the formation of the acetate 4.5.161 
 
 
Scheme 4.2: Sunlight irradiation of 4.3 in Et2O160 and in MeCHO.161 
 One of the first photochemical studies and a long-lasting photochemical riddle 
was the reaction of santonin (4.6) with sunlight. Santonin (4.6) was first found in two 
species of the genus Artemisia in 1830 by Kahler and Alms.162 It was traditionally 
used as a vermifuge,163 but due to severe side effects, it is no longer used for this 
purpose. Four years after the first isolation of 4.6, Trommsdorff observed that 
crystalline santonin (4.6) turned yellow and bursted when exposed to sunlight.164 This 
experiment represents the first solid-state photochemical reaction. Using a prism, 
Trommsdorff reported that only the violet and the blue component of sunlight were 
able to promote the isomerization to new product (4.7) with a different crystal lattice, 
promoting the rupture of the crystal. Irradiation of 4.6 produced to the biradical 4.8, 
                                               
161 Klinger, H. Justus Liebigs Ann. Chem. 1888, 249, 137−146. 
162 (a) Kahler Arch. Pharm. 1830, 34, 318−319; (b) Alms, A. Arch. Pharm. 1830, 34, 
319−320. 
163 Grieve, M. A Modern Herbal 1931. 
164 Trommsdorff, H. Ann. Chem. Pharm. 1834, 11, 190−208. 
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which delivered zwitterion 4.9 by a intersystem crossing.165 A final 1,3- alkyl shift 
furnished lumisantonin (4.7). 
 
 
Scheme 4.3: Photolysis of santonin (4.6).165 
4.1.2.! Target motivations and synthetic strategies 
4.1.2.1.! Goal of the study 
 
 In chapter 2 and 3, two examples of a remote C−H functionalization were 
described. Initially, the transformation of taiwaniaquinone F (2.3) to taiwaniaquinol A 
(2.9) was discovered due to an exposure of 2.3 to ambient light. This unexpected 
result was later confirmed by direct exposure to sunlight, whereat 2.9 was isolated in 
30% yield (Scheme 4.4). The generality of this transformation was further 
investigated. Therefore, komaroviquinone (3.11) was converted to cyclocoulterone 
(3.10) in similar yield (32%). The possibility, that this reaction constitutes a viable 
biosynthetic alternative to produce such methylenedioxy bridge natural products in 
nature, encouraged us to investigate the mechanism of this reaction. To accomplish 
this task, the design of a model substrate that would mimic the reactivity of the 
above-mentioned natural quinones, was addressed.  
 
                                               
165 Fisch, M. H.; Richards, J. H. J. Am. Chem. Soc. 1968, 90, 1547−1553. 
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Scheme 4.4: Remote C−H activation of taiwaniaquinone F (2.3) and komaroviquinone (3.11) and application of 
the mechanistic studies of a model substrate (4.10). 
 According to our previous mechanistic proposals (see chapters 2 and 3), the 
model substrate should possess the common structural features of both natural 
quinones (2.3 and 2.9) that could be relevant for this transformation. The model 
system should be structurally characterized by a 2-methoxy-1,4-quinone, which is the 
moiety chemically transformed to a 1,2-methylenedioxy-4-phenol. As seen in 
chapter 2, an isopropyl group at C3 (or C13 for 2.3 and 2.9) would force the position 
the methoxy group towards the C1 keto group (or C11 for the 2.3 and 2.9) and 
facilitate the initially proposed 1,5-hydrogen atom transfer (1,5-HAT). Furthermore, 
the isopropyl group could also be involved in the HAT reaction. The occurrence of a 
second γ-hydrogen in both 2.3 and 2.9, could participate in an additional 1,5-HAT 
reaction. Finally, the model substrate needs to furnish the methylenedioxy quinol 
upon light irradiation. With these objectives in mind, the target model substrate 4.10, 
structurally described by 2-methoxy-3-isopropyl-5-acetyldehyde-1,4-quinone, was 
chosen to investigate the mechanism of this transformation. In case of successful 
formation of methylenedioxy 4.11 upon photolysis of 4.10, it was our goal to 
substantiate the existence of a biradical species such as 4.12 by radical trapping 
experiments. 
 The importance of the γ-hydrogen for a proposed 1,5-HAT, in 2.3 and 3.11, 
could be rationalized by the formation of an intramolecular hydrogen-bond 
(H-bond) in radical intermediates. Grant and co-workers proposed a mechanism to 
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rationalize the unusual anti-oxidative activity of citrinin. 166 They suggested that the 
hydrated form of citrinin could react with a radical species to form the C8−O! in 4.13 
(Scheme 4.5, A). This newly formed radical 4.13 could then be stabilized by a 
H-bond network, which would facilitate a successive HAT and thereby delocalizing 
the radical over four additional centers and furnish the C6−O! intermediate 4.14. The 
intramolecular nature of the H-bonds is thought to be crucial. Indeed, it is known that 
intermolecular H-bonds with phenols increase their bond dissociation energy 
(BDE).166 This phenomenon is imparted by an unfavored transition state of a HAT 
reaction, where a covalent ArO-H bond and a H-bond must be broken. In the case of 
4.13, for each broken covalent O-H bond as well as H-bond two new bonds of each 
type are generated with comparable BDE in a concerted mechanism. An additional 
radical stabilization effect of H-bonds was observed by Wagner with ketones bearing 
a γ-hydrogen. 167 As a matter of fact, irradiation of ketone 4.15 (Scheme 4.5, B) in 
H-bond acceptor solvent gave a high selectivity for Norrish type II elimination 
(acetophenone and propene) and cyclized Yang photoproducts (4.16) via an 1,5-HAT 
which formed biradical 4.17 (red pathway, Scheme 4.5, B). This selectivity was 
explained by the H-bond formation between a solvent molecule and the hydroxyl 
group of the biradical 4.17, which stabilizes the latter one. This stabilization causes a 
lower selectivity for a disproportionation (reversion to ketone 4.15 by the inverse 
1,5-HAT of 4.17, blue pathway in Scheme 4.5, B). In fact, a disproportionation would 
break the newly formed H-bond, whereas all other reactions (type II elimination, and 
Yang cyclizations) would not and are thereby favored. Similarly, if the β-carbon 
would be replaced by a β-oxygen atom, an intramolecular H-bond would be formed, 
and therefore prevent reversion to the ketone starting material. 168  Moreover, this 
intramolecular H-bond would force the biradical into a coiled structure, resulting in 
the high selectivity for Yang’s cyclized products. Norrish type II elimination products 
require a stretched biradical intermediate where the two half-filled p-orbitals must be 
aligned with the breaking bond, which is not allowed due to the intramolecular 
H-bond. 
                                               
166 Heider, E. M.; Harper, J. K.; Grant, D. M.; Hoffman, A.; Dugan, F.; Tomer, D. P.; 
O'Neill, K. L. Tetrahedron 2006, 62, 1199−1208. 
167 Wagner, P. J. J. Am. Chem. Soc. 1967, 89, 5898−5901. 
168 Caldwell, R. A.; Majima, T.; Pac, C. J. Am. Chem. Soc. 1982, 104, 629−630. 
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Scheme 4.5: A) The H-bond network responsible for the facile HAT in hydrated citrinin;166 B) H-bond 
stabilization of biradical 4.17 favors Norrish type II reaction and Yang products.167 The dashed blue bonds 
represent a H-bond. 
 This biradical stabilization by a H-bond could explain the efficacy of the 
photolysis of komaroviquinone (3.11, Scheme 4.6) and taiwaniaquinone F (2.3, 
Scheme 4.7). As already proposed in chapter 3, the photolysis of 3.11 would generate 
the biphenoxyl radical 4.18. An intramolecular H-bond of the C14−O! together with 
the γ-hydrogen of the hemiacetal group would stabilize the radical. Subsequent 
1,5-HAT between these two centers, as well as between the C11−O! and one of the 
methoxy hydrogen atoms would yield 4.19. Analogous to the hydrated citrinin 
radical, two new bonds of each type are generated for each broken covalent and 
H-bond with comparable BDE in a concerted mechanism. The unpaired electron as 
well as the hydrogen atom would then be distributed between these two additional 
centers. Further radical delocalization could be obtained by the homolytic cleavage of 
the tetrahydrofurane ring of 4.19 to form the tertiary alkoky radical 4.20. The 
C10−O! of 4.20 could build a H-bond with the C11−OH group, increasing its 
stability by a subsequent 1,6-HAT in the concave face of the molecule. Radical 
recombination of the newly formed C11 phenoxyl radical 4.21 would irreversibly lead 
to the formation of cyclocoulterone (3.10) and therefore driving the whole process 
towards the natural product. 
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Scheme 4.6: Proposed effects of H-bonds for HAT reactions during the photolysis of komaroviquinone (3.11).  
 As described in chapter 2, the photolysis of taiwaniaquinone F (2.3) could 
generate the biphenoxyl radical 4.22. An intramolecular H-bond of the C14−O!  with 
the γ-hydrogen of the aldehyde group would stabilize the radical. Subsequent 
1,5-HAT between these two centers, as well as between the C11−O! and one of the 
methoxy hydrogen atoms would yield 4.23. The C11−OH of 4.23 would then form a 
H-bond with the keto group of the aldehyde, therefore preventing a reverse HAT 
between these two centers. As a matter of fact, a reversion to 4.22 would result in the 
breaking of a H-bond, a C6−C7 bond rotation, an 1,5 HAT and the formation of a 
H-bond. Similar 1,5-HAT were already discussed in chapter 3. An 1,5-HAT from the 
C1−H to the formyl radical would generate the intermediate 4.24. A subsequent 
1,5-HAT from the C11−OH to the C1! would engender 4.25, which, upon radical 
recombination, would yield taiwaniaquinol A (2.9). 
 
Scheme 4.7: Proposed effects of the H-bond for HAT reaction during the taiwaniaquinone F (2.3) photolysis. 
H
O
O
O
O O
3.11 4.18
14
γ
H
hν
H
O
O
O
O O
H
H
H
O
O
O
O O
H
H
H
OH
OH
O
OO
3.10
4.19
4.21 4.20
H
O
O
O
O O
H
11
O O
iPr
O
H
O
H
O
H
10
O
iPr
H
H
O
HO
O H
H
O
hν
OO
2.3 H
O
14
γ
H
H
O
O
H
O
H
O
OO
O HH
H
OH
OO
HO
4.22 4.23
2.9 4.25
H
O
OO
O HH
H
4.24
O
1
!Chapter 4 100 
 The feasibility of this 1,5-HAT was supported by the previous work of 
Edwards and co-workers169 with the photolysis of royleanone (4.26, Scheme 4.8) in 
benzene and acetylation of the resulting mixture. Indeed, three of the photoproducts 
obtained (4.27 to 4.29), displayed a C11−O−C1 ether bond, possibly resulting from an 
initial 1,5-HAT between a C1−H and the C11=O. 
 
 
Scheme 4.8: Photolysis of royleanone and subsequent acetylation.169 
4.1.2.2.! Retrosynthetic analysis 
 
 To support or refute our mechanistical hypothesis, the synthesis of the model 
substrate 4.10 was addressed first. The known compound 4.29, which was obtained 
from the inexpensive and commercially available 2,4-dimethoxy benzene (4.31) via 
known procedures,170 was chosen as starting material. The model substrate 4.10 could 
be obtained via an oxidative demethylation of the corresponding 
1,2,4-trimethoxy-3-isopropyl-5-acetaldehyde-6-methylphenyl 4.32. A primary 
aliphatic alcohol oxidation of the C5-ethanol side chain of 4.33 would afford the 
hexasubstituted acetaldehyde 4.32. Several possibilities to introduce the C5-ethanol 
side chain of 4.33 could be envisaged. The most direct disconnection would be at the 
C5-C2’ bond resulting in the Ar−H 4.34 and ethylene oxide as synthons. An 
ortho-lithiation of 4.34 followed by the addition of ethylene oxide would deliver 4.33. 
As an alternative, a Friedel-Crafts ring opening of ethylene oxide could be envisaged. 
Finally, the C6 methyl group of 4.34 could originate from a reduction of the starting 
compound 4.30.  
 
                                               
169 Edwards, O. E.; Ho, P.-T. Can. J. Chem. 1978, 56, 733−742. 
170 (a) Burnell, R. H.; Caron, S.  Can. J. Chem. 1992, 70, 1446−1454; (b) Maier, M. 
E.; Bayer, A. Eur. J. Org. Chem. 2006, 4034−4043. 
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Scheme 4.9: Retrosynthetic analysis of model substrate 4.10. 
4.2.!Results and discussion 
4.2.1.! Model substrate synthesis 
 
 The synthesis of the model substrate started with the known intermediate 4.30, 
which was obtained from the commercially available 4.31 in seven steps in 23% 
overall yield.170 
 
 
Scheme 4.10: Synthesis of hexasubstituted aromatic ring 4.32: 1) Ref. 170, 23% over 7 steps; 2) Pd(OH)2/C, 
MeOH, H2 (80 bar), 2 h, 98%; 3) MOMCl, SnCl4, CH2Cl2, −10 °C to rt, 3 h; 4) KCN, DMSO, rt, 12 h, 97% (over 
two steps); 5) NaOH, H2O, 115 °C, 24 h, 99%; 6) LAH, Et2O, 0 °C to rt, 3 h, 98%; 7) DMP, CH2Cl2, 0 °C to rt, 
85%, 2 h. 
 The benzylic alcohol was hydrogenated in a methanolic solutiuon using 
Pd(OH)2/C to yield the reduced compound 4.34 in excellent yield. Although the 
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4.33 in one step, a less hazardous, more efficient and stepwise alternative approach 
was pursued. Indeed, ethylene oxide is a dangerous explosive, and similar protocols 
using it lead to low yield of alcohol.170b Chloromethylation of 4.34 using MOMCl and 
SnCl4 in CH2Cl2 yielded the benzylic chloride 4.35.171  Due to silica gel stability 
issues, crude 4.35 was further reacted with KCN in DMSO to furnish the benzylic 
cyanide 4.36 (the structure was confirmed by single crystal X-ray analysis, Figure 
4.1) in nearly quantitative yield over two steps (97%). Alkaline hydrolysis (NaOH, 
H2O, 115 °C) of 4.36 gave the carboxylic acid 4.37 in quantitative yield after acidic 
workup, which was later reduced to the primary alcohol 4.33 in 98% yield using LAH 
in Et2O. Finally, DMP oxidation of 2.33 delivered the hexasubstituted aldehyde 4.32 
in 85% yield. The structure was confirmed by single crystal X-ray analysis (Figure 
4.1). 
 
 
 
 
Figure 4.1: X-ray analysis of the structure of 4.32 and 4.36. 
 Several attempts to perform an oxidative demethylation of the hexasubstituted 
benzene 4.32 to provide the desired model substrate 4.10 (Table 4.1, entries 1 to 
6) failed. The use of silver(II) oxide as a one electron oxidant furnished the model 
system, however in very poor yield (~5%).172 Unfortunately, these results could not 
be reproduced, and the instability of the model substrate 4.10 did not allow further 
studies. Alternative oxidants were subsequently investigated. However, the use of 
                                               
171 Iyer, S.; Liebeskind, L. S. J. Am. Chem. Soc. 1987, 109, 2759−2770. 
172 Snyder, D. C.; Rapoport, H. J. Am. Chem. Soc. 1972, 91, 227−231. 
4.32! 4.36!
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ceric ammonium nitrate (CAN, entry 2)173 or hypervalent iodine reagents (entries 3 to 
6),174 lead only to complex mixtures or starting material. The 1H-NMR data analysis 
of the crude mixture of the reaction using silver(II) oxide, showed the formation of  
unknown side−products with an aldehyde signals. Therefore, a protecting group 
strategy was not considered.  
 
Table 4.1: Oxidative demethylation attemps towards the model substrate 4.10. 
 
Entry Conditionsa Observations 
1 AgO, HNO3 (6 M), dioxane, 0 °C to rt 4.10 (<5%) + complex mixture 
2 CAN, MeCN/H2O, rt Complex mixture 
3 PIDA, H2O/MeOH, rt to 50 °C Starting material 
4 HITB, MeCN, rt to 90 °C Complex mixture 
5 PIFA in various solvents Complex mixture 
6 ArI, oxone®, CF3CH2OH/H2O, rt Complex mixture 
a HITB: [hydroxy(tosyloxy)iodo]benzene, ArI: 4-iodophenoxyacetic acid. 
 
4.2.2.! Alternative model substrate design and synthesis 
 
 Since the final oxidation of the advanced aldehyde 4.32 failed to furnish the 
model system 4.10 in reasonable and reproducible yield, the synthesis of the simpler 
model substrate 4.38 was addressed next (Scheme 4.11). The need of a 
hexasubstituted model substrate was crucial to avoid biaryl coupling during the 
oxidative demethylation but also during the photolysis. With this substrate, the 
influence of the γ-hydrogen could not be investigated, however, the existence of a 
biradical species could still be explored. The synthesis of 4.38 started with 
                                               
173 Jacob, P.; Callery, P. S.; Castagnoli, N. Jr. J. Org. Chem. 1976, 41, 3627−3629. 
174  (a) Tohma, H.; Morioka, H.; Harayama, Y.; Hashizume, M.; Yasuyuki, K. 
Tetrahedron Lett. 2001, 42, 6899−6902; (b) Ortín, I.; González, J. F.; Cuesta, E.; 
Avendaño, C. Tetrahedron 2010, 66, 646−652; (c) Yakura, T.; Yamaushi, Y.; Tian, 
Y.; Omoto, M. Chem. Pharm. Bull. 2008, 56, 1632−1634. 
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1,2,4-trimethoxy-3-isopropyl-phenyl 4.39, which was obtained via known 
procedures175 from the commercially available 4.40 in two steps in 45% overall yield. 
Rieche formylation of 4.39 yielded the C5-aldehyde 4.41 in an excellent yield of 
96%. The previous synthesis of this compound was achieved in lower overall yield 
(78%) from the same starting material in two steps via a C5 bromination followed by 
a Grignard reagent formation using Mg and addition of DMF.170a The aldehyde 4.41 
was reduced using Pd(OH)2/C in methanol under H2 pressure (80 bar) to the electron 
rich methylphenyl 4.42 in good yield (77%). The same formylation and reduction 
sequence furnished the hexasubstituted benzene 4.44, via aldehyde 4.43, in good 
overall yield of 84%. Silver(II) oxide oxidation of 4.44 succeeded to provide the 
model substrate 4.38 in good yield (62%). 
 
 
Scheme 4.11: Synthesis of model substrate 4.38: 1) Ref. 175, 45% over 2 steps; 2) TiCl4, CH2Cl2, Cl2CHOMe, 
−10 °C to rt, 2 h, 96%; 3) Pd(OH)2/C, MeOH, H2 (80 bar), 24 h, 77%; 4) TiCl4, CH2Cl2, Cl2CHOMe, −10 °C to rt, 
12 h, 98%; 5) Pd(OH)2/C, MeOH, H2 (80 bar), 18 h, 86%; 6) AgO, HNO3, (6 M), dioxane, rt, 80 min, 62%. 
4.2.3.! Photolysis 
 
 Having the model system in hand, the remote C−H functionalization achieved 
with taiwaniaquinone F (2.9) and komaroviquinone (3.11) was explored with 
compound 4.38. Applying the conditions developed earlier for the photolysis of 2.9 
and 3.11 (direct sunlight, Et2O, rt) led to a full conversion of the starting material 
(observed by decoloration of the reaction mixture and confirmed by TLC analysis), 
however, without formation of the desired methylenedioxy bridge. Different solvents 
                                               
175 Majetich, G.; Zhang, Y.; Tian, X.; Britton, J. E.; Li, Y.; Phillips, R. Tetrahedron 
2011, 67, 10129−10146. 
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(benzene, t-BuOH, CHCl3) and light sources (sunlight, medium pressure mercury 
lamp) were screened. Photolysis of 4.38 in t-BuOH was effective to form the desired 
compound with the methylenedioxy bridge 4.45 in 47% yield using a medium 
pressure Hg lamp at rt (Scheme 4.12). This feasibility of the reaction in t-BuOH 
rather than in Et2O could be explained by the ability of t-BuOH to forms H-bonds 
with HO−C! (see Scheme 4.5, B). An initial 1,5-HAT between the C1=O and a 
methoxy hydrogen atom would form the biradical 4.46, which would be stabilized by 
H-bonds with t-BuOH at C4−O!. Moreover, a second H−bond of an additional 
t-BuOH with the C1−OH would increase the BDE and thus rendering the reversion to 
the quinone 4.38 unfavorable. Furthermore, when the photolysis was performed in 
fully deuterated t-BuOH (d10) the yield of the reaction dropped down to 15% and the 
reaction time for the full conversion was doubled. In this case, this kinetic isotopic 
effect indicates the participation of a t-BuOH molecule in the HAT processes. 
 
 
Scheme 4.12: Successful photolysis of model substrate 4.29. 
4.2.4.! Biradical trapping upon model substrate photolysis 
 
 The formation of biradical species upon quinone photolysis was previously 
postulated and experimentally verified by biradical trapping experiments using 
paramagnetic reagent such as SO2,176 O2,177 alkenes and NO.178 Farid and co-workers 
demonstrated the biradical nature of quinone photolysis intermediates via the 
photolysis of 4.47 in condensed SO2, forming the sulfone 4.48 (Scheme 4.13, A).176 
                                               
176 Farid, S. Chem. Comm. 1971, 73−74. 
177 Wilson, R. M.; Wunderly, S. W.; Walsh, T. F.; Musser, A. K.; Outcalt, R.; Geiser, 
F.; Gee, S. K.; Brabender, W.; Yerino Jr.; L.; Conrad, T. T.; Tharp, G. A. J. Am. 
Chem. Soc. 1982, 104, 4429−4446. 
178 Depew, C. M.; Adeleke, B. B.; Rutter, A.; Wan, J. K. S. Can. J. Chem. 1985, 63, 
2281−2284. 
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Similarly, Wilson and co-workers reported the biradical trapping of a photolyzed 
benzoquinone 4.49 by the alkene 4.50 and SO2 simultaneously to give sulfone 4.51 
(Scheme 4.13, B).177 
 
 
Scheme 4.13: A) SO2 biradical trapping experiments by Farid;176 B) SO2 and alkene biradical trapping 
experiments by Wilson.177 
 Inspired by these results, the trapping of a hypothetical biradical intermediate 
with SO2 was explored. Irradiation (medium pressure Hg lamp) of a SO2 saturated 
solution of 4.38 in t-BuOH was performed. Attempts to purify the reaction mixture 
were unsuccessful due to decomposition reactions (observed by TLC analysis). 
However, GC-HRMS data analysis of this mixture showed the formation of a SO2 
adduct such as 4.52 (Scheme 4.14). Analogous results were obtained when a solution 
of 4.38 was irradiated in acetone or cyclopentene to furnish an acetone adduct such as 
4.53 or a cycloaddition adduct such as 4.54, respectively. Unfortunately, no complete 
characterization of thes biradical trapped adduct could be obtained due to stability and 
purification issues. 
 
 
Scheme 4.14: Preliminary results of biradical trapping. 
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4.2.5.! Conclusion and future directions 
 
 A short, efficient and scalable synthesis of the hexasubsituted benzene 4.32, 
precursor of 4.10 was achieved from the known intermediate 4.30 in six steps in 
excellent overall yield of 78%. The model substrate 4.38 was successfully synthesized 
from the known isopropyl 4.39 in five steps in a good overall yield of 38%. 
Furthermore, the photolysis of this model system to the corresponding 
methylenedioxy bridge was achieved in highier yield than the ones obtained with the 
natural products 2.9 and 3.11. Preliminary evidences of the formation of biradical 
quinoids were obtained by SO2, acetone and cyclopentene trapping experiments. 
Furthermore, indication of a bimolecular mechanism, involving a HAT from a 
t-BuOH molecule was suggested for the photolysis of 2.38 in t-BuOH. 
 Strong support for the biradical intermediate 4.55 could be obtained by NO 
trapping, which would produce the EPR active persistent nitroxide radical. Depew et 
al. demonstrated this concept by the photolysis of 2-isopropyloxy-1,4-naphtoquinone 
(4.57) in a NO saturated benzene solution, which delivered the nitroxide radical 4.58 
(Scheme 4.15).178 
 
 
Scheme 4.15: Envisaged nitrogen monoxide trapping of 4.55 inspired by the formation of 4.58 by Depew.178 
 A design of another model substrate bearing a γ-hydrogen would allow the 
investigation of the effect of intramolecular H-bonds on HAT reactions. Furthermore, 
the conditions developed for the model substrate could be applied on the natural 
product to assess differences in efficacy. 
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5.!Conclusion 
 
 This PhD thesis gave several examples of the potential of mimicking proposed 
biosynthetic pathways relying on the formation of intermediates with inherent 
reactivities. The focus on the successful key transformations of several reactive 
intermediates gave the ability to reproduce what nature might use to access such 
structurally diverse natural products. Moreover, a careful observation of the 
interaction of the different intermediates and natural products with light, oxygen and 
silica gel was central for the discovery of unusual reactions allowing us the 
formulation of several biosynthetic hypotheses. 
 The protecting-group free synthesis of (−)-taiwaniaquinone F was achieved in 
17 steps from the commercially available (−)-abietic acid via a Wolff ring contraction 
of a (+)-sugiol methyl ether diazo derivative. Furthermore, a sunlight-induced 
transformation of (−)-taiwaniaquinone F to (+)-taiwaniaquinol A was discovered and 
a biosynthetic hypothesis for the formation of such methylenedioxy moiety was 
proposed. Further support for this hypothesis was brought by the successful 
photolysis of (+)-komaroviquinone to afford the first synthesis of (−)-cyclocoulterone. 
The synthesis of (+)-komaroviquinone was achieved in eight steps from carnosic acid, 
isolated from Rosemarinus officinalis. The key features of the synthesis include: (1) a 
ring-expansion of a reactive abietane intermediate based on a biogenetic hypothesis, 
where the first experimental proof of such ring expanded carbocation trapping with 
water was given; and (2) a selective benzylic oxidation of salvicanol acetate. Using 
this strategy, (+)-salvicanol, (−)-coulterone, (−)-obtusinone D, (−)-obtusinone E, and 
(−)-euolutchuol E were synthesized for the first time along with seven additional 
known natural products. The stereochemical configuration of (−)-obtusinone D was 
unambiguously reassigned by X-ray crystallography. Furthermore, these syntheses 
allowed us to support other biosynthetic pathways. 
 Finally, the preliminary results indicating the presence of biradicalar 
intermediates responsible for the formation of the methylenedioxy moiety of 
(+)-taiwaniaquinol A and (−)-cyclocoulterone using radical trapping reagents were 
described. This transformation was successfully applied for the first time on a 
non-natural model substrate, showing the generality of this process.
 110
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6.!Experimental part 
6.1.!General method and materials 
 
 Unless otherwise stated, chemials were purchased from Sigma-Aldrich, 
ABCR, Acros or Landcaster and used without any further purification. Solvents used 
for work-up and" chromatography were distilled from technical quality. Solvents used 
for the chemical transformation were either puriss. quality or dried by filtration 
through activated aluminiumoxide under argon or nitrogen (H2O content < 10 ppm, 
Karl-Fisher titration) atmosphere. Reactions involving air or moisture sensitive 
reagents or intermediates, were performed under argon or nitrogen atmosphere in 
oven dried or flame dried under high vacuum glassware." Microwave-assisted (MW) 
reactions were conducted with sealed vessels using a Biotage" Initiator + instrument. 
The temperature was measured with an IR sensor. Concentration under" reduced 
pressure was performed by rotatory evaporation at 40 °C (unless otherwise specified)."
Yields refer to purified, dried and spectroscopically pure compounds. Analytical thin 
layer chromatography (TLC) was performed on Merk silica gel 60 F254 plates 
(0.25 mm thickness)" precoated with a fluorescent indicator. The developed plates 
were examined under UV light" and by staining with ceric ammonium molybdate and 
heating. Flash chromatography was" performed on silica gel 60 (230−240 mesh) from 
Fluka or Silicycle using forced-flow elution" at 0.3−0.5 bar pressure. All 1H and 
13C NMR spectra were recorded by using Bruker Avance" 400 MHz (1H) and 101 
MHz (13C), Bruker Avance 500 MHz (1H) and 126 MHz (13C) or"Bruker Advance 600 
MHz (1H) and 151 MHz (13C) spectrometers at room temperature." Chemical shifts 
(δ values) are reported in ppm, spectra were calibrated related to solvent’s" residual 
proton chemical shift (CHCl3, δ = 7.26) and the solvent residual carbon"chemical shift 
(CDCl3, δ = 77.16). Multiplicity is reported as follows: s−singlet, br, s−broad" singlet, 
d−doublet, t−triplet, q−quartet, hept−heptet, m−multiplet or unresolved and" coupling 
constant J in Hz. IR spectra were recorded using a Varian 800 FT-IR ATR"
Spectrometer, Paragon 1001 FTIR Spectrometer or a Bruker Alpha FT-IR Platinum-
ATR Spectrometer. The absorptions are reported in cm-1." Optical rotations [α]D were 
measured at the sodium D line using a 1 mL or 2 mL cell with a"1 dm path length on a 
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Jasco P-2000 digital polarimeter or a Perkin-Elmer Polarimeter 341 and" the 
concentration c is given in g/100 mL. All mass spectra were recorded by the" mass 
spectrometric Service of the University of Basel on a Bruker maXis 4G mass 
spectrometer" using electrospray ionization (HRMS-ESI) and by the mass 
spectrometry laboratory of the institute of organic chemistry of University of Zurich 
on a Thermo Fischer DFS spectrometer (HRMS-EI). X-ray analyses: Data collections 
for crystal structures were" peformed at low temperature (123 K) using Mo Ka 
radiation on an Bruker Kappa APEX" diffractometer. Integration of the frames and 
data reduction was carried out using APEX2." The structures were solved by direct 
methods using SIR92. All non hydrogen atom were" refined using anisotropically by 
full-matrix least squares on F using CRYSTALS. Hydrogen" atoms were placed in 
their calculated positions by means of the ‘riding’ model. Melting points" (m.p.) were 
determined using a Büchi B-545 apparatus in open capillaries and are"uncorrected. 
 
6.2.!Total synthesis of taiwaniquinone F and taiwaniaquinol A 
 
Dehydroabietic acid (2.60): 
 
A solution of abietic acid 2.59 (10.0 g, 28.1 mmol) in p-xylene 
was prepared in a dried flask.  Pd/C (1.00 g, 10 w%) was added 
and the resulting mixture was stirred under reflux (148 °C). After 
48 h, the reaction was filtered through celite with Et2O washing 
(50 mL) and concentrated in vacuo. Recrystallization (Et2O:pentane) gave white 
needles (8.00 g, 26.0 mmol, 95 %). Rf = 0.48 (CH2Cl2:MeOH 20:1). 1H NMR 
(400 MHz, CDCl3) δ = 7.17 (d, J = 8.2 Hz, 1H), 7.00 (dd, J = 8.2, 1.7 Hz, 1H), 6.89 
(s, 1H), 2.98−2.87 (m, 2H), 2.82 (hept, J = 7.2 Hz, 1H), 2.28−2.34 (m, 1H), 2.24 (dd, 
J = 12.5, 2.1 Hz, 1H), 1.69−1.84 (m, 4H), 1.57−1.49 (m, 3H), 1.28 (s, 3H), 1.22 (d, J 
= 7.2 Hz, 3H), 1.22 (s, 3H), 1.21 (s, 3H). All analytical data are in agreement with 
literature values: Halbrook, N. J.; Laurence, R. V. J. J. Org. Chem. 1966, 31, 
4246−4647. 
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Dehydroabietinol (2.61): 
 
A solution of dehydroabietic acid (2.60, 10.0 g, 33.3 mmol) in 
dry THF (40 mL) was added to a suspension of LiAlH4 (6.31g, 
166 mmol) in dry THF (40 mL) dropwise at 0 °C over 15 min. 
The reaction was stirred for 30 min at 0 °C then warmed up to rt 
and stirred for 2 h. Then an aqueous solution of H2SO4 (10%, 200 mL) was added 
slowly at 0 °C to the reaction mixture followed by Et2O (100 mL). The organic phase 
and the aqueous phase were separated and the aqueous phase was extracted with Et2O 
(3 x 100 mL). The combined organic phases were successively washed with an 
aqueous saturated solution of NaHCO3 (200 mL) and brine (200 mL), dried over 
Na2SO4 and concentrated under reduced pressure. The residue was purified by 
chromatography column on silica gel (Et2O:pentane, 8:5) to afford dehydroabietinol 
(2.61) as colourless gum (8.00 g, 27.9 mmol, 84 %). Rf = 0.67 (CH2Cl2: MeOH, 
20:1). 1H NMR (400 MHz, CDCl3) δ = 7.19 (dd, J = 8.1, 2.1 Hz, 1H), 7.00 (d, J = 8.1 
Hz, 1H), 6.90 (s, 1H), 3.48 (d, J = 10.7 Hz, 1H), 3.24 (d, J = 10.7 Hz, 1H), 2.98−2.76 
(m, 3H), 2.30 (d, J = 12.7 Hz, 1H), 1.88−1.61 (m, 5H), 1.47−1.36 (m, 4H), 1.28−1.20 
(m, 9H), 0.90 (d, J = 2.2 Hz, 3H). All analytical data are in agreement with literature 
values: (a) Woldemichael, G. M.; Wächter, G. Singh, M. P.; Maiese, W. M.; 
Timmermann, B. N. J. Nat. Prod. 2003, 66, 242−246; Ulubelen, A.; Topcu, G. 
Phytochemistry 1992, 31, 3949−3951. 
 
Abietadien-18-yl p-toluene sulfonate (2.62): 
 
To a solution of dehydroabietinol (2.61, 9.71 g, 33.9 mmol) in 
pyridine (270 mL) was added p-toluenesulfonyl chloride (38.8 g, 
203 mmol) at 0 °C. The resulting mixture was stirred 5 h at 0 °C 
and overnight at rt. Ice water (200mL) was then added and the 
resulting mixture was extracted with Et2O (3 x 150 mL). The combined organic 
phases were washed successively with an aqueous solution of HCl (1 mol/L, 3 x 150 
mL), water (3 x 150 mL) and brine (3 x 150 mL), dried over Na2SO4, and 
concentrated under reduced pressure. The residue was purified by chromatography 
column on silica gel (Et2O:pentane, 1:15) to afford tosylate abietadien-18-yl p-toluene 
sulfonate (2.62) as white solid (14.7 g, 33.3 µmol, 98 %). Rf = 0.32 (Et2O:pentane, 
HHO
HTsO
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1:15). 1H NMR (400 MHz, CDCl3) δ = 7.82 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.0 Hz, 
2H), 7.19 (d, J = 8.2 Hz, 1H), 7.03 (dd, J = 8.1, 2.0 Hz, 1H), 6.91 (s, 1H), 3.87 (d, J = 
9.3 Hz, 1H), 3.64 (d, J = 9.3 Hz, 1H), 2.92−2.76 (m, 3H), 2.48 (s, 3H), 2.29 (d, J = 
12.8 Hz, 1H), 1.84−1.43 (m, 8H), 1.27 (d, J = 6.9 Hz, 6H), 1.22 (s, 3H), 0.92 (s, 3H). 
All analytical data are in agreement with literature values: Tada, M.; Ishimaru, K. 
Chem. Pharm. Bull. 2006, 54, 1412−1417. 
 
Dehydroabietane (2.63):  
 
To a solution of abietadien-18-yl p-toluene sulfonate (2.62, 760 mg, 
1.72 mmol) and dried NaI (1.90 g, 12.7 mmol) in dry DMF (40 mL) 
was added Zn powder (1.13 g, 17.4 mmol) in three portions at 
100 °C every 5 h. The resulting mixture was stirred at 100 °C for 3 
d. The reaction mixture was then filtered through celite and the cake was successively 
washed with an aqueous solution of HCl (1 M, 100 mL), pentane (100 mL). The 
aqueous phase of the filtrate was extracted with pentane (2 x 50 mL). The combined 
organic phases were washed successively with an aqueous solution of HCl (1 mol/L, 
100 mL), an aqueous saturated solution of NaHCO3 (100 mL) and brine (100 mL), 
dried over Na2SO4 and concentrated under reduced pressure. The residue was purified 
by chromatography column on silica gel (pentane) to afford dehydroabietane (2.63) as 
colourless oil (373 mg, 1.38 mmol, 80 %). Rf = 0.72 (pentane). 1H NMR (400 MHz, 
CDCl3) δ = 7.19 (d, J = 8.2 Hz, 1H), 7.00 (dd, J = 8.1, 1.4 Hz, 1H), 6.90 (s, 1H), 
2.99−2.75 (m, 3H), 2.28 (br d, J = 11.6 Hz, 1H), 1.92−1.84 (m, 1H), 1.83−1.56 (m, 
3H), 1.52−1.26 (m, 4H), 1.23 (d, J = 6.9 Hz, 6H), 1.19 (s, 3H), 0.95 (s, 3H), 0.94 (s, 
3H). All analytical data are in agreement with literature values: Tada, M.; Ishimaru, 
K. Chem. Pharm. Bull. 2006, 54, 1412−1417. 
 
12-Acetyldehydroabietane (2.64): 
 
Freshly distilled AcCl (1.17 mL, 16.3 mmol) was added to a solution 
of dehydroabietane (2.63, 2.00 g, 7.39 mmol) in CH2Cl2 (31 mL). 
The resulting reaction mixture was stirred at 0 °C for 5 min. Then 
AlCl3 (1.97 g, 14.8 mmol) was added at 0 °C. After 45 min. at 0° C 
the reaction mixture was stirred to rt for 1 h. The reaction mixture was quenched with 
H
H
O
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a saturated aqueous solution of NaHCO3 (50 mL) at 0 °C. The mixture was extracted 
with Et2O (3 x 20 mL) and the combined organic phases were washed successively 
with a saturated aqueous solution of NaHCO3 (25 mL) and brine (50 mL), dried over 
Na2SO4 and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel (pentane: Et2O, 30:1) to give 12-
acetyldehydroabietane (2.64) as pale yellow solid (2.08 g, 10.6 mmol, 90%). Rf = 
0.51 (pentane: Et2O 10:1). 1H NMR (400 MHz, CDCl3) δ = 7.41 (s, 1H), 7.04 (s, 1H), 
3.47 (hept, J = 6.8 Hz, 1H), 2.99−2.79 (m, 2H), 2.54 (s, 3H), 2.32−2.25 (m, 1H), 
1.93−1.86 (m, 1H), 1.80−1.59 (m, 3H), 1.52−1.46 (m, 1H), 1.46−1.37 (m, 1H), 1.32 
(dd, J = 12.4, 2.3 Hz, 1H), 1.22 (d, J = 6.8 Hz, 3H), 1.20 (d, J = 6.8 Hz, 3H), 1.18 (s, 
3H), 1.18 (s, 1H), 0.95 (s, 3H), 0.93 (s, 3H). All analytical data are in agreement with 
literature values: Akita, H.; Oishi, T. Chem. Pharm. Bull. 1981, 29, 1567−1579. 
 
O-Acetyl-ferruginol (2.65):  
 
To a solution of 12-acetyldehydroabietane (2.64, 6.10 g, 19.5 mmol) 
in CH2Cl2 (24 mL) was added a solution of peracetic acid (35 w%, 
40 mL, 209 mmol) in AcOH. The resulting mixture was then stirred 
at rt over 72 h and water (200 mL) was added. After extraction with 
Et2O (100 mL), the aqueous phase was extracted with Et2O (2 x 100 
mL), the combined organic phases were successively washed with a saturated 
aqueous solution of NaHCO3 (2 x 300 mL) and brine (200 mL), dried over Na2SO4 
and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (pentane:Et2O, 30:1) to give O-Acetyl-ferruginol (2.65) 
as pale yellow oil (5.99 g, 18.2 mmol, 93%). Rf = 0.51 (pentane:Et2O 10:1). 1H NMR 
(400 MHz, CDCl3) δ = 6.94 (s, 1H), 6.82 (s, 1H), 2.95−2.76 (m, 3H), 2.30 (s, 3H), 
2.19−2.13 (m, 1H), 1.91−1.83 (m, 1H), 1.78−1.64 (m, 2H), 1.61−1.54 (m, 2H), 
1.49−1.36 (m, 2H), 1.33 (dd, J = 12.4, 2.3 Hz, 1H), 1.18 (m, 9H), 0.93 (d, J = 5.3 Hz, 
3H), 0.92 (s, 3H). All analytical data are in agreement with literature values: Akita, 
H.; Oishi, T. Chem. Pharm. Bull. 1981, 29, 1567−1579. 
 
 
 
 
H
O
O
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Ferruginol (2.66):  
 
A solution of NaOMe in MeOH (0.50 mol/L, 7.80 mL, 3.90 mmol) 
was added dropwise at rt to a solution of O-Acetyl-ferruginol (2.65, 
960 mg, 2.92 mmol) in MeOH (8.1 mL). The resulting reaction 
mixture was stirred for 1 h at rt. Amberlyst-15 (100 mg) was then 
added and the resulting mixture was stirred until acidic pH was observed. The 
reaction mixture was filtered, washed with MeOH (50 mL) and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica gel 
(Et2O:pentane, 1:30) to afford ferruginol (2.66) as pale yellow oil (828 mg, 2.89 
mmol, 99%). Rf = 0.37 (pentane: Et2O 10:1). 1H NMR (400 MHz, CDCl3) δ = 6.84 
(s, 1H), 6.63 (s, 1H), 4.54 (s, 1H), 3.12 (hept, J = 6.8 Hz, 1H), 2.92−2.70 (m, 2H), 
2.17 (d, J = 12.7 Hz, 1H), 1.89−1.54 (m, 4H), 1.50−1.30 (m, 4H), 1.25 (d, J = 6.7 Hz, 
3H), 1.22 (d, J = 6.7 Hz, 3H), 1.17 (s, 3H), 0.94 (s, 3H), 0.91 (s, 3H). All analytical 
data are in agreement with literature values: Tada, M.; Kurabe, J.; Yoshida, T.; 
Ohkanda, T.; Matsumoto, Y. Chem. Pharm. Bull. 2010, 58, 818−824. 
 
Ferruginol methyl ether (2.67): 
 
K2CO3 (811 mg, 5.88 mmol) and Me2SO4 (835 µL, 8.82 mmol) were 
added to a solution of ferruginol (2.66, 840 mg, 2.94 mmol) in 
acetone (16.2 mL). The resulting mixture was stirred overnight at 
60 °C. The reaction mixture was filtered and the cake was washed 
with acetone. The solvents were removed under reduced pressure and the residue was 
diluted with Et2O (50 mL) and washed with a saturated aqueous solution of NaHCO3 
(30 mL). The aqueous phase was extracted with Et2O (3 x 30 mL) and the combined 
organic phases were washed with brine, dried over Na2SO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica gel 
(pentane: Et2O 1:100) to give ferruginol methyl ether (2.67) as orange oil (820 mg, 
2.75 mmol, 94%). Rf = 0.83 (pentane:Et2O 50:1). 1H NMR (400 MHz, CDCl3) δ = 
6.84 (s, 1H), 6.72 (s, 1H), 3.79 (s, 3H), 3.22 (hept, J = 7.2 Hz, 1H), 2.91−2.71 (m, 
2H), 2.29−2.20 (m, 1H), 1.86 (dd, J = 13.1, 7.2 Hz, 1H), 1.79−1.56 (m, 3H), 
1.51−1.32 (m, 4H), 1.20 (s, 3H), 1.19 (d, J = 7.0 Hz, 3H), 1.17 (d, J = 7.0 Hz, 3H), 
H
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0.94 (s, 3H), 0.92 (s, 3H). All analytical data are in agreement with literature values: 
Tahara, A.; Ohtsuka, Y. Chem. Pharm. Bull. 1972, 20, 1637−1647. 
 
Sugiol methyl ether (2.56): 
 
A solution of CrO3 (273 mg, 2.73 mmol) in AcOH:Ac2O (1:2, 12.9 
mL) was added to a solution of ferruginol methyl ether (2.67, 684 
mg, 2.28 mmol) in AcOH (7.5 mL). The resulting mixture was 
stirred at rt for 25 min and was heated to 50 °C for 90 min. The 
reaction mixture was then immersed into an ice bath and a saturated aqueous solution 
of NaHCO3 (500 mL) was slowly added until no more effervescence occurred. Then 
water (500 mL), CH2Cl2 (200 mL) and more of saturated aqueous solution of 
NaHCO3 (500 mL) were added. After separation of the organic phase, the water phase 
was extracted with CH2Cl2 (3 x 200 mL). The combined organic phases were 
successively washed with a saturated aqueous solution of NaHCO3 (200 mL), brine 
(200 mL) and dried over Na2SO4. The combined organic phases were concentrated 
under reduced pressure and the residue was purified by column chromatography on 
silica gel (pentane:Et2O 1:20) to afford sugiol methyl ether (2.56) as white solid (541 
mg, 1.80 mmol, 79%). Rf = 0.30 (pentane:Et2O 10:1). 1H NMR (400 MHz, CDCl3) δ 
= 7.89 (s, 1H), 6.75 (s, 1H), 3.89 (s, 3H), 3.24 (hept, J = 7.2 Hz, 1H), 2.73−2.54 (m, 
2H), 2.30 (d, J = 11.9 Hz, 1H), 1.91−1.65 (m, 3H), 1.62−1.50 (m, 2H), 1.32−1.24 (m, 
1H), 1.27 (s, 1H), 1.25 (s, 3H), 1.22 (d, J = 7.0 Hz, 3H), 1.19 (d, J = 6.9 Hz, 3H), 1.00 
(s, 3H), 0.97 (s, 1H), 0.93 (s, 3H). All analytical data are in agreement with literature 
values: Kuo, Y. H.; Yu, M.T. Phytochemistry 1996, 42, 779−781. 
 
5,6-dehydrosugiol methyl ether (2.73): 
 
A drop of concentrated HClO4 was added to a solution of (2.56, 31 
mg, 98.6 µmol) in TMOF (1 mL). The resulting mixture was stirred 
for 15 minutes and Tl(ONO2)3 (52.6 mg, 0.118 mmol) was added. 
The reaction mixture was stirred for 1.5 hours. Then 2.5 mL of 
CH2Cl2 was added and the reaction mixture was filtered. Solids were washed with 
CH2Cl2 (10 mL). The filtrate was then successively washed with water (10 mL x 2) 
and with a saturated aqueous solution of NaHCO3 (10 mL x 1), dried (Na2SO4) and 
H
O
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concentrated under reduced pressure. The residue was purified by chromatography 
column on silica gel (pentane:ether, 10:1) to give 5,6-dehydrosugiol methyl ether as 
white amorphous solid (2.73, 20 mg, 64.0 µmol, 65%). Rf = 0.10 (pentane:Et2O, 5:1). 
1H NMR (400 MHz, CDCl3) δ = 7.99 (s, 1H), 6.85 (s, 1H), 6.46 (s, 1H), 6.36 (s, 1H), 
3.90 (s, 3H), 3.28 (hept, J = 6.8 Hz, 1H), 2.47−2.39 (m, 1H), 2.11−1.96 (m, 1H), 
1.79−1.72 (m, 1H), 1.69−1.63 (m, 1H), 1.54 (s, 3H), 1.43 (td, J = 13.3, 3.9 Hz, 1H), 
1.35 (s, 2H), 1.31 (s, 1H), 1.26 (s, 3H), 1.25 (d, J = 6.9 Hz, 3H), 1.22 (d, J = 6.9 Hz, 
3H). All analytical data are in agreement with literature values: Kuo, Y. H.; Yu, M.T. 
Phytochemistry 1996, 42, 779−781. 
 
Diazoketone 2.80:179 
 
To a solution of ketone 2.56 (1.33 g, 4.22 mmol) in MeCN (15 mL) 
and p-acetamidobenzenesulfonyl azide (2.43 g, 7.94 mmol) was 
added DBU (1.54 mL, 10.3 mmol) dropwise at rt. The reaction 
mixture was stirred for 72 h at rt and the solvents were removed 
under reduced pressure. The residue was filtered through a pad of celite and through a 
pad silica gel with Et2O washing (100 mL). After concentration of the filtrate under 
reduced pressure, the residue was purified by column chromatography on silica gel 
(pentane:Et2O 1:20) to afford diazoketone 2.80 (924 mg, 2.72 mmol, 65%) as a 
yellow solid together with a smaller amount of starting material (402 mg, 1.28 mmol, 
30%): Rf = 0.21 (pentane:Et2O 10:1). mp = 91.6 °C−92.2 °C. ! "#$ = &+6.9 (c 0.30, 
CHCl3). IR (neat) ν = 2928, 2099, 2072, 1732, 1705, 1626, 1592, 1493, 1462, 1276, 
1256 cm−1. 1H NMR (500 MHz, CDCl3) δ = 7.86 (s, 1H), 6.68 (s, 1H), 3.88 (s, 3H), 
3.31−3.19 (m, 1H), 2.81 (s, 1H), 2.29 (d, J = 12.2 Hz, 1H), 1.92−1.62 (m, 4H), 1.27 
(s, 3H), 1.25 (s, 1H), 1.23 (d, J = 6.9 Hz, 3H), 1.19 (d, J = 7.0 Hz, 3H), 1.17 (s, 3H), 
1.09 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 186.1, 161.1, 152.3, 135.5, 125.0, 
124.7, 104.1, 55.6, 49.06, 42.7, 39.0, 35.9, 33.4, 33.2, 29.8, 26.7, 24.1, 22.7, 22.5, 
21.7, 18.7. HRMS (ESI) m/z: calcd for C21H28N2O2Na+ [M+Na]+: 363.2043, found: 
363.2044. 
 
                                               
179  A single crystal suitable for X-ray crystallography was obtained by slow 
evaporation from Et2O. 
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Ester 2.81:180 
 
A solution of diazoketone 2.80 (271 mg, 793 µmol) in dry methanol 
(800 mL) was irradiated with bright sunlight181 for 3 h. The reaction 
mixture was then concentrated under reduced pressure and the 
residue was purified by column chromatography on silica gel 
(pentane: Et2O 1:40) to give ester 2.81 (148 mg, 429 µmol, 54%) as colorless oil with 
a d.r. of 1 : 20 in favour of the (9S)-isomer 2.81 which crystallize at 6 °C as a 
colourless solid. Rf = 0.63 (pentane: Et2O 10:1). mp = 61.4 °C−63.9 °C. & ! "#+ =&−26.9 (c 0.7, CHCl3). IR (neat) ν = 2929, 2867, 1737, 1490, 1462, 1282, 1211, 1149 
cm-1. 1H NMR (500 MHz, CDCl3) δ = 7.05 (s, 1H), 6.62 (s, 1H), 3.94 (d, J = 8.3 Hz, 
1H), 3.83 (s, 3H), 3.71 (s, 3H), 3.30−3.21 (m, 1H), 2.14 (d, J = 8.3 Hz, 1H), 
2.08−2.01 (m, 1H), 1.95−1.83 (m, 1H), 1.74−1.61 (m, 1H), 1.53−1.46 (m, 1H), 1.41 
(s, 1H), 1.37 (s, 3H), 1.21 (d, J = 6.9 Hz, 3H), 1.19−1.15 (m, 6H), 1.01 (s, 3H), 0.98 
(s, 1H). 13C NMR (126 MHz, CDCl3) δ = 175.4, 156.9, 154.0, 135.1, 131.6, 122.8, 
103.6, 63.1, 55.7, 51.7, 48.7, 46.9, 44.2, 38.3, 34.2, 32.6, 27.0, 24.4, 23.2, 22.8, 21.0, 
20.0. HRMS (ESI) m/z: calcd for C22H32O3Na+ [M+Na]+: 367.2244, found: 367.2245. 
 
Isomerization of ester 2.81: 
 
To a solution of ester 2.81 (266 mg, 771 µmol) in a solvent mixture of ethylene glycol 
and water (29 mL, 25:1) was added KOH (1.11 g, 19.8 mmol) and the reaction 
mixture was stirred at 145 °C in a sealed flask for 3 h. The reaction mixture was then 
diluted with water and acidified with an aqueous solution of HCl (1mol/L, 100 mL). 
The reaction mixture was extracted with Et2O (3 x 5 mL). The combined organic 
phases were washed with brine (2 x 5 mL), dried over Na2SO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography on silica gel 
(pentane:Et2O 3:1) to afford (9R)- carboxylic acid 2.83 as white solid (as well as its 
diastereoisomer (9S)-carboxylic acid A, 224.2 mg, 0.678 mmol, 88%) in d.r. of 8.3 : 1 
in favour of 2.83 together with B as yellow oil (30 mg, 0.080 mmol, 10.4%). 
                                               
180 A single crystal suitable for X-ray crystallography was obtained from the pure oil 
at 6°C. 
181 Alternatively, a medium pressure Hg lamp could be employed. 
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Carboxylic acid 2.83182: 
 
Rf = 0.49 (Et2O:pentane, 1:1). m.p.: 141.3 °C−141.7 °C. ! "#+ =&+40.5 (c 0.25, CHCl3 ). IR (neat) ν  = 3480, 3019, 2927, 1707, 
1364, 1261, 1215, 1032, 756, 668 cm-1. 1H NMR (500 MHz, 
CDCl3) δ = 6.97 (s, 1H), 6.56 (s, 1H), 3.83 (d, J = 11.7 Hz, 1H), 
3.81 (s, 3H), 3.30−3.20 (hept, J = 7Hz, 1H), 2.25 (d, J = 11.5 Hz, 1H), 2.08−2.02 (m, 
1H), 1.90−1.76 (m, 1H), 1.71−1.66 (m, 1H), 1.62−1.55 (m, 1H), 1.50 (m, 1H), 1.29 
(dd, J = 13.3, 4.7 Hz, 1H), 1.18 (d, J = 7.0 Hz, 3H), 1.15 (d, J = 6.9 Hz, 3H), 1.11 (s, 
3H), 1.07 (s, 3H), 0.98 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 182.3, 156.9, 152.8, 
135.3, 131.8, 121.5, 103.0, 64.0, 55.7, 48.1, 46.6, 41.9, 35.6, 34.4, 32.9, 27.0, 23.6, 
23.1, 22.9, 21.7, 19.9. HRMS (ESI) m/z: calcd for C21H29O3- [M-H]-: 329.2122, 
found: 329.2123. 
 
Carboxylic acid A: 
 
Rf = 0.55 (Et2O:pentane, 1:1). m.p.: 207.2 °C (dec.). ! "#+ =&−42.2 (c 0.6, CHCl3 ). IR (neat) ν  = 2928, 2866, 1703, 1462, 
1416, 1281, 1222 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.09 (s, 
1H), 6.63 (s, 1H), 3.95 (d, J = 8.3 Hz, 1H), 3.83 (s, 3H), 3.27 (hept, 
J = 6.9 Hz, 1H), 2.18 (d, J = 8.3 Hz, 1H), 2.04 (dt, J = 12.1, 3.3 Hz, 1H), 1.89 (qt, J = 
13.6, 4.0 Hz, 1H), 1.69−1.61 (m, 1H), 1.56−1.49 (m, 1H), 1.47−1.38 (m, 1H), 1.37 (s, 
3H), 1.27−1.28 (m, 1H), 1.21 (d, J = 6.9 Hz, 3H), 1.17 (s, 3H), 1.16 (d, J = 6.9 Hz, 
3H), 1.09 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 181.2, 157.1, 153.0, 135.3, 131.1, 
122.9, 103.7, 63.3, 55.7, 48.5, 47.0, 44.4, 38.3, 34.3, 32.5, 27.0, 24.4, 23.3, 22.7, 20.9, 
20.0. HRMS (ESI) m/z: calcd for C21H29O3- [M-H]-: 329.2122, found: 329.2125. 
 
 
 
 
 
                                               
182  A single crystal suitable for X-ray crystallography was obtained from 
crystalization from CH3CN. 
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Transester B: 
 
Rf = 0.35 (Et2O:pentane, 1:1).& ! "#$ = &+31.9 (c 0.68, CHCl3). IR 
(neat) ν  = 3459, 2957, 2929, 1726, 1463, 1287, 1169, 1062, 
1030 cm-1. 1H NMR (400 MHz, CDCl3) δ = 6.89 (s, 1H), 6.56 (s, 
1H), 4.38−4.25 (m, 2H), 3.89−3.82 (m, 3H), 3.81 (s, 3H), 3.25 
(hept, J = 6.9 Hz, 1H), 2.24 (d, J = 11.6 Hz, 1H), 2.05 (dt, J = 11.8, 3.4 Hz, 1H), 1.83 
(qt, J = 13.4, 3.6 Hz, 1H), 1.72−1.65 (m, 1H), 1.62−1.48 (m, 2H), 1.37−1.26 (m, 1H), 
1.17 (d, J = 6.9 Hz, 3H), 1.14 (d, J = 6.9 Hz, 3H), 1.11 (s, 3H), 1.07 (s, 3H), 0.91 (s, 
3H). 13C NMR (101 MHz, CDCl3) δ = 176.6, 156.7, 152.7, 135.2, 132.4, 121.3, 
103.0, 66.5, 63.9, 61.5, 55.7, 48.5, 46.5, 41.9, 35.6, 34.2, 33.0, 26.9, 23.5, 23.1, 22.9, 
21.7, 19.9. HRMS (ESI) m/z: calcd for C23H34O4Na+ [M+Na]+:397.2349, found: 
397.2348. 
 
Ester 2.63: 
 
Method 1: from 2.81: 
To a solution of ester 2.81 (139 mg, 404 µmol) in dry MeOH (3.0 mL) was added a 
solution of MeONa (25w% in MeOH, 185 µL, 805 µmol). The mixture was heated up 
to 100 °C in a MW reactor for 12 h. The mixture was then diluted with Et2O (15 mL) 
and the mixture was filtered through a pad of silica gel with Et2O washing (50 mL). 
The combined organic phases were concentrated in reduced pressure and the residue 
was purified by column chromatography on silica gel (pentane:Et2O 30:1) to give 
2.63 as colourless oil (138 mg, 0.401 mmol, 99%) in a d.r. of 100 : 3 in favour of 9R-
isomer 2.63.  
 
Method 2: from 2.83: 
To a solution of 2.83 (80 mg, 242 µmol) in a mixture solvent of C6H6/MeOH (3.5 : 1, 
2.2 mL) was added dropwise a solution of TMSCHN2 (2 mol/L in hexanes, 0.25 mL, 
500 µmol) in C6H6 (500 µL). The reaction was stirred at rt for 30 min. and the 
solvents were removed under reduced pressure. The residue was purified by column 
chromatography on silica gel (pentane:Et2O 30:1) to give 2.63 as a colourless oil (85 
mg, 241 µmol, 99%).  
O
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Rf = 0.63 (pentane:Et2O 10:1).& 3 456 = &+24.8 (c 0.5, CHCl3). IR 
(neat) ν  = 2953, 2869, 1744, 1788, 1463, 1286, 1151, 630 cm-1. 
1H NMR (500 MHz, CDCl3) δ = 6.86 (s, 1H), 6.56 (s, 1H), 3.83 
(dd, J = 11.6, 1.0 Hz, 1H), 3.80 (s, 3H), 3.75 (s, 3H), 3.25 (hept, J = 
7.0 Hz, 1H), 2.22 (d, J = 11.6 Hz, 1H), 2.04 (dt, J = 12.4, 3.3 Hz, 1H), 1.82 (m, 1H), 
1.71−1.64 (m, 1H), 1.61−1.57 (m, 1H), 1.53−1.47 (m, 1H), 1.28 (dd, J = 13.6, 4.7 Hz, 
1H), 1.17 (d, J = 6.9 Hz, 3H), 1.15 (d, J = 6.9 Hz, 3H), 1.10 (s, 3H), 1.07 (s, 3H), 0.88 
(s, 3H). 13C NMR (101 MHz, CDCl3) δ = 176.5, 156.7, 152.7, 135.1, 132.4, 121.4, 
103.0, 64.0, 55.7, 51.9, 48.4, 46.4, 42.0, 35.6, 34.2, 32.8, 27.0, 23.4, 23.1, 22.9, 21.7, 
19.9. HRMS (ESI) m/z: calcd for C22H32O3Na+ [M+Na]+: 367.2244, found: 367.2245.  
 
Hydroxy 2.62: 
 
To a suspension of LiAlH4 (49.0 mg, 1.29 mmol) in THF (500 µL) 
was added a solution of ester 2.63 (87.5 mg, 254 µmol) in THF (800 
µL) at 0 °C, the reaction mixture was then stirred 30 min at 0 °C and 
2 h at rt. Then an aqueous solution of H2SO4 (10%, 50 mL) was 
added slowly at 0 °C to the reaction mixture followed by Et2O (20 mL). The organic 
phase and the aqueous phase were separated and the aqueous phase was extracted 
with Et2O (3 x 20 mL). The combined organic phases were successively washed with 
an aqueous saturated solution of NaHCO3 (40 mL) and brine (40 mL), dried over 
Na2SO4 and concentrated under reduced pressure. The residue183 was purified for 
analysis by chromatography column on silica gel (Et2O:pentane, 1:3) to afford alcohol 
2.62 as white crystalline solid (79.6 mg, 251 µmol, 99%). Rf = 0.62 (Et2O:pentane, 
1:1). mp = 99.6 °C−100.6 °C. ! "#+ = &+11.4 (c 0.5, CHCl3). IR (neat) ν  = 3361, 
2928, 1477, 1462, 1288, 1051 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.12 (s, 1H), 
6.59 (s, 1H), 4.38−4.31 (m, 1H), 4.10 (ddd, J = 11.8, 8.7, 3.4 Hz, 1H), 3.82 (s, 3H), 
3.28 (hept, J = 6.9 Hz, 1H), 3.15−3.09 (m, 1H), 2.04 (dt, J = 12.0, 3.3 Hz, 1H), 
1.89−1.75 (m, 2H), 1.71−1.62 (m, 1H), 1.56−1.46 (m, 2H), 1.29 (td, J = 13.2, 4.3 Hz, 
1H), 1.22 (d, J = 6.9 Hz, 3H), 1.19 (d, J = 6.9 Hz, 3H), 1.14 - 1.17 (m, 1H), 1.14 (s, 
                                               
183 The crude residue could be used directly without affecting the outcome of the next 
reaction. 
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3H), 1.11 (s, 3H), 1.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 156.4, 153.8, 134.7, 
133.3, 120.4, 103.3, 62.4, 59.1, 55.8, 45.7, 44.7, 42.7, 35.7, 34.2, 34.0, 27.0, 23.7, 
23.3, 22.9, 22.4, 20.0. HRMS (ESI) m/z: calcd for C21H32O2Na+ [M+Na]+: 339.2295, 
found: 339.2293. 
 
Bromo 2.85:  
 
To a solution of crude alcohol 2.62 (80.4 mg, 254 µmol) in dry 
CH2Cl2 (3.0 mL) was added a solution of Br2 (26 µL, 508 µmol) in 
dry CH2Cl2 (500 µL) at 0 °C. The solution was then stirred at rt for 
4 h. The reaction mixture was then diluted with Et2O (20 mL) and 
quenched with a saturated aqueous solution of NaHSO3 (50 mL). After separation of 
the organic phase, the aqueous phase was extracted with Et2O (3 x 20 mL). The 
combined organic phases were washed with brine (60 mL), dried over Na2SO4 and 
concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (pentane:Et2O 7:1) to give bromo 2.85 as a yellow oil 
(81.7 mg, 206 µmol, 81%). Rf = 0.42 (Et2O:pentane, 1:2).& ! "#+ = &−10.0 (c 0.25, 
CHCl3). IR (neat) ν  = 3350, 2928, 2883, 1458, 1397, 1298, 1017 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 7.11 (s, 1H), 4.39−4.32 (m, 1H), 4.17−4.08 (m, 1H), 3.79 (s, 
3H), 3.33 (hept, J = 6.9 Hz, 1H), 3.10−3.03 (m, 1H), 2.80−2.71 (m, 1H), 1.88 (d, J = 
12.0 Hz, 1H), 1.88 (d, J = 12.0 Hz, 1H), 1.71−1.62 (m, 2H), 1.50 (m, 1H), 1.33−1.27 
(m, 2H), 1.23 (d, J = 4.2 Hz, 3H), 1.21 (d, J = 4.1 Hz, 3H), 1.17 (s, 3H), 1.14 (s, 3H), 
1.10 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 153.1, 150.6, 141.1, 140.5, 119.9, 
113.8, 61.9, 61.5, 57.8, 49.2, 45.0, 41.7, 36.3, 33.9, 33.8, 27.5, 24.3, 23.9, 22.8, 20.8, 
19.6. &HRMS (ESI) m/z: calcd for C21H31Br1O2Na+ [M+Na]+: 417.1400, found: 
417.1398. 
 
Phenol 2.84: 
 
To a mixture of TMEDA (120 µL, 0.80 mmol) and n-BuLi (1.6 M 
in hexanes, 480 µL, 768 µmol) in hexane (1.5 mL) was added a 
solution of 2.85 (31.8 mg, 80 µmol) in hexane (300 µL) dropwise at 
-10 °C under argon. After 20 min at this temperature, a stream of O2 
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(1 atm) was bubbled through the solution while the temperature was slowly brought to 
rt over 2 h. Then a saturated aqueous solution of NH4Cl (5 mL) was added to the 
reaction mixture as well as Et2O (5 mL). The aqueous phase was extracted with Et2O 
(3 x 5 mL). The combined organic phases were washed with brine (20 mL), dried 
over Na2SO4 and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel (pentane:Et2O 7:1) to give phenol 2.84 as 
yellow oil (15.6 mg, 46.9 µmol, 58%) and alcohol 2.62 (7 mg, 22.1 µmol, 27%). Rf = 
0.35 (Et2O:pentane, 1:2).& ! "#+ = &−29.4 (c 0.17, CHCl3). IR (neat) ν  = 3418, 2927, 
2869, 1452, 1423, 1310, 1018 cm-1. 1H NMR (400 MHz, CDCl3) δ = 6.70 (s, 1H), 
5.48 (s, 1H), 4.36−4.29 (m, 1H), 4.15−4.06 (m, 1H), 3.76 (s, 3H), 3.24 (hept, J = 6.9 
Hz, 1H), 3.11−3.04 (m, 1H), 2.47−2.38 (m, 1H), 1.88−1.82 (m, 1H), 1.83−1.75 (m, 
1H), 1.71−1.59 (m, 2H), 1.51−1.44 (m, 1H), 1.34−1.26 (m, 1H), 1.23 (d, J = 6.8 Hz, 
3H), 1.22 (d, J = 6.8 Hz, 3H), 1.15 (s, 3H), 1.13 (s, 3H), 1.10 (s, 3H). 13C NMR (101 
MHz, CDCl3) δ = 144.1, 143.5, 139.3, 139.2, 137.1, 111.5, 62.0, 62.0, 58.5, 46.0, 
45.3, 42.4, 36.2, 34.0, 33.9, 26.8, 24.4, 24.0, 22.5, 21.1, 20.0. HRMS (ESI) m/z: calcd 
for C21H32O3Na+ [M+Na]+: 355.2244, found: 355.2243. 
 
Quinone 2.60: 
 
To a solution of phenol 2.84 (15.6 mg, 47.0 µmol) in MeCN (600 
µL) was bubbled a stream of O2 (1 atm) for 4 h at rt in a flask 
covered by aluminium foil. The reaction mixture was then diluted 
with Et2O and filtered through a pad of silica. The pad was washed 
with Et2O (5 mL) and the filtrate was then concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel (pentane:Et2O, 7:1) to 
give 2.60 as an intense yellow/orange oil (16.3 mg, 46.9 µmol, 99%). Rf = 0.37 
(Et2O:pentane, 1:2).& ! "#$ = &−118.0 (c 0.81, CHCl3). IR (neat) ν  = 3462, 2927, 
1661, 1643, 1588, 1459, 1265, 1020 cm-1. 1H NMR (400 MHz, CDCl3) δ = 4.39−4.31 
(m, 1H), 4.09 (dd, J = 9.9, 2.8 Hz, 1H), 3.95 (s, 3H), 3.60 (ddd, J = 11.6, 7.2, 2.6 Hz, 
1H), 3.22 (hept, J = 7.2 Hz, 1H), 3.11 (ddd, J = 11.4, 7.2, 2.4 Hz, 1H), 2.31 (dt, J = 
12.6, 3.9 Hz, 1H), 1.81−1.66 (m, 1H), 1.65−1.56 (m, 2H), 1.53−1.43 (m, 2H), 
1.27−1.23 (m, 1H), 1.21 (d, J = 7.1 Hz, 3H), 1.19 (d, J = 7.1 Hz, 4H), 1.12 (s, 3H), 
1.09 (s, 3H), 1.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 189.2, 182.2, 156.1, 
O
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154.8, 148.6, 137.4, 62.7, 61.2, 57.7, 48.1, 47.4, 42.0, 34.9, 34.4, 33.9, 24.8, 22.7, 
20.7, 20.6, 20.5, 19.4. HRMS (ESI) m/z: calcd for C21H31O4+ [M+H]+: 347.2217, 
found: 347.2213. 
 
Taiwaniaquinone F (2.3): 
 
To a solution of 2.60 (8.8 mg, 25.5 µmol) in CH2Cl2 (600 µL) (in a 
flask covered by aluminium foil) was added DMP (98 mg, 281 
µmol) at 0 °C and the reaction mixture was warmed up to rt and 
stirred over 3 h. The reaction mixture was then diluted with H2O (2 
mL) and Et2O (2 mL). The aqueous phase was extracted with Et2O (3 x 1 mL) and the 
combined organic phases were washed with brine (5 mL), dried over Na2SO4 and 
concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel (pentane: Et2O, 10:1) to give taiwaniquinone F (2.3) as 
an intense yellow oil (8.6 mg, 0.0250 mmol, 98%). Rf = 0.53 (Et2O:pentane, 
1:3).& ! "#8 = &−154 (c 0.86, CHCl3). IR (neat) ν  = 2922, 2855 1734, 1660, 1583, 
1459, 1263 cm-1. 1H NMR (400 MHz, CDCl3) δ = 9.86 (d, J = 3.9 Hz, 1H), 3.94 (d, J 
= 3.1 Hz, 3H), 3.76 (dd, J = 11.5, 3.8 Hz, 1H), 3.18 (hept, J = 7.2 Hz, 1H), 2.32 (dt, J 
= 12.8, 3.2 Hz, 1H), 2.12 (d, J = 11.5 Hz, 1H), 1.85−1.71 (m, 1H), 1.70−1.47 (m, 3H), 
1.25−1.20 (m, 1H), 1.19 (d, J = 7.1 Hz, 3H), 1.17 (d, J = 7.1 Hz, 3H), 1.16 (s, 3H), 
1.07 (s, 3H), 0.81 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 200.8, 186.0 181.7, 
156.5, 155.3, 146.5, 137.2, 61.7, 61.3, 54.1, 49.3, 41.2, 35.2, 34.5, 33.8, 24.8, 22.0, 
20.6, 20.6, 20.2, 19.5.&HRMS (ESI) m/z: calcd for C21H28O4Na+ [M+Na]+: 367.1880, 
found: 367.1882. All analytical data are in agreement with literature values: Chang, 
C. I.; Chien, S. C.; Lee, S. M.; Kuo, Y. H. Chem. Pharm. Bull. 2003, 51, 1420−1422. 
 
Taiwaniaquinol A (2.9): 
 
A solution of taiwaniaquinone F (2.3) (2 mg, 5.8 µmol) in Et2O (10 
mL) was exposed to daylight for 15 min. The reaction mixture was 
then concentrated under reduced pressure. The residue was purified 
by column chromatography on silica gel (pentane:Et2O 15:1) to give 
taiwaniquinol A (2.9) as colourless amorphous solid (0.6 mg, 1.74 µmol, 30%). Rf = 
O
H CHO
O
O
H CHO
OH
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0.4 (Et2O:pentane, 1:2).& ! "#8 = &+77.7 (c 0.040, CHCl3). IR (neat) ν  = 3373, 2924, 
2856, 1716, 1661, 1430, 1259, 1053 cm-1. 1H NMR (600 MHz, CDCl3) δ = 9.50 (d, J 
= 5.0 Hz, 1H), 5.89 (d, J = 1.1 Hz, 1H), 5.84 (d, J = 1.0 Hz, 1H), 5.07 (s, 1H), 3.79 
(dd, J = 11.1, 5.0 Hz, 1H), 3.18 (hept, J = 7.2 Hz, 1H), 2.25−2.16 (m, 2H), 2.05−1.99 
(m, 1H), 1.83−1.75 (m, 1H), 1.71−1.66 (m, 1H), 1.56 (s, 1H), 1.28 (d, J = 7.2 Hz, 
6H), 1.12 (s, 3H), 1.08 (s, 3H), 0.92 (s, 3H). 13C NMR (151 MHz, CDCl3) δ = 205.2, 
147.0, 146.2, 135.3, 132.5, 116.8, 113.3, 101.0, 61.6, 54.6, 46.4, 41.8, 35.8, 34.5, 
34.1, 25.3, 22.5, 22.1, 21.3, 21.2, 19.8. HRMS (ESI) m/z: calcd for C21H27O4- [M-H]- 
343.1915, found: 343.1917. All analytical data are in agreement with literature values: 
Lin, W. H.; Fang, J. M.; Cheng, Y. S. Phytochemistry 1995, 40, 871−873. 
 
6.3.!Synthesis of icetexane members 
 
Ester 3.77: 
 
A suspension of 150 g of dried rosemary leaves was sonicated in 
EtOH (800 mL) at 45 °C for 2 h. The resulting suspension was then 
filtered through Celite, the cake was washed with EtOH 
(2 x 200 mL) and the filtrate was concentrated under reduced 
pressure. The residue was partially dissolved in Et2O (150 mL), filtrated over celite, 
the cake was washed with Et2O (2 x 200 mL) and the combined organic phases were 
extracted with an aqueous solution of NaOH (1 M, 3 x 150 mL). The combined 
aqueous phases were acidified with half-concentrated aqueous H2SO4 (pH~1) and 
extracted with Et2O (3 x 100 mL). The combined organic phases were dried over 
Na2SO4 and evaporated under reduced pressure. To a solution of the residue (5.2 g) in 
dry THF (400 mL) was added portionwise NaH (6.2 g, 60% dispersed in mineral oil). 
The resulting suspension was stirred for 1 h at rt and Me2SO4 (15 mL) was added in 
one portion. The reaction mixture was stirred overnight at rt. The reaction mixture 
was then cooled to 0 °C, diluted with Et2O (400 mL) and MeOH (50 mL) was slowly 
added until no more H2 evolution was observed. Finally, distilled water (300 mL) was 
added and the aqueous phase was extracted with Et2O (3 x 100 mL). The combined 
organic phases were dried over Na2SO4 and evaporated under reduced pressure. The 
residue was purified by column chromatography on silica gel (Et2O:pentane, 1:20) to 
OMe
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afford an inseparable mixture of 3.77, trimethylated-3.81 and dimethylated-3.82 
respectively as a yellow oil (2.05 g . A solution of this mixture in MeOH (12 mL) 
was filtered over a plug of cotton to remove the precipitated dimethylated-3.82 
precipitated (50 mg). To the filtrate was added Pd(OH)2/C (100 mg) under argon 
atmosphere and the resulting suspension was flushed with H2 and vigorously stirred 
under an atmospheric pressure of H2 for 1 h at rt. The reaction mixture was then 
filtered through celite and the cake was washed with MeOH (50 mL). The filtrate was 
evaporated under reduced pressure and the residue was diluted with Et2O (50 mL) and 
dried over Na2SO4. All volatiles were evaporated under reduced pressure to afford 
pure 3.77 as a colorless oil (1.97 g, 1.31% from dried mass . Rf = 0.54 (Et2O:pentane, 
3:10). 3 45: = &+122 (c 0.20, CHCl3). IR (neat) ν = 2958, 2870, 1727, 1447, 1214, 
754 cm-1.  1H NMR (400 MHz, CDCl3) δ = 6.70 (s, 1H), 3.77 (s, 3H), 3.67 (s, 3H), 
3.66 (s, 3H), 3.47−3.41 (m, 1H), 3.24 (hept, J = 6.8 Hz, 1H), 2.88−2.82 (m, 2H), 
2.32−2.15 (m, 3H), 1.87−1.78 (m, 1H), 1.57−1.50 (m, 3H), 1.33−1.27 (m, 1H), 1.22 
(d, J = 6.9 Hz, 3H), 1.22 (d, J = 6.9 Hz, 3H), 1.19−1.15 (m, 1H), 0.99 (s, 3H), 0.79 (s, 
3H). All analytical data are in agreement with the litterature values: Kelecom, A. 
Tetrahedron 1983, 39, 3603−3608. 
 
Alkohol 3.75: 
 
To a solution of 3.77 (1.34 g, 3.58 mmol) in dry Et2O (30 mL) was 
added dropwise a suspension of LAH (2.2 g, 58.0 mmol) in dry Et2O 
(30 mL) under argon at rt and the resulting mixture was refluxed 
(T = 45 °C) for 6 h. The reaction mixture was then diluted with Et2O 
(100 mL) and cooled down to 0 °C and an aqueous H2SO4 solution (10%) was added 
dropwise until no more H2 evolution was observed (pH~1) with a continuous flow of 
N2. Water was then added (50 mL) and the aqueous phase was extracted with Et2O 
(3 x 40 mL). The combined organic phases were washed with brine (100 mL) and 
dried over Na2SO4. All volatiles were evaporated under reduced pressure to afford 
pure 3.75 as a white solid (1.10 g, 3.17 mmol, 89% . Rf = 0.37 (Et2O:pentane, 3:10). 
mp = 80.0−81.0 °C. 3 45; = &+148 (c 0.67, CHCl3). IR (neat) ν = 3476, 2957, 2867, 
1469, 1401, 1326, 1302, 1049 cm-1. 1H NMR (400 MHz, CDCl3) δ = 6.72 (s, 1H), 
4.14 (d, J = 10.8 Hz, 1H), 3.89 (s, 3H), 3.82 (d, J = 10.8 Hz, 1H), 3.74 (s, 3H), 3.24 
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(hept, J = 6.9 Hz, 1H), 3.10 (dt, J = 13.4, 3.3 Hz, 1H), 2.90−2.82 (m, 2H), 1.82−1.65 
(m, 4H), 1.60−1.54 (m, 1H), 1.53−1.47 (m, 1H), 1.44 (dd, J = 11.9, 2.7 Hz, 1H), 
1.38−1.24 (m, 4H), 1.22 (d, J = 7.0 Hz, 3H), 1.17 (d, J = 6.9 Hz, 3H), 0.97 (s, 3H), 
0.96 (s, 3H). All analytical data are in agreement with the literature values: Kelecom, 
A. Tetrahedron 1983, 39, 3603−3608. 
Alkohol 3.4: 
 
A solution of 3.75 (17.0 mg, 49.1 µmol) in dry THF (1.0 mL) was 
added dropwise to a suspension of freshly purified LiAlH4 (16.0 mg, 
422 µmol) in dry THF (1.0 mL) at rt. The reaction was then warmed 
up to 50 °C and stirred for 7 h. An aqueous solution of H2SO4 (10%, 
10 mL) was added slowly at 0  °C to the reaction mixture, followed by addition of 
Et2O (10 mL). The organic phase and the aqueous phase were separated and the 
aqueous phase was extracted with Et2O (3 x 5 mL). The combined organic phases 
were washed with brine (15 mL), dried over Na2SO4 and concentrated under reduced 
pressure. The residue was purified by column chromatography on silica gel 
(Et2O:pentane, 1:2) to afford methylpisiferol (3.4) as a colourless foam (13.7 mg, 
39.5 µmol, 80%). mp = 63.7−65.0 °C. Rf = 0.22 (Et2O:pentane, 3:10).& 3 45; = &+55.0 
(c 0.43, CHCl3). IR (neat) ν = 3400, 2923, 2854, 1501, 1462, 1254, 1023, 623 cm-1. 
1H NMR (500 MHz, CDCl3) δ = 6.92 (s, 1H), 6.75 (s, 1H), 3.96−3.91 (m, 1H), 3.80 
(s, 3H), 3.69 (dd, J = 11.0, 2.7 Hz, 1H), 3.24 (hept, J = 6.8 Hz, 1H), 2.96−2.80 (m, 
2H), 2.67−2.60 (m, 1H), 1.92−1.58 (m, 5H), 1.54−1.48 (m, 2H), 1.22 (dd, J = 4.6, 
2.1 Hz, 1H), 1.20 (d, J = 6.9 Hz, 3H), 1.19 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 7.2 Hz, 
6H), 0.85 (d, J = 4.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ = 154.6, 141.5, 135.3, 
128.4, 127.3, 108.5, 64.1, 55.8, 50.3, 43.0, 41.9, 33.7, 33.4, 33.1, 28.9, 26.6, 22.9, 
22.9, 22.4, 19.1, 18.6. HRMS (ESI) m/z: calcd for C21H33O2 [M+H]+: 317.2475, 
found: 317.2477. 
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Biomimetic ring expansion of 3.75: 
 
 To a solution of 3.75 (1.35 g, 3.90 mmol) in 
THF (135 mL) was added MsCl (4.0 mL, 
51.7 mmol) in one portion at −10 °C, 
followed by a dropwise addition of Et3N 
(7.2 mL, 51.6 mmol). The white milky mixture was stirred at this temperature for 20 
min (the mesylation could be followed by TLC) before distilled H2O (108 mL) was 
added and the resulting clear solution was stirred at 40 °C for 12 h. The reaction 
mixture was then diluted with Et2O (200 mL) and distilled H2O (200 mL) was added. 
The aqueous phase was extracted with Et2O (3 x 100 mL). The combined organic 
phases were dried over Na2SO4. All volatiles were evaporated under reduced pressure. 
The residue was purified by column chromatography on silica gel, using a mixture of 
pentane:Et2O (20:1) as eluent to afford a mixture of alkenes mixture 3.100 as a 
colourless oil (843 mg, 2.43 mmol, 62%) and 3.76 as a white solid (431 mg, 
1.24 mmol, 32%). 
 
3.100: Rf = 0.69 (Et2O:pentane, 1:10). 
 
3.76: Rf = 0.28 (Et2O:pentane, 1:10). 3 45; = &+17.6  (c 0.41, CHCl3). 
mp = 80.6−81.6 °C. IR (neat) ν = 3475, 2932, 1449, 1412, 1298, 1049, 874 cm-1. 1H 
NMR (400 MHz, CDCl3) δ = 6.74 (s, 1H), 3.81 (s, 6H), 3.27 (hept, J = 6.9 Hz, 1H), 
3.23 (d, J = 14.1 Hz, 1H), 2.82−2.74 (m, 1H), 2.71−2.62 (m, 1H), 2.49 (d, 
J = 14.0 Hz, 1H), 2.02−1.95 (m, 1H), 1.91−1.78 (m, 2H), 1.60−1.50 (m, 1H), 
1.48−1.38 (m, 2H), 1.36−1.24 (m, 3H), 1.22 (d, J = 7.0 Hz, 3H), 1.20 (d, J = 6.9 Hz, 
3H), 0.92 (s, 3H), 0.88 (s, 3H). All analytical data are in agreement with the literature 
values: Majetich, G.; Zou, G. Org. Lett. 2008, 10, 81−83. 
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(+)-Salvicanol (3.6): 
Method 1: from 3.76: 
L-Selectride  (3.70 mL, 1 M in THF, 3.70 mmol) was added to 
compound 3.76 (128 mg, 368 µmol) under argon at rt in a sealed 
tube. The reaction was stirred at 80 °C for 2 h (a longer reaction 
time lead to the formation of demethylsalvicanol). The reaction mixture was then 
diluted with Et2O (10 mL) and cooled down to 0 °C and a saturated aqueous solution 
of NH4Cl (10%) was added dropwise until no more H2 evolution was observed. The 
aqueous phase was extracted with Et2O (3 x 40 mL). The combined organic phases 
were washed with brine (20 mL) and dried over Na2SO4. All volatiles were then 
evaporated under reduced pressure. The residue was purified by column 
chromatography on silica gel (Et2O:pentane, 1:5) to afford salvicanol (3.6) as a white 
solid (98 mg, 295 µmol, 80%). 
 
Method 2: from 3.100: 
To a solution of 3.100 (36.4 mg, 111 µmol) in DCM (1 mL) was added m-CPBA 
(83.7 mg, 485 µmol) at 0 °C. The reaction mixture was then stirred for 2 h and 
quenched with an aqueous solution of NaOH (5%, 10 mL). The aqueous phase was 
extracted with Et2O (3 x 5 mL). The combined organic phases were washed with an 
aqueous solution of NaOH (5%, 3 x 10 mL) and dried over Na2SO4. All volatiles were 
evaporated under reduced pressure. To the resulting residue, was added a solution of 
L-Selectride  (1.1 mL, 1 M in THF, 1.1 mmol) under argon in a sealed tube. The 
reaction mixture was stirred at 80 °C for 3 h (a longer reaction time would lead to the 
formation of demethylsalvicanol). The reaction mixture was diluted with Et2O 
(10 mL) and cooled down to 0 °C. A saturated aqueous solution of NH4Cl (10%, 
10 mL) was added dropwise until no more H2 evolution was observed. The aqueous 
phase was extracted with Et2O (3 x 10 mL). The combined organic phases were 
washed with brine (20 mL) and dried over Na2SO4. All volatiles were evaporated 
under reduced pressure. The residue was purified by column chromatography on 
silica gel (Et2O:pentane, 1:5) to afford salvicanol (3.6) as a white solid (16.5 mg, 
48.1 µmol, 42% over two steps). 
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3.6: Rf = 0.26 (Et2O:pentane, 2:5). mp=97−100 °C. 3 45; = &+39.0 (c 0.19, CHCl3). 
IR (neat) ν = 3486, 2930, 1450, 1422, 1334, 1298, 1079, 972 cm-1. 1H NMR 
(400 MHz, CDCl3) δ = 6.54 (s, 1H), 5.68 (s, 1H), 3.75 (s, 3H), 3.26−3.17 (m, 2H), 
2.79−2.62 (m, 3H), 2.51 (d, J = 14.2 Hz, 1H), 2.00−1.80 (m, 3H), 1.55 (s, 1H), 
1.47−1.38 (m, 3H), 1.34−1.26 (m, 3H), 1.25 (d, J = 7.0 Hz, 3H), 1.20 (d, J = 6.9 Hz, 
3H), 1.12 (d, J = 1.6 Hz, 1H), 0.92 (s, 3H), 0.89 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 148.0, 142.5, 141.6, 139.3, 119.8, 116.90, 71.0, 61.9, 58.3, 42.7, 42.3, 
41.2, 36.5, 34.6, 32.4, 26.6, 24.2, 24.1, 23.7, 21.8, 18.9. HRMS (ESI) m/z: calcd for 
C21H32O3Na1 [M+Na]+: 355.2244, found: 355.2244. All analytical data are in 
agreement with the litterature values: (a) Fraga, B. M.; Gonzalez, A. G.; Herrera, J. 
R.; Luis, J. G.; Ravelo, A. G. Phytochemistry 1986, 25, 269−271; (b) Bruno, M.; 
Savona, G.; Piozzi, F.; de la Torre, M. C.; Rodriguez, B.; Marlier, M. Phytochemistry 
1991, 30, 2339−2343. 
 
Quinone 3.105: 
 
To a solution of 3.6 (16.5 mg, 4.96 µmol) in MeCN (1.0 mL) was 
added Co(salen) (95%, 17.4 mg, 5.07 µmol) at rt. The resulting 
mixture was stirred for 3 h under oxygen atmosphere. The 
reaction mixture was then diluted with Et2O (3 mL) and filtered through a pad of 
silica. The pad was washed with Et2O (2 x 5 mL) and the filtrate was concentrated 
under reduced pressure. The residue was purified by column chromatography on 
silica gel using pentane/Et2O (20:1) as eluent to yield 3.105 (12.6 mg, 3.64 µmol, 
73%) as an orange oil. Rf = 0.44 (Et2O:pentane, 2:5). 3 45; = &+46.6 (c 0.51, CHCl3). 
IR (neat) ν  = 3500, 2936, 1647, 1243, 765, 630 cm-1. 1H NMR (500 MHz, CDCl3) 
δ = 3.91 (s, 3H), 3.38−3.31 (m, 1H), 3.29−3.21 (m, 1H), 3.14 (d, J = 14.2 Hz, 1H), 
2.25 (dd, J = 14.3, 0.9 Hz, 1H), 2.05−1.97 (m, 1H), 1.90−1.72 (m, 3H), 1.61−1.53 (m, 
1H), 1.47−1.38 (m, 2H), 1.34−1.30 (m, 1H), 1.29−1.24 (m, 2H), 1.20 (d, J = 7.1 Hz, 
6H), 0.91 (s, 3H), 0.88 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 187.1, 184.5, 155.5, 
147.2, 140.0, 137.4, 70.8, 61.1, 58.2, 42.7, 42.3, 40.1, 34.5, 32.2, 25.61, 25.0, 21.7, 
20.8, 20.8, 20.7, 18.4. HRMS (ESI) m/z: calcd for C21H31O4 [M+H]+: 347.2217, 
found: 347.2218. 
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Salvicanol acetate (3.112): 
 
To a solution of salvicanol (3.6, 10.0 mg, 30.1 µmol) in pyridine 
(0.5 mL) was added Ac2O (0.5 mL) at rt. The reaction mixture 
was stirred for 1 h at rt and subsequently diluted with Et2O (5 mL) 
before an aqueous solution of HCl (1 M, 5 mL) was added. The aqueous phase was 
extracted with Et2O (3 x 5 mL). The combined organic phases were washed with 
aqueous solution of HCl (1 M, 3 x 5 mL) and dried over Na2SO4. All volatiles were 
evaporated under reduced pressure to afford pure salvicanol acetate (3.112) as a white 
solid (10.2 mg, 27.2 µmol, 90%). Rf = 0.61 (Et2O:pentane, 2:5). mp = 98.5−99.9 °C. 3 45; = &+19.7 (c 0.42, CHCl3). IR (neat) ν  = 3514, 2945, 1750, 1451, 1374, 1220 
cm-1. 1H NMR (400 MHz, CDCl3) δ = 6.90 (s, 1H), 3.72 (s, 3H), 3.24 (hept, 
J = 6.9 Hz, 1H), 2.83 (ddd, J = 14.4, 7.6, 1.4 Hz, 1H), 2.73−2.59 (m, 3H), 2.37 (s, 
3H), 1.97−1.80 (m, 2H), 1.69 (br. s, 1H), 1.62−1.35 (m, 6H), 1.27 (dd, J = 8.4, 
3.6 Hz, 1H), 1.23 (d, J = 6.9 Hz, 3H), 1.20 (d, J = 6.9 Hz, 3H), 0.92 (s, 3H), 0.89 (s, 
3H). 13C NMR (63 MHz, CDCl3) δ 170.6, 147.1, 143.4, 140.7, 140.6, 127.7, 123.8, 
70.7, 61.6, 58.6, 43.5, 42.6, 42.5, 36.6, 34.5, 32.4, 26.7, 24.0, 23.6, 23.6, 21.8, 20.9, 
18.8. HRMS (ESI) m/z: calcd for C23H34O4Na1 [M+Na]+: 397.2349, found: 397.2349. 
All analytical data are in agreement with the literature values: Fraga, B. M.; Gonzalez, 
A. G.; Herrera, J. R.; Luis, J. G.; Ravelo, A. G. Phytochemistry 1986, 25, 269−271. 
 
Ketone 3.109: 
 
To a solution of salvicanol acetate (3.112) 
(9.8 mg, 25 µmol) in t-BuOOH (70% aq.) 
(1 mL) was added a solution of RuCl3!xH2O 
(167 µg) in pyridine (500 µL), at rt in a 
sealed tube. The reaction mixture was stirred for 5.5 h at 90 °C. The reaction mixture 
was diluted with Et2O (10 mL) and an aqueous solution of HCl (10%, 10 mL) was 
added. The aqueous phase was extracted with Et2O (3 x 40 mL). The combined 
organic phases were washed with an aqueous solution of HCl (10%, 3 x 10 mL) and 
dried over Na2SO4. All volatiles were evaporated under reduced pressure. The residue 
was purified by column chromatography on silica gel to afford a mixture of 3.109 and 
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3.111 as an amorphous white solid (3.0 mg, 7.7 µmol, 31%) along with recovered 
starting material (3.112, 1.8 mg, 4.8 µmol, 19%). Rf = 0.31 (Et2O:pentane, 1:1). 3 45; = &−15.1 ± 2.8& (c 0.15, CHCl3). IR (neat) ν  = 3387, 2934, 1765, 1672, 1200, 
781 cm-1. HRMS (ESI) m/z: calcd for C23H32O5Na1 [M+Na]+: 411.2142, found: 
411.2141. 
 
Ketone 3.74: 
 
To a solution of 3.109 and 3.111 (5.5 mg, 
14.16 µmol) in MeOH (1.0 mL) was added 
KOH (85%, 34 mg, 515 µmol) at rt. The 
reaction mixture was allowed to stirr for 12 h at rt. The reaction mixture was then 
diluted with Et2O (10 mL) and an aqueous solution of HCl (1 M, 10 mL) was added. 
The aqueous phase was extracted with Et2O (3 x 40 mL). The combined organic 
phases were washed with distilled water (3 x 10 mL) and dried over Na2SO4. All 
volatiles were evaporated under reduced pressure. The residue (3.74, 4.9 mg, 
14.14 µmol, 99%) was used without further purification. Rf = 0.31 (Et2O:pentane, 
1:1). 3 45; = &−10.5 (c 0.24, CHCl3). IR (neat) ν  = 3381, 2926, 1710, 1670, 1455, 
1425, 1314, 1042 cm-1. HRMS (ESI) m/z: calcd for C21H31O4 [M+H]+: 347.2217, 
found: 347.2213. 
Komaroviquinone (3.11): 
 
To a solution of crude 3.74 (4.90 mg, 14.1 µmol) in MeCN 
(6.0 mL) was added Co(salen) (20 mg, 58.4 µmol) at rt. The 
resulting mixture was stirred 12 h under O2 pressure (5 bar). The 
following process was done under exclusion from light. The reaction mixture was 
diluted with dist. Et2O (3 mL) and filtered through a pad of silica. The pad was 
washed with Et2O (5 mL) and the filtrate was then concentrated under reduced 
pressure. All volatiles were evaporated under reduced pressure and the residue was 
purified on column chromatography on silica gel, using pentane:Et2O (2:1) as eluent 
to afford pure komaroviquinone (3.11, 2.83 mg, 7.85 µmol, 56% over two steps). 
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Rf = 0.45 (Et2O:pentane, 1:1). 3 45; = &+40.4 (c 0.14, CHCl3). IR (neat) ν = 3405, 
2950, 1651, 1603, 1457, 1395, 1243, 1055, 777 cm-1. 1H NMR (400 MHz, CDCl3) 
δ = 5.98 (s, 1H), 3.98 (s, 3H), 3.23 (hept, J = 7.1 Hz, 1H), 2.55 (br d, J = 19.5 Hz, 
1H), 2.29 (dd, J = 12.8, 8.6 Hz, 1H), 2.25 (d, J = 19.5 Hz, 1H), 2.07−1.98 (m, 2H), 
1.94−1.82 (m, 1H), 1.77−1.68 (m, 2H), 1.64−1.56 (m, 3H), 1.21 (d, J = 7.1 Hz, 3H), 
1.21 (d, J = 7.1 Hz, 3H), 1.17−1.12 (m, 1H), 0.95 (s, 3H), 0.86 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ 189.3, 183.7, 156.2, 142.3, 139.1, 137.2, 101.0, 79.5, 61.3, 51.6, 
45.9, 39.1, 32.2, 31.3, 30.5, 29.9, 27.2, 24.5, 20.6, 20.5, 15.8. HRMS (ESI) m/z: calcd 
for C21H29O5 [M+H]+:361.2010, found: 361.2010. All analytical data are in 
agreement with the literature values: Uchiyama, N.;  Kiuchi, F.;  Ito, M.; Honda, G.;  
Takeda, Y.; Khodzhimatov, O. K.; Ashurmetov, O. A. J. Nat. Prod. 2003, 66, 
128−131. 
Photolysis of komaroviquinone (3.11): 
 
 A solution of komaroviquinone (3.11, 
2.8 mg, 7.8 µmol) in Et2O (5.0 mL) was 
exposed to daylight in a glass vial 
(T = 4 °C) for 45 min. The volatiles were 
removed under reduced pressure and the 
residue was purified by column chromatography on silica gel, using pentane:Et2O 
(3:1) as eluent to yield komarovispirone (3.12, 0.85 mg, 2.4 µmol, 31%) as a light 
yellow oil and cyclocoulterone (3.10, 0.90 mg, 2.5 µmol, 32%) as colorless 
amorphous solid. 
 
Komarovispirone (3.12): Rf = 0.65 (Et2O:pentane, 1:1). & 3 45; = &+266&  (c 0.040, 
MeOH). IR (neat) ν = 2934, 1651, 1558, 1180, 1100 cm-1. 1H NMR (600 MHz, 
C6D6) δ = 13.33 (s, 1H), 3.71 (s, 3H), 3.57 (hept, J = 7.1 Hz, 1H), 2.05 (d, 
J = 12.0 Hz, 1H), 1.96−1.85 (m, 2H), 1.75 (br d, J = 13.7, 1H), 1.48−1.44 (m, 1H), 
1.41−1.38 (m, 1H), 1.36 (d, J = 6.0 Hz, 5H), 1.35 (d, J = 5.8 Hz, 4H), 1.27−1.21 (m, 
3H), 1.19 (d, J = 12.0 Hz, 1H), 0.89 (dd, J = 13.3, 4.3 Hz, 1H), 0.87 (s, 3H), 0.74 (td, 
J = 14.3, 13.8, 4.4 Hz, 1H), 0.52 (s, 3H), 0.39 (s, 6H). 13C NMR (151 MHz, C6D6) 
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δ = 195.5, 169.6, 160.4, 154.7, 143.6, 107.2, 91.5, 59.9, 55.5, 51.7, 43.6, 40.5, 40.4, 
34.4, 33.5, 31.6, 26.1, 20.6, 20.5, 19.9, 18.6. HRMS (ESI) m/z: calcd for C21H29O5 
[M+H]+: 361.2010, found: 361.2009. All analytical data are in agreement with the 
literature values: Uchiyama, N.; Ito, M.; Kiuchi, F.; Honda, G.; Takeda, Y.; 
Khodzhimatov, O. K.; Ashurmetov, O. A. Tetrahedron Lett. 2004, 45, 531−533. 
 
Cyclocoulterone (3.10): Rf = 0.38 (Et2O:pentane, 1:1). & 3 45; = &−123&  (c 0.040, 
MeOH). IR (neat) ν = 3469, 2930, 1643, 1601, 1436, 1406, 1341, 1174, 1140, 1094, 
1060, 970, 933 cm-1. 1H NMR (500 MHz, CDCl3) δ = 13.42 (s, 1H), 5.94 (d, 
J = 1.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 3.41 (hept, J = 7.2 Hz, 1H), 3.02 (d, 
J = 14.0 Hz), 2.99 (dd, J = 18.0, 9.8 Hz, 1H), 2.74 (d, J = 14.0 Hz, 1H), 2.62 (d, 
J = 18.0 Hz, 2H), 1.91−1.81 (m, 1H), 1.76−1.68 (m, 1H), 1.59−1.51 (m, 2H), 
1.48−1.40 (m, 2H), 1.31 (d, J = 7.1 Hz, 3H), 1.28 (d, J = 7.1 Hz, 3H), 1.21 (ddd, 
J = 7.0, 4.3, 2.7 Hz, 1H), 1.14 (td, J = 13.8, 3.0 Hz, 1H), 0.99 (s, 3H), 0.86 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 208.7, 160.8, 150.8, 139.4, 117.3, 114.9, 112.7, 
100.9, 73.8, 49.8, 41.5, 40.7, 40.2, 38.7, 34.1, 32.2, 24.5, 21.6, 20.9, 20.7, 18.8. 
HRMS (ESI) m/z: calcd for C21H29O5 [M+H]+: 361.2010, found: 361.2006. All 
analytical data are in agreement with the litterature values: Uchiyama, N.; Kiuchi, F.; 
Ito, M.; Honda, G.;  Takeda, Y.; Khodzhimatov, O. K.; Ashurmetov, O. A. J. Nat. 
Prod. 2003, 66, 128−131. 
Coulterone (3.9): 
 
To a solution of komaroviquinone (3.11, 2.00 mg, 5.55 µmol) in 
Et2O (5.0 mL) in a separating funnel was added a solution of 
Na2S2O4 (10% aq., 5.0 mL) and the mixture was shaken until the 
bright orange solution became slightly yellow. The reaction was 
followed by TLC. The organic phase was then separated from the aqueous phase, 
dried over Na2SO4 and all volatiles were removed under reduced pressure. The 
residue was then purified by pTLC using Et2O:pentane (1:1) as eluent to yield pure 
coulterone (1.65 mg, 4.55 µmol, 82%). Rf = 0.28 (pentane:Et2O, 1:1).& 3 45; = &−209& 
(c 0.04, MeOH). IR (neat) ν = 3405, 2924, 1721, 1612, 1460, 1416, 1259, 801 cm-1. 
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1H NMR (400 MHz, CDCl3) δ = 12.30 (s, 1H), 5.30 (s, 1H), 3.82 (s, 3H), 3.35 (hept, 
J = 6.9 Hz), 3.34 (d, J = 14.0 Hz), 3.00 (dd, J = 18.4, 10.0 Hz, 2H), 2.66 (d, 
J = 18.4 Hz), 2.65 (d, J = 14.0 Hz), 1.88 (dt, J = 13.3, 3.7 Hz, 1H), 1.75 (s, 1H), 1.55 
(m, 4H), 1.41 (d, J = 10.1 Hz), 1.41 (d, J = 7.1 Hz, 3H), 1.38 (d, J = 7.1 Hz, 3H), 
1.14 (td, J = 13.5, 3.8 Hz, 1H), 1.00 (s, 3H), 0.85 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ = 210.8, 157.3, 150.7, 139.7, 127.6, 121.2, 116.9, 73.9, 62.1, 49.1, 40.8, 
40.7, 40.6, 38.6, 34.0, 32.3, 26.3, 21.6, 20.8, 20.5, 18.9. HRMS (ESI) m/z: calcd for 
C21H31O5 [M+H]+: 363.2166, found: 363.2166. All analytical data are in agreement 
with the litterature values: Frontana, B.; Cárdenas, J.; Rodríguez-Hahn, L. 
Phytochemistry 1994, 36, 739−741. 
 
Orthoquinone 3.106: 
To a solution of salvicanol (3.6, 15.0 mg, 45.1 µmol) in aqueous 
acetone (1.0 mL acetone/dist. water, 9/1) was added DDQ (31 mg, 
136.6 µmol). The red reaction mixture was stirred at rt for 10 min 
and then partitioned between Et2O (5 mL) and brine (10 mL). The aqueous phase was 
extracted with Et2O (3 x 5 mL). The combined organic phases were dried over 
Na2SO4 and all volatiles were evaporated under reduced pressure. The residue was 
passed quickly through a pad of SiO2 and the cake was washed with Et2O:pentane 
(10 mL, 1:1) to yield crude 3.106  (13.7 mg, 43.3 µmol, 96%) as a red amorphous 
solid. Rf = 0.50 (Et2O:pentane, 1:1). 1H NMR (400 MHz, CDCl3) δ = 6.59 (s, 1H), 
3.05 (d, J = 14.7 Hz, 1H), 2.92 (hept, J = 6.7 Hz, 1H), 2.63 (dd, J = 14.8, 11.5 Hz, 
1H), 2.47 (dd, J = 14.5, 7.3 Hz, 1H), 2.17 (d, J = 14.7 Hz, 1H), 1.91−1.83 (m, 1H), 
1.83−1.77 (m, 1H), 1.74−1.68 (m, 1H), 1.60−1.53 (m, 2H), 1.53−1.49 (m, 1H), 
1.44−1.39 (m, 1H), 1.42−1.39 (m, 1H), 1.29−1.25 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H), 
1.10 (d, J = 6.9 Hz, 3H), 0.92 (s, 3H), 0.91 (s, 3H). All analytical data are in 
agreement with the litterature values: Aoyagi, Y.; Takahashi, Y.; Fukaya, H.; Takeya, 
K.; Aiyama, R.; Matsuzaki, T.; Hashimoto, S.; Kurihara, T. Chem. Pharm. Bull. 2006, 
54, 1602−1604. 
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Przewalskin E (3.8) and brussonol (3.7): 
Method 1: close system 
A solution of 3.106 (13.7 mg, 
43.3 µmol) in Et2O (1.0 mL) was 
absorbed on silica gel (1.29 g). The 
powder mixture was left overnight at rt 
and purified by column chromatography on silica gel, using pentane:Et2O (1:1) as 
eluent to yield przewalskin E (3.8, 2.39 mg, 7.60 µmol, 18%) as a red amorphous 
solid and brusonnol (3.7, 2.83 mg, 8.94 µmol, 21%) as a brownish gum. 
Method 2: open system 
A solution of 3.106 (15 mg, 47.4 µmol) in Et2O (1.0 mL) was absorbed on silica gel 
(1.41 g). The powder mixture was left 12 h at rt in an opened round bottom flask with 
frequent mixing (every 4 h). The powder was then purified by column 
chromatography on silica gel, using pentane:Et2O (1:1) as eluent to yield 
przewalskin E (3.8, 7.48 mg, 23.8 µmol, 50%). 
Method 3: reduction 
To a solution of przewalskin E (3.8, 2.50 mg, 7.95 µmol) in Et2O (5.0 mL) in a 
separating funnel was added a solution of Na2S2O4 (10% aq., 5.0 mL) and the mixture 
was shaken until the bright orange solution became slightly yellow. The reaction was 
followed by TLC. The organic phase was then separated from the aqueous phase, 
dried over Na2SO4 and all volatiles were removed under reduced pressure. The 
residue was then purified by column chromatographie using Et2O:pentane (1:1) as 
eluent to yield pure brussonol (3.7, 2.36 mg, 7.47 µmol, 94%). 
 
Przewalskin E (3.8): Rf = 0.54 (Et2O:pentane, 1:1). & 3 45; = &−85.9&  (c 0.097, 
CHCl3). IR (neat) ν = 2949, 1660, 1462, 1396, 1045 cm-1. 1H NMR (500 MHz, 
CDCl3) δ = 6.46 (s, 1H), 4.48 (d, J = 6.9 Hz, 1H), 2.95 (hept, J = 6.9 Hz, 1H), 2.49 
(d, J = 18.6 Hz, 1H), 2.18 (d, J = 18.8 Hz, 1H), 2.15−2.09 (m, 1H), 2.05 (ddd, 
J = 12.6, 8.4, 1.2 Hz, 1H), 2.00−1.92 (m, 1H), 1.82−1.72 (m, 3H), 1.66−1.57 (m, 1H), 
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1.52−1.46 (m, 1H), 1.19−1.13 (m, 1H), 1.11 (dd, J = 6.9, 2.2 Hz, 6H), 0.97 (s, 3H), 
0.85 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 180.7, 179.9, 153.1, 148.1, 132.0, 
129.6, 80.5, 75.1, 51.7, 38.3, 38.0, 32.2, 31.8, 30.5, 30.0, 27.4, 26.9, 21.7, 21.7, 16.0. 
HRMS (ESI) m/z: calcd for C20H26O3Na1 [M+Na]+: 337.1774, found: 337.1776. 
All analytical data are in agreement with the litterature values: Aoyagi, Y.; Takahashi, 
Y.; Fukaya, H.; Takeya, K.; Aiyama, R.; Matsuzaki, T.; Hashimoto, S.; Kurihara, T. 
Chem. Pharm. Bull. 2006, 54, 1602−1604. 
 
Brussonol (3.7): Rf = 0.29 (Et2O:pentane, 1:1).& 3 45; = &−54.3& (c 0.14, CHCl3). IR 
(neat) ν = 3365, 2956, 2922, 1458, 1364 cm-1. 1H NMR (400 MHz, CDCl3) δ = 6.45 
(s, 1H), 4.97 (s, 2H), 4.85 (d, J = 6.6 Hz, 1H), 3.11 (hept, J = 7.0 Hz, 1H), 2.74 (d, 
J = 16.2 Hz, 1H), 2.39 (d, J = 16.2 Hz, 1H), 2.12 (dt, J = 11.9, 6.8 Hz, 1H), 2.01 (dt, 
J = 10.5, 3.6 Hz, 1H), 1.89 (ddd, J = 12.0, 8.3, 1.0 Hz, 1H), 1.84−1.75 (m, 3H), 
1.65−1.59 (m, 1H), 1.54−1.47 (m, 1H), 1.24 (d, J = 3.5 Hz, 3H), 1.22 (d, J = 3.6 Hz, 
3H), 0.96 (s, 3H), 0.84 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 141.6, 139.5, 134.5, 
132.0, 116.6, 112.9, 80.1, 76.3, 51.3, 39.9, 38.9, 32.4, 32.0, 30.9, 30.8, 27.3, 26.8, 
22.9, 22.7, 16.3. HRMS (ESI) m/z: calcd for C20H27O3 [M-H]−: 315.1966, found: 
315.1970. All analytical data are in agreement with the litterature values: Aoyagi, Y.; 
Takahashi, Y.; Fukaya, H.; Takeya, K.; Aiyama, R.; Matsuzaki, T.; Hashimoto, S.; 
Kurihara, T. Chem. Pharm. Bull. 2006, 54, 1602−1604. 
 
Obtusinone D (R3.124) and obtusinone E (R3.125): 
 
 Neat Przewalskin E (3.8) (7.01 mg, 22.3 µmol) 
was heated up in a conical vial at 100 °C for 6 h. 
The reaction mixture was purified by preparative 
TLC on silica gel, using pentane:toluene:Et2O 
(5:5:1) as eluent. Pure obtusinone D (R3.124, 
3.02 mg, 4.80 µmol, 43%) as light yellow 
crystalline solid, obtusinone E (R3.125, 1.80 mg, 
2.86 µmol, 26%) as a light yellow oil and starting 
material (3.8, 750 µg, 2.38 µmol, 11%) were 
obtained. 
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Obtusinone D (R3.124): Rf = 0.45 (pentane:toluene:Et2O, 5:5:1). 
mp = 221.0 °C (dec.). & 3 45; = &−292&  (c 0.14, CHCl3). IR (neat) ν = 2923, 1683, 
1449, 1367, 1043, 726 cm-1. 1H NMR (500 MHz, CDCl3) δ = 6.45 (s, 1H), 4.83 (d, 
J = 6.6 Hz, 1H), 4.77 (d, J = 6.9 Hz, 1H), 4.49 (s, 1H), 3.13 (hept, J = 6.9 Hz, 1H), 
2.76 (d, J = 17.1 Hz, 1H), 2.59 (d, J = 18.3, 1H), 2.58 (d, J = 17.1, 1H), 2.32−1.75 
(m, 12H), 1.70−1.47 (m, 5H), 1.23−1.15 (m, 2H), 1.12 (d, J = 6.9, 3H), 1.11 (d, 
J = 6.9, 3H), 1.07 (d, J = 6.7 Hz, 3H), 1.02 (s, 3H), 1.01 (d, J = 6.9 Hz, 3H), 0.99 (s, 
3H), 0.88 (s, 3H), 0.86 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 191.9, 185.9, 158.4, 
139.8, 138.4, 136.6, 135.7, 134.4, 118.8, 113.3, 86.5, 80.3, 80.2, 76.1, 74.1, 73.0, 
51.7, 51.2, 39.6, 38.8, 38.6, 37.9, 32.7, 32.2, 32.1, 31.3, 31.2, 31.1, 30.8, 30.4, 29.7, 
27.1, 26.7, 26.6, 23.4, 22.5, 17.1, 16.5, 16.3, 15.9. HRMS (ESI) m/z: calcd for 
C40H52O6Na1 [M+Na]+: 651.3656, found: 651.3657. All analytical data are in 
agreement with the litterature values: Sanae, A.-W.; Boonnak, N. Tetrahedron Lett. 
2013, 54, 1356−1359. 
 
Obtusinone E (R3.125): Rf = 0.27 (pentane:toluene:Et2O, 5:5:1). & 3 45; =−&283& (c 0.080, CHCl3). IR (neat) ν = 2920, 2851, 1741, 1684, 1443, 1044, 726 cm-
1. 1H NMR (400 MHz, CDCl3) δ = 6.55 (s, 1H), 4.83 (d, J = 6.4 Hz, 1H), 4.80 (d, 
J = 6.9 Hz, 1H), 4.62 (s, 1H), 3.28 (hept, J = 6.7 Hz, 1H), 2.62 (d, J = 17.2 Hz, 1H), 
2.59 (d, J = 18.4 Hz, 1H), 2.34−2.16 (m, 3H), 2.12−1.98 (m, 4H), 1.95−1.73 (m, 5H) 
1.68−1.61 (m, 1H), 1.54−1.47 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H), 1.28 (d, J = 6.9 Hz, 
3H), 1.12 (d, J = 6.6 Hz, 3H), 1.02 (s, 3H), 1.01 (d, J = 6.6 Hz, 3H), 0.96 (s, 3H), 
0.89 (s, 3H), 0.81 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 191.3, 185.6, 158.2, 
139.9, 137.7, 135.9, 134.4, 134.2, 118.9, 115.0, 86.2, 80.4, 80.0, 75.9, 74.0, 72.6, 
51.8, 50.9, 40.3, 39.1, 38.6, 37.9, 32.2, 32.0, 31.5, 31.5, 31.1, 30.6, 30.4, 30.1, 29.8, 
27.7, 27.3, 27.1, 22.6, 22.3, 17.1, 16.2, 16.1, 15.9. HRMS (ESI) m/z: calcd for 
C40H52O6Na1+ [M+Na]+:651.3656, found: 651.3656. All analytical data are in 
agreement with the litterature values: Sanae, A.-W.; Boonnak, N. Tetrahedron Lett. 
2013, 54, 1356−1359.  
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Methylpisiferanol (3.4) and 3.124: 
 
 To a solution of 3.84 (51 mg, 161 µmol) in 
THF (10 mL) was added MsCl (170 µL,  
2.20 mmol) in one portion at −10 °C, 
followed by a dropwise addition of Et3N (300 
µL, 2.18 mmol). The white milky mixture was stirred at this temperature for 20 min. 
(the mesylation could be followed by TLC) before distilled H2O (8 mL) was added 
and the resulting clear solution was stirred at 40 °C overnight. The reaction mixture 
was then diluted with Et2O (200 mL) and distilled H2O (200 mL) was added. The 
aqueous phase was extracted with Et2O (3 x 100 mL). The combined organic phases 
were dried over Na2SO4. All volatiles were evaporated under reduced pressure. The 
residue was purified by column chromatography on silica gel, using a mixture of 
pentane:Et2O (20:1) as eluent to afford a mixture of alkenes 3.126 as a colourless oil 
(30 mg, 102 µmol, 62%) and methylpisiferanol (3.4, 15 mg, 47.4 µmol, 29%) as a 
thick oil. 
 
3.126 : Rf = 0.85 (Et2O:pentane, 2:5). 
 
3.4: Rf = 0.69 (Et2O:pentane, 2:5). 3 45; = &+13.0 (c 0.47, MeOH). 1H NMR (400 
MHz, CDCl3) δ 6.93 (s, 1H), 6.61 (s, 1H), 3.78 (s, 3H), 3.25 (hept, J = 7.0 Hz, 1H), 
3.01 (d, J = 13.9 Hz, 1H), 2.79−2.73 (m, 1H), 2.71−2.63 (m, 1H), 2.54 (d, 
J = 13.9 Hz, 1H), 2.01−1.95 (m, 1H), 1.91−1.74 (m, 2H), 1.54−1.38 (m, 4H), 1.31 
(td, J = 12.0, 2.9 Hz, 3H), 1.27−1.23 (m, 2H), 1.21 (d, J = 6.9 Hz, 3H), 1.17 (d, 
J = 6.9 Hz, 3H), 1.14 (d, J = 1.9 Hz, 1H), 0.92 (s, 3H), 0.88 (s, 3H). HRMS (ESI) 
m/z: calcd for C21H32O2Na1 [M+Na]+: 339.2293, found: 339.2295. All analytical data 
are in agreement with the litterature values: Lin, T.-C.; Fang, J.-M.; Cheng, Y. S. 
Phytochemistry 1999, 51, 793−791. 
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Pisiferanol (3.2): 
 
To a solution of EtSH (44.5 µL, 51.7 mg, 832 µmol) in DMF 
(0.5 mL) was added NaH (60% in mineral oil, 23.6 mg, 354 µmol) 
and the resulting mixture was stirred at rt for 30 min. To this 
mixture was added a solution of 3.4 (9.5 mg, 30.0 µmol) in DMF (0.5 mL) at rt. The 
reaction mixture was stirred for 12 h at 140 °C. The reaction mixture was then diluted 
with Et2O (5 mL) and a saturated aqueous solution of NH4Cl (5 mL) was added. The 
aqueous phase was extracted with Et2O (3 x 4 mL). The combined organic phases 
were dried over Na2SO4. All volatiles were evaporated under reduced pressure. The 
residue was purified by column chromatography on silica gel using a mixture of 
pentane:Et2O (5:2) as eluent to afford pisiferanol (3.2, 8.82 mg, 29.2 µmol, 97%) as a 
colorless oil. Rf = 0.20 (Et2O:pentane, 5:2). 3 45; = &+23.2 (c 0.38, MeOH). IR (neat) 
ν  = 3549, 3319, 2928, 2869, 1615, 1438, 1265, 733 cm-1. 1H NMR (400 MHz, 
CDCl3) δ = 6.92 (s, 1H), 6.74 (s, 1H), 6.57 (s, 1H), 3.20 (hept, J = 7.0 Hz, 1H), 3.05 
(d, J = 13.9 Hz, 1H), 2.82−2.63 (m, 2H), 2.61 (d, J = 14.1 Hz, 1H), 2.07−1.97 (m, 
1H), 1.94−1.80 (m, 2H), 1.60−1.51 (m, 1H), 1.45 (dd, J = 13.6, 5.0, 2.8 Hz, 2H), 1.35 
(dd, J = 12.3, 2.5 Hz, 1H), 1.32−1.24 (m, 1H), 1.23 (s, 3H), 1.20 (s, 3H), 0.94 (s, 3H), 
0.91 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 151.9, 135.6, 133.4, 133.3, 126.7, 
118.9, 71.9, 58.1, 51.1, 42.5, 41.9, 35.5, 34.5, 32.4, 26.7, 24.5, 23.0, 22.7, 21.8, 18.8. 
HRMS (ESI) m/z: calcd for C20H30O2Na1 [M+Na]+: 325.2138, found: 325.2139. 
 
Euolutchuol E (3.3): 
 
To a solution of 3.2 (1.80 mg, 5.95 µmol) in dioxane (0.6 mL) 
was added a solution of DDQ (3.00 mg, 13.2 µmol) and the 
resulting mixture was stirred overnight at rt. The reaction mixture 
was then diluted with Et2O and brine. The aqueous phase was extracted with Et2O 
(3 x 5 mL). The combined organic phases were washed with brine and dried over 
Na2SO4. All volatiles were removed under reduced pressure. The residue was purified 
by pTLC on silica gel, using a mixture of pentane:Et2O (5:2) as eluent to afford 3.3 as 
OH
H
OH
OH
H
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a white amorphous solid (0.80 mg, 2.66 µmol, 45%) and starting material (0.30 mg, 
0.99 µmol, 17%). Rf = 0.53 (Et2O:pentane, 3:4). 3 45; = &−36.5 (c 0.040, MeOH). IR 
(neat) ν = 3321, 2952, 2922, 2853, 1433, 1323, 1234 cm-1. 1H NMR (600 MHz, 
CDCl3) δ = 6.81 (s, 1H), 6.45 (s, 1H), 4.87 (d, J = 6.6 Hz, 1H), 4.52 (s, 1H), 3.13 
(hept, J = 6.9 Hz, 1H), 2.87 (d, J = 16.4 Hz, 1H), 2.43 (d, J = 16.4 Hz, 1H), 2.11 (dt, 
J = 11.7, 6.8 Hz, 2H), 1.96 (td, J =7.0, 4.0 Hz, 1H) 1.89 (dd, J = 11.5, 8.6 Hz, 1H), 
1.83−1.72 (m, 3H), 1.63−1.56 (m, 1H), 1.52−1.47 (m, 1H), 1.24 (d, J = 6.9 Hz, 3H), 
1.22 (d, J = 6.9 Hz, 3H), 1.19−1.11 (m, 1H), 0.96 (s, 3H), 0.83 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ = 151.6, 134.5, 131.7, 131.6, 121.8, 115.6, 80.4, 76.1, 50.7, 
43.9, 40.1, 32.0, 32.0, 30.7, 30.5, 27.1, 27.0, 23.0, 22.7, 16.2. HRMS (ESI) m/z: calcd 
for C20H28O2Na1 [M+Na]+: 323.1982, found: 323.1983. All analytical data are in 
agreement with the litterature values: Inaba, Y.; Hasuda, T.; Hitotsuyanagi, Y.; 
Aoyagi, Y.; Fujikawa, N.; Onozaki, A.; Watanabe, A.; Kinoshita, T.; Takeya, K. J. 
Nat. Prod. 2013, 76, 1085−1090. 
 
6.4.!Synthesis of model systems 
 
Aryl 4.34: 
 
To a solution of benzylic alcohol 4.30 (230 mg, 959 µmol) in MeOH 
(7.0 mL), was added Pd(OH)2/C (10% on C, 46.1 mg, 32.8 µmol, 3.4 
mol%) under an argon atmosphere. The reaction mixture was placed in 
an autoclave and flushed with H2 (3 x) and finally stirred for 2 h at rt under a pressure 
of H2 (80 bar). The reaction mixture was put back in an atmosphere of argon and 
filtered through a pad of celite. The cake was washed with MeOH (3 x 5 mL) and the 
filtrate was evaporated under reduced pressure. The residue was dissolved in Et2O (10 
mL) and dried over Na2SO4. The volatiles were removed under reduced pressure to 
yield 4.34 as a colorless oil (211.4 mg, 942 µmol, 98%), which was used without 
further purification. Rf = 0.52 (Et2O:pentane, 1:10). 1H NMR (500 MHz, CDCl3) 
δ = 6.42 (d, J = 0.7 Hz, 1H), 3.82 (s, 3H), 3.77 (s, 3H), 3.76 (s, 3H), 3.47 (p, J = 7.1 
Hz, 1H), 2.24 (d, J = 0.7 Hz, 3H), 1.29 (d, J = 7.1 Hz, 6H). All analytical data are in 
agreement with the litterature values: Maier, M. E.; Bayer, A. Eur. J. Org. Chem. 
2006, 4034−4043. 
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Nitrile 4.36:184 
 
To a solution of 4.34 (271 mg, 1.21 mmol) in dry CH2Cl2 was added 
MOMCl (184 µL, 2.42 mmol) at −10°C, followed by a slow addition of 
SnCl4 (142 µL, 1.21 mmol). The reaction mixture was warmed up to rt 
and stirred for 3 h. The reaction mixture was poured into ice-water (15 mL) and 
CH2Cl2 (10 mL) was added. The aqueous phase was extracted with CH2Cl2 
(3 x 5 mL). The combined organic phases were washed with water (15 mL) and dried 
over Na2SO4. All volatiles were removed under reduced pressure. The residue (329 
mg) was dissoled in DMSO (5 mL) and KCN (130 mg, 2.0 mmol) was added at rt and 
the reaction mixture was stirred 12 h. The reaction mixture was then diluted with Et2O 
(15 mL) and water (10 mL). The aqueous phase was extracted with Et2O (3 x 10 mL). 
The combined organic phases were dried over Na2SO4. All volatiles were removed 
under reduced pressure. The residue was purified by column chromatography on 
silica gel, using a mixture of pentane:Et2O (6:1) as eluent to afford 4.36 as a colorless 
crystalline solid (309 mg, 1.17 mmol, 97% over two steps). Rf = 0.52 (Et2O:pentane, 
1:2). mp = 61.2−62.0 °C. IR (neat) ν  = 2957, 2360, 1457, 1410, 1342, 1070, 788 
cm-1. 1H NMR (500 MHz, CDCl3) δ = 3.88 (s, 3H), 3.76 (s, 3H), 3.75 (s, 3H), 3.67 (s, 
2H), 3.36 (hept, J = 7.1 Hz, 1H), 2.28 (s, 3H), 1.33 (d, J = 7.1 Hz, 6H). 13C NMR 
(126 MHz, CDCl3) δ = 153.4, 152.2, 148.8, 133.1, 129.6, 118.4, 118.2, 62.6, 60.5, 
60.1, 26.27, 22.1, 22.1, 15.5, 12.2. HRMS (ESI) m/z: calcd for C15H21N1O3Na1 
[M+Na]+: 286.1414, found: 286.1416. 
 
Carboxylic acid 4.37: 
 
To a suspension of 4.36 (200 mg, 759 µmol) in H2O (2.0 mL), was 
added NaOH (63.0 mg, 1.57 mmol) and the resulting suspension 
was heated up to 115 °C in a sealed tube for 24 h. The resulting 
solution was diluted with H2O (5 mL) and Et2O (5 mL). The aqueous phase was 
acidified with an aqueous solution of H2SO4 (10%, 5 mL) and then extracted with 
                                               
184  A single crystal suitable for X-ray crystallography was obtained from 
crystalization from Et2O. 
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Et2O (3 x 5 mL). The combined organic phases were washed with brine and dried 
over Na2SO4. All volatiles were removed under reduced pressure. The residue was 
purified by column chromatography on silica gel, using a mixture of CH2Cl2:MeOH 
(20:1) as eluent to afford 4.37 as a colorless crystalline solid (214 mg, 758 µmol, 
99%). Rf = 0.10 (Et2O:pentane, 1:1). mp = 103.4−105.5 °C. IR (neat) ν  = 3672, 
2973, 1710, 1454, 1409, 1250, 1070 cm-1. 1H NMR (400 MHz, CDCl3) δ = 3.88 (s, 
3H), 3.75 (s, 3H), 3.72 (s, 2H), 3.68 (s, 3H), 3.36 (hept, J = 7.1 Hz, 1H), 2.17 (s, 3H), 
1.33 (d, J = 7.1 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ = 177.1, 152.6, 152.5, 148.6, 
132.5, 129.9, 121.6, 62.3, 60.4, 60.0, 32.9, 26.3, 22.2, 22.2, 12.3. HRMS (ESI) m/z: 
calcd for C15H22O5Na1 [M+Na]+: 305.1359, found: 305.1362. 
 
Compound 4.33: 
 
To a solution of LAH (138 mg, 3.64 mmol) in dry Et2O (2.0 mL) 
was added dropwise a suspension of 4.37 (206 mg, 730 µmol) in 
dry Et2O (2.0 mL) under argon at 0 °C and the resulting mixture 
was brought to rt and stirred for 3 h. The reaction mixture was then diluted with Et2O 
(10 mL), cooled down to 0 °C and an aqueous H2SO4 solution (10%, 10 mL) was 
added dropwise until no more H2 evolution was observed (pH~1) with a continuous 
flow of N2. Water was then added (10 mL) and the aqueous phase was extracted with 
Et2O (3 x 5 mL). The combined organic phases were washed with brine (10 mL) and 
dried over Na2SO4. All volatiles were evaporated under reduced pressure to afford 
pure 4.33 as a white solid (193 mg, 719 µmol, 98% . Rf = 0.37 (Et2O:pentane, 1:1). 
mp = 62.0−63.2 °C. IR (neat) ν  = 3375, 2934, 1454, 1408, 1343, 1121, 633 cm-1. 1H 
NMR (400 MHz, CDCl3) δ = 3.87 (s, 3H), 3.78−3.74 (m, 5H), 3.69 (s, 3H), 3.34 
(hept, J = 7.1 Hz, 1H), 2.90 (t, J = 6.7 Hz, 2H), 2.20 (s, 3H), 1.34 (d, J = 7.1 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ = 152.5, 151.8, 148.8, 132.4, 129.2, 125.7, 63.0, 62.0, 
60.4, 59.9, 30.7, 26.3, 22.3, 22.3, 12.1. HRMS (ESI) m/z: calcd for C15H24O4Na1 
[M+Na]+: 291.1567, found: 291.1571. 
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Aldehyde 4.32:185 
 
To a solution of 4.33 (105 mg, 391 µmol) in CH2Cl2 (4.6 mL) was 
added DMP (359 mg, 846 µmol) at 0 °C and the reaction mixture was 
warmed up to rt and stirred over 2 h. The reaction mixture was then 
diluted with H2O (10 mL) and Et2O (10 mL). The aqueous phase was extracted with 
Et2O (3 x 5 mL) and the combined organic phases were washed with brine (10 mL), 
dried over Na2SO4 and concentrated under reduced pressure. The residue was purified 
by column chromatography on silica gel (pentane: Et2O, 10:1) to give aldehyde 4.32 
as a colorless crystalline solid (88.5 mg, 332 µmol, 85%). Rf = 0.52 (Et2O:pentane, 
1:2). IR (neat) ν  = 2936, 1724, 1455, 1409, 1342, 1245, 1121, 1077, 1014, 632 
cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.69 (t, J = 2.0 Hz, 1H), 3.89 (s, 3H), 3.76 (s, 
3H), 3.69 (d, J = 2.1 Hz, 2H), 3.60 (s, 3H), 3.37 (hept, J = 7.1 Hz, 1H), 2.12 (s, 3H), 
1.34 (d, J = 7.1 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ = 199.9, 152.8, 152.6, 148.7, 
132.7, 129.8, 120.5, 61.8, 60.4, 60.0, 42.9, 26.2, 22.2, 22.2, 12.6. HRMS (ESI) m/z: 
calcd for C15H22O4Na1 [M+Na]+: 289.1410, found: 289.1412. 
 
Aldehyde 4.41: 
 
To a solution of 4.39 (500 mg, 2.38 mmol) in dry CH2Cl2 (13 mL) 
was added TiCl4 (1 M in CH2Cl2, 12 mL, 12 mmol) followed by 1,1-
dichlorodimethyl ether (430 µL, 4.75 mmol) at −10 °C. The reaction 
mixture was stirred for 30 min at -10 °C and 1.5 h at rt. The mixture was slowly 
poured slowly onto ice-water (20 mL), Et2O was added (20 mL). The aqueous phase 
was extracted with Et2O (2 x 15 mL) and the combined organic phases were washed 
with water (50 mL), saturated aqueous solution of NaHCO3 (50 mL) and brine (50 
mL) and dried over Na2SO4. The volatiles were removed under reduced pressure. The 
residue was purified by column chromatography (silica gel, pentane:Et2O, 10:1) to 
afford the aldehyde 4.41 as orange oil (546 mg, 2.29 mmol, 96 %). Rf = 0.64 
(Et2O:pentane, 1:1). 1H NMR (400 MHz, CDCl3) δ = 10.27 (s, 1H), 7.24 (s, 1H), 3.93 
(s, 3H), 3.87 (s, 3H), 3.84 (s, 3H), 3.45 (hept, 1H, J =8.0 Hz), 1.35 (d, 6H, J  = 8.0 
                                               
185  A single crystal suitable for X-ray crystallography was obtained from 
crystalization from Et2O. 
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Hz). All analytical data are in agreement with the litterature values: Majetich, G.; 
Zhang, Y.; Tian, X.; Britton, J. E.; Li, Y.; Philipps, R. Tetrahedron, 2011, 67, 
10129−10146. 
 
Compound 4.42 
 
To a solution a 4.41 (310 mg, 1.30 mmol) in MeOH (9.5 mL), was 
added Pd(OH)2/C (10% on C, 62.1 mg, 44.2 µmol, 3.4 mol%) under an 
argon atmosphere. The reaction mixture was placed in an autoclave and 
flushed with H2 (3 x) and finally stirred for 24 h at rt under a pressure of H2 (80 bar). 
The reaction mixture was put back in an atmosphere of argon and filtered through a 
pad of celite. The cake was washed with MeOH (3 x 5 mL) and the filtrate was 
evaporated under reduced pressure. The residue was dissolved in Et2O (10 mL) and 
dried over Na2SO4. The volatiles were removed under reduced pressure to yield 4.42 
as a colorless oil (224 mg, 1.00 mmol, 77%), which was used without further 
purification. Rf = 0.74 (Et2O:pentane, 1:10). IR (neat) ν  = 2949, 1430, 1337, 1480, 
1230, 1116, 1042, 845, 640 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.57 (s, 1H), 3.82 
(s, 6H), 3.67 (s, 3H), 3.43 (hept, J = 8.0 Hz, 1H), 2.25 (s, 3H), 1.34 (d, J = 8.0 Hz, 
6H). 13C NMR (101 MHz, CDCl3) δ = 150.2, 149.4, 146.7, 135.0, 125.8, 112.2 61.2, 
60.9, 56.0, 26.1, 22.2, 22.2, 16.6. HRMS (ESI) m/z: calcd for C13H21O3 [M+H]+: 
225.1485, found 225.1485. 
 
Aldehyde 4.43: 
 
To a solution of 4.42 (224 mg, 1.00 mmol) in dry CH2Cl2 (6 mL) 
was added TiCl4 (1 M in CH2Cl2, 4.8 mL, 4.8 mmol) followed by 
1,1-dichlorodimethyl ether (186 µL, 2.05 mmol) at −10 °C. The 
reaction mixture was stirred for 30 min at −10 °C and 3.5 h at rt. The mixture was 
slowly poured slowly onto ice-water (20 mL), Et2O was added (20 mL). The aqueous 
phase was extracted with Et2O (2 x 15 mL) and the combined organic phases were 
washed with water (50 mL), saturated aqueous solution of NaHCO3 (50 mL) and 
brine (50 mL) and dried over Na2SO4. The volatiles were removed under reduced 
pressure. The residue was purified by column chromatography (silica gel, 
pentane:Et2O, 20:1) to afford the aldehyde 4.43 as yellow oil (248 mg, 985 µmol, 98 
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%). Rf = 0.46 (Et2O:pentane, 1:5). IR (neat) ν  = 2949, 1690, 1574, 1457, 1420, 
1383, 1339, 1315, 1267, 1124, 1105, 1087, 1035, 1016, 989, 958, 769 cm−1. 1H NMR 
(400 MHz, CDCl3) δ = 10.48 (s, 1H), 3.89 (s, 6H), 3.66 (s, 3H), 3.49 (hept, J =7.5 Hz, 
1H), 2.46 (s, 3H), 1.35 (d, J =7.5 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ = 192.4, 
154.4, 153.2, 150.7, 142.6, 128.7, 127.2, 61.9, 61.5, 60.8, 26.7, 21.9, 21.9, 13.2. 
HRMS (ESI) m/z: calcd for C14H20O4Na1 [M+Na]+: 275.1254, found 275.1252. 
 
Compound 4.44: 
 
To a solution a 4.43 (500 mg, 1.98 mmol) in MeOH (15 mL), was 
added Pd(OH)2/C (10% on C, 100 mg, 71.2 µmol, 3.6 mol%) under an 
argon atmosphere. The reaction mixture was placed in an autoclave and 
flushed with H2 (3 x) and finally stirred for 18 h at rt under a pressure of H2 (80 bar). 
The reaction mixture was put back in an atmosphere of argon and filtered through a 
pad of celite. The cake was washed with MeOH (3 x 5 mL) and the filtrate was 
evaporated under reduced pressure. The residue was dissolved in Et2O (10 mL) and 
dried over Na2SO4. The volatiles were removed under reduced pressure. The residue 
was purified by column chromatography (silica gel, pentane:Et2O, 30:1) to yield 4.44 
as a white crystalline solid (224 mg, 1.00 mmol, 77%). Rf = 0.70 (Et2O:pentane, 1:3). 
mp = 35.3−35.8 °C. IR (neat) ν  = 2935, 1457, 1409, 1339, 1258, 1120, 1088, 1057, 
1017, 958, 631 cm−1. 1H NMR (400 MHz, CDCl3) δ = 3.86 (s, 3H), 3.75 (s, 3H), 3.65 
(s, 3H), 3.42 (hept, J =8.0 Hz, 1H), 2.15 (s, 6H), 1.33 (d, J =8.0 Hz, 6H). 13C NMR 
(101 MHz, CDCl3) δ = 152.3, 150.6, 148.2, 132.1, 129.1, 125.4, 61.4, 60.6, 60.1, 
26.0, 22.4, 22.4, 13.0, 12.4. HRMS (ESI) m/z: calcd for C14H22O3Na1 [M+Na]+: 
261.1461, found 261.1459. 
 
Quinone 4.38: 
 
To a solution of 4.44 (212 mg, 889 µmol) in dioxane (8.9 mL) was 
added AgO (1.25 g, 10.2 mmol) and the resulting suspension was 
sonicated for 1 min. An aqueous solution of HNO3 (6 M, 0.90 mL, 5.3 
mmol) was added and the reaction mixture was stirred at rt for 80 min in the dark. An 
additional amount of HNO3 (0.90 mL, 5.3 mmol, 6.0 eq.) was added and the reaction 
mixture was stirred for further 30 min. Et2O (20 mL) and water (20 mL) were added 
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to the mixture. The aqueous phase was extracted with Et2O (3 x 20 mL). The 
combined organic phases were dried over Na2SO4 and the volatiles were removed 
under reduced pressure. The residue was purified by column chromatography (silica 
gel, pentane:Et2O 30:1) to afford the quinone 4.38 as a intense yellow oil (119 mg, 
0.56 mmol, 62 %). Rf = 0.56 (Et2O:pentane, 1:10). IR (neat) ν  = 2932, 1657, 1459, 
1377, 1249, 1153, 1050, 650 cm−1. 1H NMR (400 MHz, CDCl3) δ = 3.93 (s, 3H), 
3.25 (hept, J =8.0 Hz, 1H), 2.00 (s, 6H), 1.21 (d, J =8.0 Hz, 6H). 13C NMR (101 
MHz, CDCl3) δ = 188.1, 184.2, 155.8, 141.1, 138.7, 137.7, 61.1, 24.9, 20.7, 20.7, 
12.7, 12.0. HRMS (ESI) m/z: calcd for C12H17O3 [M+H]+: 209.1174, found 209.1172. 
 
Methylenedioxy bridge 4.45: 
 
A solution of quinone 4.38 (10.5 mg, 50.4 µmol) in t-BuOH (10 mL) 
was irradiated with a medium pressure mercury lamp at rt for 45 min. 
The volatiles were removed under reduced pressure and the residue was 
purified by column chromatography (silica gel, pentane:Et2O, 10:1) to afford 
compound 4.45 as a yellow oil (4.94 mg, 23.7 µmol, 47.0 %). Rf = 0.25 (Et2O:pentane, 
1:10). IR (neat) ν  = 3487, 2962, 2361, 1428, 1260, 1085, 1028, 959, 880, 798, 660, 
614 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.83 (s, 2H), 4.30 (s, 1H), 3.23 (hept, 
J =7.0 Hz, 1H), 2.12 (s, 3H), 2.08 (s, 3H), 1.32 (d, J =7.0 Hz, 6H). 13C NMR (101 
MHz, CDCl3) δ = 145.6, 143.0, 140.1, 115.7, 115.3, 114.3, 100.0, 25.7, 21.4, 21.4, 
12.3, 11.7. HRMS (EI) m/z: calcd for C12H16O3 [M]+: 208.10940, found 208.10938. 
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7.!Appendices 
 
7.1.!1H and 13C NMR spectra 
 
7.1.1.! Taiwaniaquinoids 
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7.1.2.! Icetexanes 
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7.2.!Crystal structures 
 
 
X-ray: Crystal data for 2.80 (CCDC 923474) 
Formula C21H28N2O2 
 
Formula weight                    340.47 
Z, calculated density                        2, 1.236 Mg · m-3 
F(000) 368 
Description and size of crystal         colourless plate, 0.020 · 0.210 · 0.290 
mm3 
Absorption coefficient                     0.079 mm-1 
Min/max transmission                     0.98 / 1.00 
Temperature                                     123K 
Radiation (wavelength)                   Mo Kα (λ = 0.71073 Å) 
Crystal system, space group            monoclinic, P 21 
a 8.2832(8) 
b 9.5668(10) Å 
c 12.0181(13) Å 
β 90° 
α 106.113(6)° 
γ 90° 
V 914.67(17) Å3 
min/max Θ  2.765° / 36.373° 
number of collected reflections       32024 
number of independent refections 4635 (merging r = 0.056) 
!Chapter 7 194 
number of observed reflections 3262 (I>2.0σ(I)) 
number of refined parameters  226 
r  0.0488 
rW 0.0932 
goodness of fit 1.0812 
 
 
X-ray: Crystal data for 2.81 (CCDC 923475) 
Formula C22H32O3 
 
Formula weight                    344.49 
 
Z, calculated density                        2, 1.174 Mg · m-3 
F(000) 376 
Description and size of crystal         colourless plate, 0.030 · 0.170 · 0.220 
mm3 
Absorption coefficient                     0.076 mm-1 
Min/max transmission                     0.99 / 1.00 
Temperature                                     123K 
Radiation (wavelength)                   Mo Kα (λ = 0.71073 Å) 
Crystal system, space group            monoclinic, P 1 
a 8.6948(3) 
b 11.5644(4) Å 
c 11.6368(4) Å 
β 61.764(2)° 
α 79.806(2)° 
γ 71.019(2)° 
V 974.42(6) Å3 
Appendices! 195 
min/max Θ  1.987° / 30.092° 
number of collected reflections       16556 
number of independent refections 5626 (merging r = 0.069) 
number of observed reflections 4610 (I>2.0σ(I)) 
number of refined parameters 451 
r  0.0421 
rW 0.0663 
goodness of fit 1.1386 
 
 
X-ray: Crystal data for 2.83 (CCDC 923476) 
Formula C21H30O3 
 
Formula weight                    330.47 
 
Z, calculated density                        4, 1.088 Mg · m-3 
F(000) 720 
Description and size of crystal         colourless plate, 0.030 · 0.110 · 0.250 
mm3 
Absorption coefficient                     0.071 mm-1 
Min/max transmission                     0.99 / 1.00 
Temperature                                     123K 
Radiation (wavelength)                   Mo Kα (λ = 0.71073 Å) 
Crystal system, space group            monoclinic, P 21 
a 6.7983(6) 
b 24.649(2) Å 
!Chapter 7 196 
c 12.2575(11) Å 
β 90° 
α 100.838(6)° 
γ 90° 
V 2017.3(3) Å3 
min/max Θ  1.692° / 30.174° 
number of collected reflections       17151 
number of independent refections 5955 (merging r = 0.072) 
number of observed reflections 4221 (I>2.0σ(I)) 
number of refined parameters 433 
r  0.0699 
rW 0.0866 
goodness of fit 1.0975 
 
  
X-ray. Crystal data for 4.36 
Formula C15H21N1O3 
 
Formula weight                    263.34 
Z, calculated density                        2, 1.185 Mg · m-3 
F(000) 284 
Description and size of crystal         colourless plate, 0.020 · 0.090 · 0.190 
mm3 
Absorption coefficient                     0.082 mm-1 
Min/max transmission                     0.99 / 1.00 
Temperature                                     123K 
OMe
OMe
OMe
CN
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Radiation (wavelength)                   Mo Kα (λ = 0.71073 Å) 
Crystal system, space group            triclinic, P −1 
a 8.8272(8) 
b 9.6685(9) Å 
c 10.0078(10) Å 
β 78.281(6)° 
α 67.452(6)° 
γ 90° 
V 737.85(13) Å3 
min/max Θ  2.176° / 28.276° 
number of collected reflections       12357 
number of independent refections 3643 (merging r = 0.027) 
number of observed reflections 2290 (I>2.0σ(I)) 
number of refined parameters 172 
r  0.0409 
rW 0.0841 
goodness of fit 1.1034 
 
 
X-ray. Crystal data for 4.32 
Formula C15H22O4 
 
Formula weight                    266.34 
Z, calculated density                        16, 1.215 Mg · m-3 
F(000) 2304 
OMe
OMe
OMe
CHO
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Description and size of crystal         colourless plate, 0.040 · 0.060 · 0.210 
mm3 
Absorption coefficient                     0.087 mm-1 
Min/max transmission                     0.99 / 1.00 
Temperature                                     123K 
Radiation (wavelength)                   Mo Kα (λ = 0.71073 Å) 
Crystal system, space group            orthorhombic, F d d 2 
a 17.2182(17) 
b 58.441(6) Å 
c 5.7859(6) Å 
β 90(6)° 
α 90° 
γ 90° 
V 5822.1(10) Å3 
min/max Θ  2.466° / 28.323° 
number of collected reflections       20964 
number of independent refections 1979 (merging r = 0.059) 
number of observed reflections 1974 (I>2.0σ(I)) 
number of refined parameters 191 
r  0.0368 
rW 0.0970 
goodness of fit 0.8900 
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X-ray. Crystal data for R3.124 
Formula C40H52O6 
 
Formula weight                    628.85 
Z, calculated density                        4, 1.219 Mg · m-3 
F(000) 1359.987 
Description and size of crystal         yellow needle, 0.040 · 0.050 · 0.160 mm3 
Absorption coefficient                     0.637 mm-1 
Min/max transmission                     0.97 / 0.97 
Temperature                                     123K 
Radiation (wavelength)                   Cu Kα (λ = 1.54178 Å) 
Crystal system, space group            orthorhombic, P 21 21 21 
a 11.6660(9) Å 
b 12.2902(9) Å 
c 23.9003(17) Å 
β 90° 
α 90° 
γ 90° 
V 3426.8(2) Å3 
min/max Θ  3.699° / 69.119° 
number of collected reflections       88204 
number of independent refections 6347 (merging r = 0.036) 
number of observed reflections 6227 (I>2.0σ(I)) 
number of refined parameters 438 
O
H
O
O
H O
O HO
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r  0.0267 
rW 0.0294 
goodness of fit 1.1150 
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